Auger-Electron Literature 1925–2007
2007
Breeman WA, Kwekkeboom DJ, de Blois E, de Jong M,
Visser TJ, Krenning EP. 2007. Radiolabelled
regulatory peptides for imaging and therapy. Anticancer Agents Med Chem. 7,
345–357.
Chen
L, Jiang SP, Wan LB, Ma XD, Li MF. 2007. Radiobiological investigations of soft
X-rays near carbon, nitrogen, oxygen K-shell edges on Aspergillus oryzae spores. Radiat Prot Dosimetry. Advance access 2
June.
Cornelissen
B, Hu M, McLarty K, Costantini D, Reilly RM. 2007. Cellular penetration and
nuclear importation properties of 111In-labeled and 123I-labeled
HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells. Nucl Med Biol.
34, 37–46.
Costantini
DL, Chen C, Cai Z, Vallis KA, Reilly RM. 2007. 111In-labeled trastuzumab (herceptin) modified with nuclear localization
sequences (NLS): an Auger electron-emitting radiotherapeutic agent for
HER2/neu-amplified breast cancer. J Nucl Med. 48, 1357–1368.
Datta
K, Weinfeld M, Neumann RD, Winters TA. 2007. Determination and analysis of
site-specific 125I decay-induced DNA double-strand break end-group
structures. Radiat Res. 167, 152–166.
Emfietzoglou
D, Nikjoo H. 2007. Accurate electron inelastic cross sections and stopping
powers for liquid water over the 0.1–10 keV range based on an improved
dielectric description of the Bethe surface. Radiat Res. 167, 110–120.
Foss
CA, Fox JJ, Feldmann G, Maitra A, Iacobuzio-Donohue C, Kern SE, Hruban R, Pomper
MG. 2007. Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen:
initial imaging in experimental models of pancreatic cancer. Mol Imaging. 6,
131–139.
Hikosaka
Y, Lablanquie P, Penent F, Kaneyasu T, Shigemasa E, Eland JHD, Aoto T, Ito K.
2007. Double photoionization into double core-hole states in Xe. Phys Rev Lett.
98, 183002.
Hu M, Chen P, Wang J, Scollard DA, Vallis KA,
Reilly RM. 2007. 123I-labeled HIV-1 tat peptide
radioimmunoconjugates are imported into the nucleus of human breast cancer
cells and functionally interact in vitro and in vivo with the cyclin-dependent
kinase inhibitor, p21WAF-1/Cip-1. Eur J Nucl Med Mol Imaging. 34,
368–377.
Konijnenberg M, Melis M, Valkema R, Krenning
E, de Jong M. 2007. Radiation
dose distribution in human kidneys by octreotides in peptide receptor
radionuclide therapy. J Nucl Med. 48, 134–142.
Korde
A, Pandey U, Banerjee S, Sarma HD, Mukherjee A, Venkatesh M. 2007. Preparation
and biological studies of 125I-DOTA-TATE. Appl Radiat Isot. 65, 687–690.
Reske
SN, Deisenhofer S, Glatting G, Zlatopolskiy BD, Morgenroth A, Vogg ATJ, Buck
AK, Friesen C. 2007. 123I-ITdU–mediated nanoirradiation of DNA efficiently
induces cell kill in HL60 leukemia cells and in doxorubicin-, b-, or g-radiation–resistant cell lines. J Nucl Med.
48, 1000–1007.
Rousseau
J, Boudou C, Estève F, Elleaume H. 2007. Convection-enhanced delivery of an
iodine tracer into rat brain for synchrotron stereotactic radiotherapy. Int J
Radiat Oncol Biol Phys. 68, 943–951.
Schipper
ML, Riese CGU, Seitz S, Weber A, Béhé M, Schurrat T, Schramm N, Keil B, AlfkeH,
Behr TM. 2007. Efficacy of 99mTc pertechnetate and 131I
radioisotope therapy in sodium/iodide symporter (
Sgouros
G, Knox SJ, Joiner MC, Morgan WF, Kassis AI. 2007. MIRD continuing education: Bystander
and low–dose-rate effects: are these relevant to radionuclide therapy? J Nucl
Med. 48, 1683–1691.
Sohoel
A,
Uiberacker
M, Uphues T, Schultze M, Verhoef AJ, Yakovlev V, Kling MF, Rauschenberger J,
Kabachnik NM, Schröder H, Lezius M, Kompa KL, Muller H-G, Vrakking MJJ, Hendel
S, Kleineberg U, Heinzmann U, Drescher M, Krausz F. 2007. Attosecond real-time
observation of electron tunnelling in atoms. Nature. 446, 627–632.
Valdés
D, Monreal RC, Esaulov VA. 2007. Hybridization effects on the Auger neutralization
process of He+ on Ag(100) surface. Nucl Instr Meth B. 256,
6–10.
VanBrocklin HF, Hanrahan SM, Enas JD, Nandanan E,
O’Neil JP. 2007. Mitochondrial
avid radioprobes. Preparation and evaluation of 7’(Z)-[125I]iodorotenone and 7’(Z)-[125I]iodorotenol. Nucl Med Biol. 34, 109–116.
Wang K, Kirichian AM, Al Aowad AF, Adelstein SJ,
Kassis AI. 2007. Evaluation of chemical,
physical, and biologic properties of tumor-targeting radioiodinated
quinazolinone derivative. Bioconjugate Chem. 18, 754–764.
Xu
Y, Jagtap MR,
Yasui LS, Chen K, Wang K, Jones TP, Caldwell J, Guse D, Kassis AI. 2007. Using Hoechst 33342 to target radioactivity to the cell nucleus. Radiat Res. 167, 167–175.
2006
Adam J-F, Joubert A, Biston M-C, Charvet A-M,
Peoc'h M, Le Bas J-F, Balosso J, Estève F, Elleaume H. 2006. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced
synchrotron stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 64, 603–611.
Balagurumoorthy P, Chen K, Bash RC, Adelstein SJ, Kassis AI. 2006. Mechanisms underlying production of double-strand breaks in plasmid DNA after decay of 125I-Hoechst. Radiat Res. 166, 333–344.
Bé M-M, Chisté V, Dulieu C. 2006. Detailed
calculation of K- and L-Auger electron emission intensities
following radioactive disintegration. Appl Radiat Isot. 64, 1435–1439.
Bolognesi P, Coreno M, Avaldi L, Storchi L, Tarantelli F. 2006. Site-selected Auger electron spectroscopy of N2O. J Chem Phys. 125, 054306.
Boyd M, Ross SC, Dorrens J,
Buchegger
F, Perillo-Adamer F, Dupertuis YM, Bischof Delaloye A. 2006. Auger radiation
targeted into DNA: a therapy perspective. Eur J Nucl Med Mol Imaging. 33, 1352–1363.
Cai
Z, Cloutier P, Hunting D, Sanche L. 2006. Enhanced DNA damage induced by
secondary electron emission from a tantalum surface exposed to soft X rays.
Radiat Res. 165, 365–371.
Cai
Z, Dextraze M-E, Cloutier P, Hunting D, Sanche L. 2006. Induction of strand breaks
by low-energy electrons (8–68 eV) in a self-assembled monolayer of
oligonucleotides: effective cross sections and attenuation lengths. J Chem
Phys. 124, 024705.
Capello
A, Krenning EP, Bernard BF, Breeman WAP, Erion JL, de Jong M. 2006. Anticancer
activity of targeted proapoptotic peptides. J Nucl Med. 47, 122–129.
Carles
AG, Malonda AG. 2006. Combined electron emission effects on the biologically
damaging efficiency of 125I. Int J Radiat Biol. 82, 211–220.
Chen
K, Wang K, Kirichian AM, Al Aowad AF, Iyer LK, Adelstein SJ, Kassis AI. 2006, In silico design, synthesis, and
biological evaluation of radioiodinated quinazolinone derivatives for alkaline
phosphatase–mediated cancer diagnosis and therapy. Mol Cancer Ther. 5,
3001–3013.
Chen
P, Wang J, Hope K, Jin L, Dick J, Cameron R, Brandwein J,
Datta K, Jaruga P,
Dizdaroglu M, Neumann RD, Winters TA. 2006. Molecular analysis of base damage
clustering associated with a site-specific radiation-induced DNA double-strand
break. Radiat Res. 166, 767–781.
Edel S, Terrissol M, Peudon A, Kümmerle E, Pomplun E. 2006. Computer simulation of strand break yields in plasmid pBR322: DNA damage following 125I decay. Radiat Prot Dosimetry. 122, 136–140.
Elgqvist J, Andersson H, Bäck T, Claesson I, Hultborn R, Jensen H, Johansson BR, Lindegren S, Olsson M, Palm S, Warnhammar E, Jacobsson L. 2006. a-Radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: outcome related to measured tumor size and mean absorbed dose J Nucl Med. 47, 1342–1350.
Grafström
G, Jönsson B-A, El Hassan AM, Tennvall J,
Grimm M, Langer B, Schlemmer S, Lischke T, Becker
U, Widdra W, Gerlich D, Flesch R, Rühl E. 2006. Charging mechanisms of trapped element-selectively excited nanoparticles
exposed to soft x rays. Phys Rev Lett. 96, 066801.
Hikosaka
Y, Aoto T, Lablanquie P, Penent F, Shigemasa E, Ito K. 2006. Experimental
investigation of core-valence double photoionization. Phys Rev Lett. 97,
053003.
Howell
RW, Neti PVSV, Pinto M, Gerashchenko BI, Narra VR, Azzam EI. 2006. Challenges
and progress in predicting biological responses to incorporated radioactivity.
Radiat Prot Dosimetry. 122, 521–527.
Huang
L, Krauss TD. 2006. Quantized bimolecular Auger recombination of excitons in
single-walled carbon nanotubes. Phys Rev Lett. 96, 057407.
Ickenstein
LM, Edwards K, Sjöberg S, Carlsson J, Gedda L. 2006. A novel 125I-labeled
daunorubicin derivative for radionuclide-based cancer therapy. Nucl Med Biol.
33, 773–783.
Kishikawa H, Wang K, Adelstein SJ, Kassis AI. 2006. Inhibitory and stimulatory bystander effects are differentially induced by iodine-125 and iodine-123. Radiat Res. 165, 688–694.
Li WB. 2006. Calculation of DNA strand breakage by neutralisation effect after 125I decays in a synthetic oligodeoxynucleotide using charge transfer theory. Radiat Prot Dosimetry. 122, 89–94.
Maina T, Nock BA, Cordopatis P, Bernard BF, Breeman WAP, van Gameren A, van den Berg R, Reubi J-C, Krenning EP, de Jong M. 2006. [99mTc]demotate 2 in the detection of sst2-positive tumours: a preclinical comparison with [111In]DOTA-tate. Eur J Nucl Med Mol Imaging. 33, 831–840.
Malonda AG, Carles AG, Garcia G. 2006. Mean values of the LMM Auger transition in a KLM model. Appl Radiat Isot. 64, 1485–1491.
Marx K, Moka, D, Schomäcker K, Fischer T, Gabruk-Szostak B, Kobe C, Dietlein M, Schicha H. 2006. Cell death induced by 131I in a differentiated thyroid carcinoma cell line in vitro: necrosis or apoptosis? Nucl Med Commun. 27, 353–358.
Melero
García E, Kivimäki A, Pettersson LGM, Álvarez Ruiz J, Coreno M, de Simone M,
Richter R, Prince KC. 2006. Fluorescence emission of excited hydrogen atoms
after core excitation of water vapor. Phys Rev Lett. 96, 063003.
Mondal
S, Singh RK, Shanker R. 2006. Doppler effect in fluorine K-Auger line produced in electron-induced core ionization of SF6.
J Chem Phys. 124, 034301.
Morishita
Y, Liu X-J, Saito N, Lischke T, Kato M, Prümper G, Oura M, Yamaoka H, Tamenori
Y, Suzuki IH, Ueda K. 2006. Experimental evidence of interatomic coulombic decay
from the Auger final states in argon dimers. Phys Rev Lett. 96, 243402.
Nikjoo H, Girard P, Charlton DE, Hofer KG, Laughton CA. 2006. Auger electrons—a nanoprobe for structural, molecular and cellular processes. Radiat Prot Dosimetry. 122, 72–79.
Perillo-Adamer F, Bischof Delaloye A, Genton CS, Schaffland AO, Dupertuis YM, Buchegger F. 2006. Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine. Eur J Nucl Med Mol Imaging. 33, 613–620.
Pernpointner
M, Knecht S, Cederbaum LS. 2006. Ionization spectra and electronic decay in
small iodide clusters: fully relativistic results. J Chem Phys. 125, 034309.
Peudon
A, Edel S, Terrissol M. 2006. Molecular basic data calculation for radiation
transport in chromatin. Radiat Prot Dosimetry. 122, 128–135.
Pomplun E, Terrissol M, Kümmerle E. 2006. Estimation of a radiation weighting factor for 99mTc. Radiat Prot Dosimetry. 122, 80–81.
Reilly RM, Chen P, Wang J, Scollard D, Cameron R, Vallis KA. 2006. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an Auger electron–emitting radiotherapeutic agent for epidermal growth factor receptor–positive breast cancer. J Nucl Med. 47, 1023–1031.
Singh
R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, Bianco A, Kostarelos
K. 2006. Tissue biodistribution and blood clearance rates of
intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci
Sokolov MV, Smirnova NA,
Strigari
L, Menghi E, D’Andrea M, Benassi M. 2006.
Takahashi
O, Odelius M, Nordlund D, Nilsson A, Bluhm H, Pettersson LGM. 2006. Auger decay
calculations with core-hole excited-state molecular-dynamics simulations of
water. J Chem Phys. 124, 064307.
Urashima T, Nagasawa H, Wang K, Adelstein SJ, Little JB, Kassis AI. 2006. Induction of apoptosis in human tumor cells after exposure to Auger electrons: comparison with g-ray exposure. Nucl Med Biol. 33, 1055–1063.
Uusijärvi H, Bernhardt P, Ericsson T, Forssell-Aronsson E. 2006. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution. Med Phys. 33, 3260–3269.
Uusijärvi H, Bernhardt P, Rösch F, Maecke HR,
Forssell-Aronsson E. 2006. Electron- and positron-emittting
radiolanthanides for therapy: aspects of dosimetry and production. J Nucl Med. 47, 807–814.
Valdés D, Blanco JM, Esaulov VA, Monreal RC. 2006. Role of d electrons in Auger neutralization at metal surfaces. Phys Rev Lett. 97, 047601.
Van Essen M, Krenning EP, Kooij PP, Bakker WH, Feelders RA, de Herder WW, Wolbers JG, Kwekkeboom DJ. 2006. Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma. J Nucl Med. 47, 1599–1606.
Watanabe N, Sawai H, Ogihara-Umeda I, Tanada S, Kim EE, Yonekura Y, Sasaki Y. 2006. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides. J Nucl Med. 47, 1670–1677.
Webb
LJ, Michalak DJ, Biteen JS, Brunschwig BS, Chan ASY, Knapp DW, Meyer HM III,
Nemanick EJ, Traub MC, Lewis NS. 2006. High-resolution soft X-ray photoelectron
spectroscopic studies and scanning Auger microscopy studies of the air
oxidation of alkylated silicon(111) surfaces. J Phys Chem B. 110, 23450–23459.
Wethekam
S, Winter H. 2006. Auger neutralization of He ions at an Al(100) surface using
isotope effect. Phys Rev Lett. 96, 207601.
Yokoya
A, Fujii K, Ushigome T, Shikazono N, Urushibara A, Watanabe R. 2006. Yields of
strand breaks and base lesions induced by soft X-rays in plasmid DNA. Radiat
Prot Dosimetry. 122, 86–88.
Zalutsky MR. 2006. Targeted a-particle therapy of microscopic disease: providing a further rationale for clinical investigation. J Nucl Med. 47, 1238–1240.
Zhang M, Yao Z, Zhang Z,
Garmestani K, Talanov VS, Plascjak PS, Yu S, Kim H-S, Goldman CK, Paik CH,
Brechbiel MW, Carrasquillo JA, Waldmann TA. 2006. The anti-CD25 monoclonal
antibody 7G7/B6, armed with the a-emitter 211At, provides effective
radioimmunotherapy for a murine model of leukemia, Cancer Res. 66, 8227–8232.
2005
Adam J-F, Biston M-C, Joubert A, Charvet A-M, Le
Bas J-F, Estève F, Elleaume H. 2005. Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by
means of intracarotid injection and blood–brain barrier disruption:
quantitative iodine biodistribution studies and associated dosimetry. Int J
Radiat Oncol Biol Phys. 61, 1173–1182.
Alnaser
AS, Landers AL,
Bapat K, Chintalwar GJ, Pandey U, Thakur VS, Sarma HD, Samuel G, Pillai MRA, Chattopadhyay S, Venkatesh M. 2005. Preparation and in vitro evaluation of radioiodinated bakuchiol as an anti tumor agent. Appl Radiat Isot. 62, 389–393.
Barth S, Joshi S, Marburger S, Ulrich V, Lindblad A, Öhrwall G, Björneholm O, Hergenhahn U. 2005. Observation of resonant interatomic coulombic decay in Ne clusters. J Chem Phys.122, 241102.
Boswell
CA, Brechbiel MW. 2005. Auger electrons: lethal, low energy, and coming soon to
a tumor cell nucleus near you. J Nucl Med. 46, 1946–1947.
Boudou C, Balosso J, Estève F, Elleaume H. 2005.
Cai
Z, Cloutier P, Hunting D, Sanche L. 2005. Comparison between X-ray photon and
secondary electron damage to DNA in vacuum. J Phys Chem B. 109, 4796–4800.
Capello
A, Krenning E, Bernard B, Reubi J-C, Breeman W, de Jong, M. 2005. 111In-labelled
somatostatin analogues in a rat tumour model: somatostatin receptor status and
effects of peptide receptor radionuclide therapy. Eur J Nucl Med Mol Imaging.
32, 1288–1295.
Corde S, Adam J-F, Biston M-C, Joubert A, Charvet A-M, Estève F, Le Bas J-F, Elleaume H, Balosso J. 2005. Sensitivity variation of doped Fricke gel irradiated with monochromatic synchrotron X rays between 33.5 and 80 keV. Radiat Prot Dosimetry. 117, 425–431.
Datta K, Neumann RD, Winters TA. 2005. Characterization of complex apurinic/apyrimidinic-site clustering associated with an authentic site-specific radiation-induced DNA double-strand break. Proc Natl Acad Sci USA. 102, 10569–10574.
Datta K, Neumann RD, Winters TA. 2005.
Characterization of a complex 125I-induced DNA double-strand break:
implications for repair. Int J
Radiat Biol. 81, 13–21.
Dietlein M, Pels H, Schulz H, Staak O, Borchmann P,
Schomäcker K, Fischer T, Eschner W, Pogge von Strandmann E, Schicha H, Engert
A, Schnell R. 2005. Imaging of
central nervous system lymphomas with iodine-123 labeled rituximab. Eur J
Haematol. 74, 348–352.
Dingli
D, Peng K-W, Harvey ME, Vongpunsawad S, Bergert ER, Kyle RA, Cattaneo R, Morris
JC, Russell SJ. 2005. Interaction of measles virus vectors with Auger electron
emitting radioisotopes. Biochem Biophys Res Commun. 337, 22–29.
Elmroth K, Stenerlöw B. 2005. DNA-incorporated 125I induces
more than one double-strand break per decay in mammalian cells. Radiat Res.
163, 369–373.
Emfietzoglou
D, Kostarelos K, Papakostas A, Yang W-H, Ballangrud Å, Song H, Sgouros G. 2005.
Liposome-mediated radiotherapeutics within avascular tumor spheroids:
comparative dosimetry study for various radionuclides, liposome systems, and a
targeting antibody. J Nucl Med. 46, 89–97.
Emfietzoglou
D, Nikjoo H. 2005. The effect of model approximations on single-collision
distributions of low-energy electrons in liquid water. Radiat Res. 163,
98–111.
Feyer V, Bolognesi P, Coreno M, Prince KC, Avaldi
L, Storchi L, Tarantelli F. 2005. Effects of nuclear dynamics in the low-kinetic-energy Auger spectra of
CO and CO2. J Chem Phys. 123, 224306.
Ghirmai
S, Mume E, Tolmachev V, Sjöberg S. 2005. Synthesis and radioiodination of some
daunorubicin and doxorubicin derivatives. Carbohydr Res. 340,
15–24.
Ginj M, Chen J, Walter MA, Eltschinger V, Reubi JC,
Maecke HR. 2005. Preclinical
evaluation of new and highly potent analogues of octreotide for predictive
imaging and targeted radiotherapy. Clin Cancer Res. 11, 1136–1145.
Ginj
M, Hinni K, Tschumi S, Schulz S, Maecke HR. 2005. Trifunctional
somatostatin-based derivatives designed for targeted radiotherapy using Auger
electron emitters. J Nucl Med. 46, 2097–2103.
Ginj
M, Maecke HR. 2005. Synthesis of trifunctional somatostatin based derivatives
for improved cellular and subcellular uptake. Tetrahedron Lett. 46,
2821–2824.
Haefliger P, Agorastos N, Renard A,
Giambonini-Brugnoli G, Marty C, Alberto R. 2005. Cell uptake and radiotoxicity studies of an nuclear localization signal
peptide—intercalator conjugate labeled with [99mTc(CO)3]+.
Bioconjugate Chem. 16, 582–587.
Häfliger P, Agorastos N, Spingler B, Georgiev O,
Viola G, Alberto R. 2005. Induction
of DNA-double-strand breaks by Auger electrons from 99mTc complexes
with DNA-binding ligands. Chembiochem. 6, 414–421.
Hilgers
K, Shubin YN, Coenen HH, Qaim SM. 2005. Experimental measurements and nuclear
model calculations on the excitation functions of natCe(3He,
xn) and 141Pr(p, xn)
reactions with special reference to production of the therapeutic radionuclide 140Nd.
Radiochim Acta. 93, 553–560.
Hilgers
K, Sudár S, Qaim SM. 2005. Experimental study and nuclear model calculations on
the 192Os(p,n)192Ir reaction: comparison of reactor and
cyclotron production of the therapeutic radionuclide 192Ir. Appl
Radiat Isot. 63, 93–98.
Jääskelä-Saari
HA, Grénman R, Ramsay HA, Tarkkanen J, Paavonen T, Kairemo KJA. 2005.
Indium-111-bleomycin complex in squamous cell cancer xenograft tumors of nude
mice. Cancer Biother Radiopharm. 20, 426–435.
Jiang
C, Bai B, Li R, Xiao H, Fu X, Zhao Z. 2005. Hydriding performance of
LaNi4.7Al0.3 alloy before and after poisoning with oxygen. Xiyou Jinshu. 29,
43–46.
Joubert
A, Biston M-C, Boudou C, Ravanat J-L, Brochard T, Charvet A-M, Estève F,
Balosso J, Foray N. 2005. Irradiation in presence of iodinated contrast agent
results in radiosensitization of endothelial cells: consequences for computed
tomography therapy. Int J Radiat Oncol Biol Phys. 62, 1486–1496.
Kaltsas GA, Papadogias D, Makras P, Grossman AB.
2005. Treatment of advanced
neuroendocrine tumours with radiolabelled somatostatin analogues. Endocr Relat
Cancer. 12, 683–699.
Kassis AI. 2005. Radiotargeting agents for
cancer therapy. Expert Opin Drug
Deliv. 2, 981–991.
Kassis AI, Adelstein SJ. 2005. Radiobiologic principles in radionuclide
therapy. J Nucl Med. 46(suppl 1), 4S–12S.
Kawai
J. 2005. Radiative Auger effect and extended X-ray emission fine structure
(EXEFS). Anal Sci. 21, 733–735.
Kawai
J, Ohta M, Konishi T. (2005) Chemical effects in high-resolution nickel Ka X-ray fluorescence spectra. Anal Sci. 21,
865–868.
Knapp FF Jr, Mirzadeh H, Beets AL, Du M. 2005. Production of therapeutic isotopes in the
ORNL High Flux Isotope Reactor (HFIR) for applications in nuclear medicine,
oncology and interventional cardiology. J Radioanal Nucl Chem. 263, 503–509.
Kullberg
EB, Stenerlöw B, Ghirmai S, Lundqvist H, Malmström P-U, Orlova A, Tolmachev V,
Gedda L. 2005. An aminoacridine derivative for radionuclide therapy: DNA
binding properties studied in a novel cell-free in vitro assay. Int J Oncol. 27, 1355–1360.
Kümmerle EA, Pomplun E. 2005. A computer-generated supercoiled model of
the pUC19 plasmid. Eur Biophys J. 34, 13–18.
Limouris
GS, Dimitropoulos N, Kontogeorgakos D, Papanikolos G, Koutoulidis V,
Hatzioannou A, Mourikis D, Lyra M, Dimitriou P, Stravaka A, Vlahos L. 2005.
Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted
therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US
findings. Cancer Biother Radiopharm. 20, 215–217.
Lobachevsky
PN, Martin RF. 2005. DNA breakage by decay of Auger electron emitters:
experiments with 123I-iodoHoechst 33258 and plasmid DNA. Radiat Res.
164, 766–773.
Marques F, Paulo A, Campello MP, Lacerda S, Vitor
RF, Gano L, Delgado R, Santos I. 2005. Radiopharmaceuticals for targeted
radiotherapy. Radiat Prot Dosimetry. 116, 601–604.
Michel RB, Andrews PM, Castillo ME, Mattes MJ.
2005. In vitro
cytotoxicity of carcinoma cells with 111In-labeled antibodies to
HER-2. Mol Cancer Ther. 4, 927–937.
Michel
RB, Andrews PM,
Michel RB, Rosario AV, Andrews PM, Goldenberg DM,
Mattes MJ. 2005. Therapy of
small subcutaneous B-lymphoma xenografts with antibodies conjugated to
radionuclides emitting low-energy electrons. Clin Cancer Res. 11, 777–786.
Obata
A, Kasamatsu S, Lewis JS, Furukawa T, Takamatsu S, Toyohara J, Asai T, Welch
MJ, Adams SG, Saji H, Yonekura Y, Fujibayashi Y. 2005. Basic characterization
of 64Cu-ATSM as a radiotherapy agent. Nucl Med Biol. 32, 21–28.
Öhrwall
G, Fink RF, Tchaplyguine M, Ojamäe L, Lundwall M, Marinho RRT, Naves de Brito
A, Sorensen SL, Gisselbrecht M, Feifel R, Rander T, Lindblad A, Schulz J,
Saethre LJ, Mårtensson N, Svensson S, Björneholm O. 2005. The electronic
structure of free water clusters probed by Auger electron spectroscopy. J Chem
Phys. 123, 054310.
Panyutin
IG, Neumann RD. 2005. The potential for gene-targeted radiation therapy of
cancers. Trends Biotechnol. 23, 492–496.
Panyutin IV, Sedelnikova OA, Bonner WM, Panyutin
IG, Neumann RD. 2005. DNA
damage produced by 125I-triplex–forming oligonucleotides as a
measure of their succesful delivery into cell nuclei. Ann N Y Acad Sci. 1058,
140–150.
Pernpointner
M, Knecht S. 2005. The influence of relativistic effects on the ionization
spectra of the alkali iodides. Chem Phys Lett. 410, 423–429.
Safaie Semnani E, Wang K, Adelstein SJ, Kassis AI.
2005. 5-[123I/125I]iodo-2'-deoxyuridine
in metastatic lung cancer: radiopharmaceutical formulation affects targeting. J
Nucl Med. 46, 800–806.
Smirnova O, Yakovlev VS, Ivanov M. 2005. Use of electron correlation to make
attosecond measurements without attosecond pulses. Phys Rev Lett. 94, 213001.
Usami
N, Furusawa Y, Kobayashi K, Frohlich H, Lacombe S, Le Sech C. 2005. Fast He2+
ion irradiation of DNA loaded with platinum-containing molecules. Int J Radiat
Biol. 81, 515–522.
Valdés
D, Goldberg EC, Blanco JM, Monreal RC. 2005. Linear combination of atomic
orbitals calculation of the Auger neutralization rate of He+ on
Al(111), (100), and (110) surfaces. Phys Rev B. 71, 245417.
Valkema
R, Pauwels SA, Kvols LK, Kwekkeboom DJ, Jamar F, de Jong M, Barone R, Walrand
S, Kooij PPM, Bakker WH, Lasher J, Krenning EP. 2005. Long-term follow-up of
renal function after peptide receptor radiation therapy with 90Y-DOTA0,Tyr3-octreotide
and 177Lu-DOTA0,Tyr3-octreotate. J Nucl Med.
46, 83S–91S.
Yakushev
EA, Kovalik A, Filosofov DV, Korolev NA, Lebedev NA, Lubashevski AV, Rösch F,
Novgorodov AF. 2005. An experimental comparison of the K- and L-Auger electron
spectra generated in the decays of 140Nd and 111In. Appl Radiat
Isot. 62, 451–456.
2004
Akamatsu
K, Fujii K, Yokoya A. 2004. Low-energy Auger- and photo-electron effects on the
degradation of thymine by ultrasoft X-irradiation. Int J Radiat Biol. 80, 849–853.
Bernhardt P, Friedland W, Paretzke HG. 2004. The role
of atomic inner shell relaxations for photon-induced DNA damage. Radiat Environ
Biophys. 43, 77–84.
Beyer GJ, Zeisler SK, Becker DW. 2004. The Auger-electron emitter 165Er:
Excitation function of the 165Ho(p,n)165Er process.
Radiochim Acta. 92, 219–222.
Biston M-C, Joubert A, Adam J-F, Elleaume H, Bohic S, Charvet A-M, Estève F, Foray N, Balosso J. 2004. Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Res. 64, 2317–2323.
Buchegger
F, Adamer F, Schaffland AO, Kosinski M, Grannavel C, Dupertuis YM, de Tribolet
N, Mach J-P, Delaloye AB. 2004. Highly efficient DNA incorporation of
intratumourally injected [125I]iododeoxyuridine under thymidine
synthesis blocking in human glioblastoma xenografts. Int J Cancer. 110,
145–149.
Cecchini
S, Girouard S, Huels MA, Sanche L, Hunting DJ. 2004. Single-strand -specific
radiosensitization of DNA by bromodeoxyuridine. Radiat Res. 162, 604–615
Chen
K, Adelstein SJ, Kassis AI. 2004. Molecular simulation of ligand-binding with
DNA: implications for 125I-labeled pharmaceutical design. Int J Radiat
Biol. 80, 921–926.
Chen K, Adelstein SJ, Kassis AI. 2004. Molecular modeling of the interaction of
iodinated Hoechst analogs with DNA: implications for new radiopharmaceutical
design. J Mol Struct (Theochem). 711, 49–56.
Corde
S, Joubert A, Adam JF, Charvet AM, Le Bas JF, Estève F, Elleaume H, Balosso J.
2004. Synchrotron radiation-based experimental determination of the optimal
energy for cell radiotoxicity enhancement following photoelectric effect on
stable iodinated compounds. Br J Cancer. 91, 544–551.
de
Jong M, Valkema R, van Gameren A, van Boven H, Bex A, van de Weyer EP,
Burggraaf JD, Körner M, Reubi J-C, Krenning EP. 2004. Inhomogeneous
localization of radioactivity in the human kidney after injection of [111In-DTPA]
octreotide. J Nucl Med. 45, 1168–1171.
Feinendegen
LE, Neumann RD. 2004. Dosimetry and risk from low- versus high-LET radiation of
Auger events and the role of nuclide carriers. Int J Radiat Biol. 80,
813–822.
Fischer T, Schomäcker K, Schicha H. 2004. Labelling, purification, and receptor
affinity of radioactive iododiethylstilbestrol (*I-DES) with high specific
activity and first structure analysis with natI-DES. J Label Compd Radiopharm.
47, 669–678.
Fujii
K, Akamatsu K, Yokoya A. 2004. Decomposition of 2-deoxy-D-ribose by irradiation with 0.6 keV electrons and by 0.5 keV
ultrasoft X-rays. Int J Radiat Biol. 80, 909–914.
Fujii
K, Akamatsu K, Yokoya A. 2004. Ion desorption from DNA components irradiated
with 0.5 keV ultrasoft X-ray photons. Radiat Res. 161, 435–441.
Gaidamakova
EK, Neumann RD, Panyutin IG. 2004. Antisense radiotherapy: targeting full-size mdr 1 mRNA with 125I-labelled
oligonucleotides. Int J Radiat Biol. 80, 889–893.
Garnuszek
P. 2004. Marked survival prolongation of mice bearing a transplantable colon
adenocarcinoma by treatment with radioactive platinum-[125I]histamine
complex. Preliminary report. Nucl Med Rev Cent East Eur. 7, 113–116.
Goldsmith
SJ. 2004. Improving insight into radiobiology and radionuclide therapy. J Nucl
Med. 45, 1104–1105.
Goorley
T, Zamenhof R, Nikjoo H. 2004. Calculated DNA damage from gadolinium Auger
electrons and relation to dose distributions in a head phantom. Int J Radiat
Biol. 80, 933–940.
He
Y, Das B, Baruchel S, Kumar P, Wiebe L, Reilly RM. 2004.
He
Y, Panyutin IG, Karavanov A, Demidov VV,
He
Y,
Hu
Z, Caló A, Nikkinen J, Matila T, Kukk E, Aksela H, Aksela S. 2004. Normal Auger
spectra of Br in alkali bromide molecules. J Chem Phys. 121, 8246–8252.
Karagiannis
TC. 2004. Auger electron emitting isotopes in cancer therapy: cellular effects
and therapeutic potential of 125I. Hellenike Pyrenike Latr. 7, 111–116.
Kassis
AI. 2004. The amazing world of Auger electrons. Int J Radiat Biol. 80,
789–803.
Kassis AI. 2004. In vivo validation of the bystander effect. Hum Exp
Toxicol. 23, 71–73.
Kassis
AI, Kirichian AM, Wang K, Safaie Semnani E, Adelstein SJ. 2004. Therapeutic
potential of 5-[125I]iodo-2'-deoxyuridine and methotrexate in the
treatment of advanced neoplastic meningitis. Int J Radiat Biol. 80, 941–946.
Kato
HS, Furukawa M, Kawai M, Taniguchi M, Kawai T, Hatsui T, Kosugi N. 2004.
Electronic structure of bases in DNA duplexes characterized by resonant
photoemission spectroscopy near the Fermi level. Phys Rev Lett. 93, 086403.
Klenberger R, Goullelmakis E, Ulberacker M,
Baltuska A, Yakovlev V, Bammer F, Scrinzl A, Westerwalbesloh T, Kleineberg U,
Heinzmann U, Drescher M, Krausz F. 2004. Atomic transient recorder. Nature. 427, 817–821.
Konijnenberg MW, Bijster M, Krenning EP, de Jong M.
2004. A stylized computational
model of the rat for organ dosimetry in support of preclinical evaluations of
peptide receptor radionuclide therapy with 90Y, 111In, or
177Lu. J Nucl Med. 45, 1260–1269.
Koppe
MJ, Bleichrodt RP, Soede AC, Verhofstad AA, Goldenberg DM, Oyen WJG, Boerman
OC. 2004. Biodistribution and therapeutic efficacy of 125/131I-, 186Re-,
88/90Y-, or 177Lu-labeled monoclonal antibody MN-14 to
carcinoembryonic antigen in mice with small peritoneal metatases of colorectal
origin. J Nucl Med. 45, 1224–1232.
Kou
J, Mori T, Kumar SVK, Haruyama Y, Kubozono Y, Mitsuke K. 2004. Double
photoionization of C60 and C70 in the valence region. J Chem Phys.
120, 6005–6009.
Kriehuber R, Riedling M, Simkó M, Weiss DG. 2004. Cytotoxicity, genotoxicity and intracellular
distribution of the Auger electron emitter 65Zn in two human cell
lines. Radiat Environ Biophys. 43, 15–22.
Kriehuber R, Kadenbach K, Schultz F, Weiss D-G.
2004. Study on cell survival,
induction of apoptosis and micronucleus formation in SCL-II cells after
exposure to the Auger electron emitter 99mTc. Int J Radiat Biol. 80,
875–880.
Kugeler O, Prümper G, Hentges R, Viefhaus J, Rolles
D, Becker U, Marburger S, Hergenhahn U. 2004. Intramolecular electron scattering and electron transfer following
autoionization in dissociating molecules. Phys Rev Lett. 93, 033002.
Laughton
CA, Grindon C, Girard P, Nikjoo H. 2004. The mysteries of telomere structure
and recognition: could radioprobing help? Int J Radiat Biol. 80, 805–811.
Li
WB, Friedland W, Jacob P, Panyutin IG, Paretzke HG. 2004. Simulation of 125I
decay in a synthetic oligodeoxynucleotide with normal and distorted geometry
and the role of radiation and non-radiation actions. Radiat Environ Biophys.
43, 23–33.
Lobachevsky
PN, Martin RF. 2004. An improved approach to the analysis of plasmid DNA
breakage by decay of DNA-associated Auger emitters. Int J Radiat Biol. 80, 861–866.
Lobachevsky
PN, Martin RF. 2004. Plasmid DNA breakage by decay of DNA-associated Auger
emitters: experiments with 123I/125I-iodoHoechst 33258.
Int J Radiat Biol. 80, 915–920.
Lobachevsky
PN, Karagiannis TC, Martin RF. 2004. Plasmid DNA breakage by decay of
DNA-associated Auger electron emitters: approaches to analysis of experimental
data. Radiat Res. 162, 84–95.
Maeda M, Kobayashi K, Hieda K. 2004. Efficiencies of induction of DNA double
strand breaks in solution by photoabsorption at phosphorus and platinum. Int J
Radiat Biol. 80, 841–847.
McQuade
P, Knight LC, Welch MJ. 2004. Evaluation of 64Cu- and 125I-radiolabeled
bitistatin as potential agents for targeting avb3 integrins in tumor angiogenesis. Bioconjugate Chem. 15, 988–996.
Michel
RB, Castillo ME, Andrews PM, Mattes MJ. 2004. In vitro toxicity of A-431 carcinoma cells with antibodies to
epidermal growth factor receptor and epithelial glycoprotein-1 conjugated to
radionuclides emitting low-energy electrons. Clin Cancer Res. 10, 5957–5966.
Nettleton
JS, Lawson RS, Prescott MC, Morris ID. 2004. Uptake, localization, and
dosimetry of 111In and 201Tl in human testes. J Nucl Med.
45, 138–146. Olovsson W,
Peters
AM, White JF, Chilvers ER. 2004. Physiologic granulocyte destruction in vivo by
apoptosis. J Nucl Med. 45, 526.
Pomplun
E, Sutmann G. 2004. Is Coulomb explosion a damaging mechanism for 125IUdR?
Int J Radiat Biol. 80, 855–860.
Reilly RM, Scollard DA, Wang J, Mondal H, Chen P,
Henderson LA, Bowen BM, Vallis KA. 2004. A kit formulated under good manufacturing practices for labeling human
epidermal growth factor with 111In for radiotherapeutic
applications. J Nucl Med. 45, 701–708.
Rolleman EJ, Krenning EP, van Gameren A, Bernard BF,
de Jong M. 2004. Uptake of [111In-DTPA0]octreotide
in the rat kidney is inhibited by colchicine and not by fructose. J Nucl Med.
45, 709–713.
Sajeev Y, Mishra MK, Vaval N, Pal S. 2004. Fock space multireference coupled cluster
calculations based on an underlying bivariational self-consistent field on
Auger and shape resonances. J Chem Phys. 120, 67–72.
Schaffland
AO, Bischof Delaloye A, Kosinski M, Dupertuis YM, Buchegger F. 2004. The
preparation of clinical grade 5-[123I]iodo-2'-deoxyuridine and 5-[125I]iodo-2'-deoxyuridine
with high in vitro stability and the
potential for early proliferation scintigraphy. Nucl Med Commun. 25, 461–468.
Schneeweiss
FHA, Zerhusen S, Sharan RN. 2004. Effects of Auger-electron-emitting
radionuclides on human cells. Radiobiology and Bio-Medical Research
Proceedings, pp. 66-71.
Sedelnikova
OA, Panyutin IV, Neumann RD, Bonner WM, Panyutin IG. 2004. Assessment of DNA
damage produced by 125I-triplex-forming oligonucleotides in cells.
Int J Radiat Biol. 80, 927–931.
Stokkel
MPM, Verkooijen RBT, Bouwsma H, Smit JWA. 2004. Six month follow-up after 111In-DTPA-octreotide
therapy in patients with progressive radioiodine non-responsive thyroid cancer:
a pilot study. Nucl Med Commun. 25, 683–690.
Takakura
K, Gotoh E, Sakano A, Funada A, Kanasugi Y, Okabe A, Kobayashi K. 2004.
Chromosomal aberrations in normal human cells induced by the Auger effect via
Ca atoms. Int J Radiat Biol. 80, 881–888.
Tanis JA, Landers AL, Pole DJ, Alnaser AS, Hossain
S, Kirchner T. 2004. Evidence
for Pauli exchange leading to excited-state enhancement in electron transfer.
Phys Rev Lett. 92, 133201.
Terrissol M, Edel S, Pomplun E. 2004. Computer evaluation of direct and indirect
damage induced by free and DNA-bound iodine-125 in the chromatin fibre. Int J Radiat
Biol. 80, 905–908.
Urashima T, Wang K, Adelstein SJ, Kassis AI. 2004. Activation of diverse pathways to apoptosis
by 125IdUrd and g-photon exposure. Int J
Radiat Biol. 80, 867–874.
Viefhaus
J, Cvejanovic S, Langer B, Lischke T, Prumper G, Rolles D, Golovin AV,
Grum-Grzhimailo AN, Kabachnik NM, Becker U. 2004. Energy and angular
distributions of electrons emitted by direct double Auger decay. Phys Rev Lett.
92, 083001.
Villani
C, Tarantelli F. 2004. Double ionization of fluorinated benzenes: hole
localization and delocalization effects. J Chem Phys. 120, 1775–1791.
Watanabe
R, Yokoya A, Fujii K, Saito K. 2004. DNA strand breaks by direct energy
deposition by Auger and photo-electrons ejected from DNA constituent atoms
following K-shell photoabsorption. Int J Radiat Biol. 80, 823–832.
Yasui
LS. 2004. gH2AX foci induced by g rays and 125IdU decay. Int J
Radiat Biol. 80, 895–903.
Yokoya
A, Akamatsu K, Fujii K, Ukai M. 2004. "In
situ" observation of guanine radicals induced by ultrasoft X-ray
irradiation around the K-edge regions of nitrogen and oxygen. Int J Radiat Biol.
80, 833–839.
Zubarev
RA. 2004. Electron-capture dissociation tandem mass spectrometry. Curr Opin
Biotechnol. 15, 12–16.
2003
Adelstein
SJ, Kassis AI, Bodei L, Mariani G. 2003. Radiotoxicity of iodine-125 and other Auger-electron-emitting
radionuclides: background to therapy. Cancer Biother Radiopharm. 18, 301–316.
Bodei
L, Kassis AI, Adelstein SJ, Mariani G. 2003. Radionuclide therapy with
iodine-125 and other Auger-electron-emitting radionuclides: experimental models
and clinical applications. Cancer Biother Radiopharm. 18, 861–877.
Britz-Cunningham
SH, Adelstein SJ. 2003. Molecular targeting with radionuclides: state of the
science. J Nucl Med. 44, 1945–1961.
Buchegger
F, Vieira J-M, Blaeuenstein P, Dupertuis YM, Schaffland AO, Grannavel C, de
Tribolet N, Slosman DO, Delaloye AB. 2003. Preclinical Auger and gamma
radiation dosimetry for fluorodeoxyuridine-enhanced tumour proliferation
scintigraphy with [123I]iododeoxyuridine. Eur J Nucl Med. 30,
239–246.
Busani R, Giniger R, Hippler T, Cheshnovsky O.
2003. Auger recombination and
charge-carrier thermalization in Hgn–-cluster
photoelectron studies. Phys Rev Lett. 90, 083401.
Capello
A, Krenning EP,
Chen K, Adelstein SJ, Kassis AI. 2003. Molecular simulation of ligand binding with
DNA: implications for new radiopharmaceutical design. J Nucl Med. 44(5, suppl),
302P–303P.
Chen
P, Cameron R, Wang J, Vallis KA, Reilly RM. 2003. Antitumor effects and normal
tissue toxicity of 111In-labeled epidermal growth factor
administered to athymic mice bearing epidermal growth factor receptor–positive
human breast cancer xenografts. J Nucl Med. 44, 1469–1478.
Corde
S, Balosso J, Elleaume H, Renier M, Joubert A, Biston M-C, Adam J-F, Charvet A-M,
Brochard T, Le Bas J-F, Estève F, Foray N. 2003. Synchrotron photoactivation of
cisplatin elicits an extra number of DNA breaks that stimulate RAD51-mediated
repair pathways. Cancer Res. 63, 3221–3227.
Dupertuis
YM, Buchegger F, Pichard C. 2003. A balanced deoxyribonucleoside mixture
increased the rate of DNA incorporation of 5-[125I]iodo-2'-deoxyuridine
in glioblastoma cells. Cancer Biother Radiopharm. 18, 7–16.
Endo
A, Yamaguchi Y, Eckerman KF. 2003. Development and assessment of a new
radioactive decay database used for dosimetry calculation. Radiat Prot Dosimetry.
105, 565–569.
Felton
MJ. 2003. On the surface with Auger electron spectroscopy. Anal Chem. 75, 269A–271A.
Ge
C, Liao J, Yu W, Gu N. 2003. Electric potential control of DNA immobilization
on gold electrode. Biosens Bioelectron. 18, 53–58.
Karamychev
VN, Tatusov A, Komissarova N, Kashlev M, Neumann RD, Zhurkin VB, Panyutin IG.
2003. Iodine-125 radioprobing of E. coli
RNA polymerase transcription elongation complexes. Methods Enzymol. 371,
106–120.
Kassis
AI. 2003. Cancer therapy with Auger electrons: are we almost there? J Nucl Med.
44, 1479–1481.
Kassis
AI, Kirichian AM, Wang K, Safaie Semnani E, Adelstein SJ. 2003. Therapeutic
potential of 5-[125I]iodo-2'-deoxyuridine and methotrexate in the
treatment of advanced neoplastic meningitis. J Nucl Med. 44(5, suppl), 35P–36P.
Kellerer AM, Chen J. 2003. Comparative microdosimetry of photoelectrons
and Compton electrons: an analysis in terms of generalized proximity functions.
Radiat Res. 160, 324–333.
Mamede
M, Saga T, Kobayashi H, Ishimori T, Higashi T, Sato N, Brechbiel MW, Konishi J.
2003. Radiolabeling of avidin with very high specific activity for internal
radiation therapy of intraperitoneally disseminated tumors. Clin Cancer Res. 9,
3756–3762.
Michel RB, Brechbiel MW, Mattes MJ. 2003. A comparison of 4 radionuclides conjugated
to antibodies for single-cell kill. J Nucl Med. 44, 632–640.
Panyutin IG, Sedelnikova OA, Karamychev VN, Neumann
RD. 2003. Antigene
radiotherapy: targeted radiodamage with 125I-labeled triplex-forming
oligonucleotides. Ann N Y Acad Sci. 1002, 134–140.
Panyutin IG, Winters TA, Feinendegen LE, Neumann
RD. 2003. Development of
DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene
radiotherapy. Molecular Nuclear Medicine Proceedings, pp. 697–712.
Pastwa
E, Neumann RD, Mezhevaya K, Winters TA. 2003. Repair of radiation-induced DNA
double-strand breaks is dependent upon radiation quality and the structural
complexity of double-strand breaks. Radiat Res. 159, 251–261.
Pignol J-P, Rakovitch E, Beachey D, Le Sech C.
2003. Clinical significance of
atomic inner shell ionization (ISI) and Auger cascade for radiosensitization
using IUdR, BUdR, platinum salts, or gadolinium porphyrin compounds. Int J
Radiat Oncol Biol Phys. 55, 1082–1091.
Santra
R, Cederbaum LS. 2003. Coulombic energy transfer and triple ionization in
clusters. Phys Rev Lett. 90, 153401.
Toyohara
J, Hayashi A, Sato M, Gogami A, Tanaka H, Haraguchi K, Yoshimura Y, Kumamoto H,
Yonekura Y, Fujibayashi Y. 2003. Development of radioiodinated nucleoside
analogs for imaging tissue proliferation: comparisons of six 5-iodonucleosides.
Nucl Med Biol. 30, 687–696.
Ünak
T. 2003. Some microdosmetric data on astatine-211. Appl Radiat Isot. 58, 115–117.
Winters
TA, Pastwa E, Datta K, Neumann RD. 2003. Rational drug development using
gene-targeted agents and their application in anti-gene radiotherapy. Curr
Genomics. 4, 275–294.
Xu
Y-J, Li Q-N, Zhu R, Zhu B-X, Zhang Y-P, Zhang X-D, Fan W, Hong C-J, Li W-X.
2003. Radiotoxicity induced by Auger electron emitters in human osteosarcoma
cell line using comet assay. Nucl Sci Techniques. 14, 171–173.
Zhou
C-M, Huang X-L, Wu Z-D. 2003. Auger electron energies and their absolute
intensities calculations associated with internal conversion electron emission.
Yuanzineng Kexue Jishu. 37, 415–418.
Zhou C-M, Huang X-L, Wu Z-D. 2003. Data calculation of X-ray and Auger electron
arising from nuclear decay. Gaoneng Wuli Yu Hewuli. 27, 341–348.
2002
Anthony
LB, Woltering EA, Espenan GD, Cronin MD, Maloney TJ, McCarthy KE. 2002.
Indium-111–pentetreotide prolongs survival in gastroenteropancreatic
malignancies. Semin Nucl Med. 32, 123–132.
Behr
TM, Béhé M, Sgouros G. 2002. Correlation of red marrow radiation dosimetry with
myelotoxicity: empirical factors influencing the radiation-induced
myelotoxicity of radiolabeled antibodies, fragments and peptides in
pre-clinical and clinical settings. Cancer Biother Radiopharm. 17, 445–464.
Beyer
GJ. 2002. Radioactive ion beams for bio-medical research and nuclear medical
application. Seventh International Conference on Advanced Technology and
Particle Physics, Como, Italy, October 15–19, 2001, Proceedings, pp. 504–511.
Chen
P, Mrkobrada M, Vallis KA, Cameron R, Sandhu J, Hendler A, Reilly RM. 2002. Comparative
antiproliferative effects of 111In-DTPA-hEGF, chemotherapeutic
agents and g-radiation on EGFR-positive breast cancer
cells. Nucl Med Biol. 29, 693–699.
Choe
JG, Kim M-K, Oh EJ, Yoon EJ, Sohn J, Park MK, Park GH. 2002. Pharmacokinetics
of 111In-labeled triplex-forming oligonucleotide targeting human N-myc gene. Mol Cells. 14, 93–100.
Corde
S, Biston MC, Elleaume H, Estève F, Charvet AM, Joubert A, Ducros V, Bohic S,
Simionovici A, Brochard T, Nemoz C, Renier M, Troprès I, Fiedler S, Bravin A,
Thomlinson W, Le Bas JF, Balosso J. 2002. Lack of cell death enhancement after
irradiation with monochromatic synchrotron X rays at the K-shell edge of
platinum incorporated in living SQ20B human cells as cis-diamminedichloroplatinum (II). Radiat Res. 158, 763–770.
Dodson
CL. 2002. Generalized efficiency monitor for liquid scintillation counting. LSC
2001, Advances in Liquid Scintillation Spectrometry, Karlsruhe, Germany, May
7–11, 2001, Proceedings, pp. 99–106.
Dupertuis
YM, Xiao W-H, De Tribolet N, Pichard C, Slosman DO, Bischof Delaloye A,
Buchegger F. 2002. Unlabelled iododeoxyuridine increases the rate of uptake of
[125I]iododeoxyuridine in human xenografted glioblastomas. Eur J Nucl
Med Mol Imaging. 29, 499–505.
El-Shaboury
G, El-Tawousy M. 2002. Synthesis of radioiodinated 4-[*I]iodoantipyrine via
isotopic exchange. J Radioanal Nucl Chem. 252, 109–114.
Fayard
B, Touati A, Abel F, Herve du Penhoat MA, Despiney-Bailly I, Gobert F, Ricoul
M, L'Hoir A, Politis MF, Hill MA, Stevens DL, Sabatier L, Sage E, Goodhead DT,
Chetioui A. 2002. Cell inactivation and double-strand breaks: the role of core
ionizations, as probed by ultrasoft X rays. Radiat Res. 157, 128–140.
Gaidamakova
EK, Neumann RD, Panyutin IG. 2002. Site-specific strand breaks in RNA produced
by 125I radiodecay. Nucleic Acids Res. 30, 4960–4965.
Govindan SV,
Howell
RW, Bishayee A. 2002. Bystander effects caused by nonuniform distributions of
DNA-incorporated 125I. Micron. 33, 127–132.
Kellerer
AM. 2002. Electron spectra and the RBE of X rays. Radiat Res. 158, 13–22.
Kobayashi
K, Frohlich H, Usami N, Takakura K, Le Sech C. 2002. Enhancement of
X-ray-induced breaks in DNA bound to molecules containing platinum: a possible
application to hadrontherapy. Radiat Res. 157, 32–37.
Lubberink
M, Lundqvist H, Tolmachev V. 2002. Production, PET performance and dosimetric
considerations of 134Ce/134La, an Auger electron and
positron-emitting generator for radionuclide therapy. Phys Med Biol. 47, 615–629.
Ludwików
G, Xiao Y, Hoebe RA, Franken NAP, Darroudi F, Stap J, van Oven CH, van Noorden
CJF, Aten JA. 2002. Induction of chromosome aberrations in unirradiated
chromatin after partial irradiation of a cell nucleus. Int J Radiat Biol. 78,
239–247.
Mattes
MJ. 2002. Radionuclide-antibody conjugates for single-cell cytotoxicity. Cancer. 94,
1215–1223.
Michel
RB, Mattes MJ. 2002. Intracellular accumulation of the anti-CD20 antibody 1F5
in B-lymphoma cells. Clin Cancer Res. 8, 2701–2713.
Michel
RB, Ochakovskaya R, Mattes MJ. 2002. Antibody localization to B-cell lymphoma
xenografts in immunodeficient mice: importance of using residualizing
radiolabels. Clin Cancer Res.
8, 2632–2639.
Moiseenko VV, Karnas SJ, Yu E, Battista JJ. 2002. Monte Carlo simulations of DNA damage from
incorporated cold iodine following photoelectrically induced Auger electron
cascades. Radiat Prot Dosimetry. 99, 113–116.
Nikjoo
H,
Radford
IR. 2002. DNA lesion complexity and induction of apoptosis by ionizing
radiation. Int J Radiat Biol. 78, 457–466.
Radford
IR. 2002. Transcription-based model for the induction of interchromosomal
exchange events by ionizing irradiation in mammalian cell lines that undergo
necrosis. Int J Radiat Biol. 78, 1081–1093.
Radford
IR. 2002. Response of mammalian cell lines that undergo necrosis after ionizing
irradiation to DNA-incorporated tritium and iodine-125 decays: implications for
models of radiation action. Int J Radiat Biol. 78, 1069–1080.
Regulla D, Schmid E, Friedland W, Panzer W,
Heinzmann U, Harder D. 2002. Enhanced
values of the RBE and H ratio for cytogenetic effects induced by secondary
electrons from an X-irradiated gold surface. Radiat Res. 158, 505–515.
Sedelnikova OA, Karamychev VN, Panyutin IG, Neumann
RD. 2002. Sequence-specific
gene cleavage in intact mammalian cells by 125I-labeled
triplex-forming oligonucleotides conjugated with nuclear localization signal
peptide. Antisense Nucleic Acid Drug Dev. 12, 43–49.
Sedelnikova
OA, Rogakou EP, Panyutin IG, Bonner WM. 2002. Quantitative detection of 125IdU-induced
DNA double-strand breaks with g-H2AX
antibody. Radiat Res. 158, 486–492.
Silva CR, Valsa JO, Caldeira-de-Araújo A, Amaral
A, Bernardo-Filho M. 2002. Evaluation
of the cytotoxic and mutagenic potentiality of technetium-99m in Escherichi coli. Cell Mol
Biol. 48, 783–787.
Terrissol M, Pomplun E, Martin C. 2002. Computer simulation of 57Fe
bleomycin Auger effects in DNA. Radiat Prot Dosimetry. 99, 69–72.
Toyohara
J, Hayashi A, Sato M, Tanaka H, Haraguchi K, Yoshimura Y, Yonekura Y,
Fujibayashi Y. 2002. Rationale of 5-125I-iodo-4'-thio-2'-deoxyuridine
as a potential iodinated proliferation marker. J Nucl Med. 43, 1218–1226.
Unak
P. 2002. Targeted tumor therapy. Braz Arch Biol Technol. 45(special issue),
97–110.
Valkema R, de Jong M, Bakker WH, Breeman WAP, Kooij
PPM, Lugtenburg PJ, de Jong FH, Christiansen A, Kam BLR, de Herder WW,
Stridsberg M, Lindemans J, Ensing G, Krenning EP. 2002. Phase I study of peptide receptor
radionuclide therapy with [111In-DTPA0]octreotide: the
Xue
LY,
2001
Amaral A, Colas-Linhart N, Stabin M, Petiet A,
Guiraud-Vitaux F, Jacquet N. 2001. In vitro irradiation of blood with 99mTc: evaluation of dose
and chromosome aberrations in irradiated lymphocytes. Cell Mol Biol. 47, 545–548.
Barendswaard
EC, Humm JL, O'Donoghue JA, Sgouros G, Finn RD, Scott AM, Larson SM, Welt S.
2001. Relative therapeutic efficacy of 125I- and 131I-labeled
monoclonal antibody A33 in a human colon cancer xenograft. J Nucl Med. 42,
1251–1256.
Bernhardt
P, Forssell-Aronsson E, Jacobsson L, Skarnemark G. 2001. Low-energy electron
emitters for targeted radiotherapy of small tumours. Acta Oncol. 40, 602–608.
Bugaj JE, Erion JL, Johnson MA, Schmidt MA,
Srinivasan A. 2001. Radiotherapeutic
efficacy of 153Sm-CMDTPA-Tyr3-octreotate in tumor-bearing
rats. Nucl Med Biol. 28, 327–334.
Chi
K-H, Wang H-E, Chen F-D, Chao Y, Liu R-S, Chou S-L, Wang Y-S, Yen S-H. 2001.
Preclinical evaluation of locoregional delivery of radiolabeled
iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model. J Nucl
Med. 42, 345–351.
de
Jong M, Breeman WAP, Bernard BF, Bakker WH, Schaar M, van Gameren A, Bugaj JE,
Erion J, Schmidt M, Srinivasan A, Krenning EP. 2001. [177Lu-DOTA0,Tyr3]octreotate
for somatostatin receptor-targeted radionuclide therapy. Int J Cancer. 92, 628–633.
Dupertuis
YM, Vazquez M, Mach J-P, De Tribolet N, Pichard C, Slosman DO, Buchegger F.
2001. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with
radiolabeled iododeoxyuridine. Cancer Res. 61, 7971–7977.
El-Shaboury
G, El-Tawousy M. 2001. Advances on the synthesis of radioiodinated
4-[*I]iodoantipyrin via no carrier added (N.C.A.) isotopic exchange. Mansoura
Sci Bull A: Chem. 28, 111–126.
Ercan MT, Caner B, Erbas B. 2001. Radiopharmaceuticals, radiation counters,
cameras and scanners. In: Arshady R (Ed). Microspheres, Microcapsules, Liposomes,
vol 3. Kentus Books, London, pp. 41–78.
Guillemin
R, Shigemasa E, Le Guen K, Ceolin D, Miron C, Leclercq N, Morin P, Simon M.
2001. Dynamical angular correlation in molecular Auger decay. Phys Rev Lett.
87, 203001.
Gulec
SA, Gaffga CM, Anthony CT, Su LJ, O'Leary JP, Woltering EA. 2001.
Antiangiogenic therapy with somatostatin receptor-mediated in situ radiation. Am Surg. 67, 1068–1071.
Gulec
SA, Drouant GJ, Fuselier J, Anthony CT, Heneghan J, DelCarpio JB, Coy DH,
Murphy WA, Woltering EA. 2001. Antitumor and antiangiogenic effects of
somatostatin receptor-targeted in situ
radiation with 111In-DTPA-JIC 2DL. J Surg Res. 97, 131–137.
Ho N, Tumeh PC, Kassis AI. 2001. Synthesis and biologic studies of iodinated
(125I/127I) ethidium. Nucl Med Biol. 28, 983–990.
Hoyes
KP, Lord BI, McCann C, Hendry JH, Morris ID. 2001. Transgenerational effects of
preconception paternal contamination with 55Fe. Radiat Res. 156, 488–494.
Kaminski JM, Kaminski RJ, Dicker AP, Urbain JLC.
2001. Defining a future role
for radiogenic therapy. Cancer Treat Rev. 27, 289–294.
Karnas SJ, Moiseenko VV, Yu E, Truong P, Battista
JJ. 2001. Monte Carlo
simulations and measurement of DNA damage from x-ray-triggered Auger cascades
in iododeoxyuridine (IUdR). Radiat Environ Biophys. 40, 199–206.
Lenarczyk
M, Goddu SM, Rao DV, Howell RW. 2001. Biologic dosimetry of bone marrow:
induction of micronuclei in reticulocytes after exposure to 32P and 90Y.
J Nucl Med. 42, 162–169.
Li WB, Friedland W, Pomplun E, Jacob P, Paretzke
HG, Lassmann M, Reiners C. 2001. Track
structures and dose distributions from decays of 131I and 125I
in and around water spheres simulating micrometastases of differentiated
thyroid cancer. Radiat Res. 156, 419–429.
McCready
VR, Cornes P. 2001. The potential of intratumoural unsealed radioactive source
therapy. Eur J Nucl Med. 28, 567–569.
Mil'shtein
S, Joy DC. 2001. Microanalysis using secondary electrons in scanning electron
microscopy. Scanning. 23, 295–297.
Ochakovskaya R, Osorio L, Goldenberg DM, Mattes MJ.
2001. Therapy of disseminated
B-cell lymphoma xenografts in severe combined immunodeficient mice with an
anti-CD74 antibody conjugated with 111indium, 67gallium,
or 90yttrium. Clin Cancer Res. 7, 1505–1510.
Ong GL, Elsamra SE, Goldenberg DM, Mattes MJ. 2001.
Single-cell cytotoxicity with
radiolabeled antibodies. Clin Cancer Res. 7, 192–201.
Panyutin IV, Luu AN, Panyutin IG, Neumann RD. 2001.
Strand breaks in whole plasmid
DNA produced by the decay of 125I in a triplex-forming
oligonucleotide. Radiat Res. 156, 158–166.
Persson
P, Lunell S, Szöke A, Ziaja B, Hajdu J. 2001. Shake-up and shake-off
excitations with associated electron losses in X-ray studies of proteins.
Protein Sci. 10, 2480–2484.
Pouget J-P, Mather SJ. (2001) General aspects of the cellular response to low- and high-LET radiation. Eur J Nucl Med. 28, 541–561.
Qaim
SM. 2001. Therapeutic radionuclides and nuclear data. Radiochim Acta. 89, 297–302.
Sedelnikova OA, Luu AN, Karamychev VN, Panyutin IG,
Neumann RD. 2001. Development
of DNA-based radiopharmaceuticals carrying Auger-electron emitters for antigene
radiotherapy. Int J Radiat Oncol Biol Phys. 49, 391–396.
Smit BS, Slabbert JP, Reinecke SA, Böhm L. 2001. Comparison of cell inactivation by Auger
electrons using the two reagents 4-[123I]iodoantipyrine and [123I]NaI.
Radiat Environ Biophys. 40, 47–52.
Thierens HM, Monsieurs MA, Brans B, Van Driessche
T, Christiaens I, Dierckx RA. 2001. Dosimetry from organ to cellular dimensions. Comput Med Imaging Graph. 25, 187–193.
Towu E, Boxer G, Begent R, Zweit J, Spitz L, Hobbs
K, Winslet M. 2001. In-vitro
uptake of radioactive lipiodol I-131 and I-125 by hepatoblastoma: implications
for targeted radiotherapy. Pediatr Surg Int. 17, 609–613.
Utteridge
TD,
Verkhoturov
SV, Schweikert EA, Chechik V, Sabapathy RC, Crooks RM, Parilis ES. 2001. Auger
stimulated ion desorption of negative ions via K-capture radioactive decay. Phys Rev Lett. 87, 037601.
Walicka MA, Adelstein SJ, Kassis AI. 2001. Chemical
modification of 5-[125I]iodo-2'-deoxyuridine toxicity in mammalian
cells in vitro. Int J Radiat Biol.
77, 625–630.
Yasui
LS, Hughes A, DeSombre ER. 2001. Cytotoxicity of 125I-oestrogen
decay in non-oestrogen receptor-expressing human breast cancer cells, MDA-231
and oestrogen receptor-expressing MCF-7 cells. Int J Radiat Biol. 77, 955–962.
Yasui
LS, Hughes A, DeSombre ER. 2001. Relative biological effectiveness of
accumulated 125IdU and 125I-estrogen decays in estrogen
receptor-expressing MCF-7 human breast cancer cells. Radiat Res. 155, 328–334.
2000
Behr TM, Béhé M, Löhr M, Sgouros G, Angerstein C,
Wehrmann E, Nebendahl K, Becker W. 2000. Therapeutic advantages of Auger electron- over b-emitting radiometals or radioiodine when
conjugated to internalizing antibodies. Eur J Nucl Med. 27, 753–765.
Bernard BF, Krenning E, Breeman WAP, Visser TJ,
Bakker WH, Srinivasan A, de Jong M. 2000. Use of rat pancreatic CA20948 cell line for the comparison of radiolabelled
peptides for receptor-targeted scintigraphy and radionuclide therapy. Nucl Med
Commun. 21, 1079–1085.
Beyer
GJ. 2000. Radioactive ion beams for biomedical research and nuclear medical
application. Hyperfine Interact. 129, 529–553.
Bingham
D, Bonner PT, Cox R, Edwards AA, Gardin I, Haines JW, Harrison JD. 2000.
Comparison of cytogenetic damage in cultured cells from cobalt-60
gamma-radiation and the Auger emitter zinc-65. Int J Radiat Biol. 76,
1223–1231.
Bingham
D, Gardin I, Hoyes KP. 2000. The problem of Auger emitters for radiological
protection. Radiat Prot Dosimetry. 92, 219–228.
Bishayee
A, Rao DV, Howell RW. 2000. Radiation protection by cysteamine against the
lethal effects of intracellularly localized Auger electron, a- and b-particle emitting radionuclides. Acta
Oncol. 39, 713–720.
Bishayee
A, Rao DV, Bouchet LG, Bolch WE, Howell RW. 2000. Protection by DMSO against
cell death caused by intracellularly localized iodine-125, iodine-131 and
polonium-210. Radiat Res. 153, 416–427.
Bishayee
A, Rao DV,
Bouchet
LG, Bolch WE, Goddu SM, Howell RW, Rao DV. 2000. Considerations in the
selection of radiopharmaceuticals for palliation of bone pain from metastatic
osseous lesions. J Nucl Med. 41, 682–687.
Charlton
DE. 2000. Radiation effects in spheroids of cells exposed to alpha emitters.
Int J Radiat Biol. 76, 1555–1564.
DeSombre
ER, Hughes A, Hanson RN,
Ercan
MT, Caglar M. 2000. Therapeutic radiopharmaceuticals. Curr Pharm Des. 6, 1085–1121.
Goorley
T, Nikjoo H. 2000. Electron and photon spectra for three gadolinium-based
cancer therapy approaches. Radiat Res. 154, 556–563.
Govindan
SV, Goldenberg DM, Elsamra SE, Griffiths GL, Ong GL, Brechbiel MW,
Hanson
RN. 2000. Synthesis of Auger electron-emitting radiopharmaceuticals. Curr Pharm
Des. 6, 1457–1468.
Hofer
KG. 2000. Biophysical aspects of Auger processes. Acta Oncol. 39, 651–657.
Hofer KG, Lin X, Schneiderman MH. 2000. Paradoxical effects of iodine-125 decays in
parent and daughter DNA: a new target model for radiation damage. Radiat Res.
153, 428–435.
Hornick
CA, Anthony CT, Hughey S, Gebhardt BM, Espenan GD, Woltering EA. 2000.
Progressive nuclear translocation of somatostatin analogs. J Nucl Med. 41, 1256–1263.
Howell
RW, Rao DV. 2000. Mechanism of the radiotoxicity of Auger electron emitters in
mammalian cells. Eleventh International Congress of Radiation Research, Dublin,
Ireland, July 18–23, 1999, Proceedings, vol 2, pp. 150–153.
Hung
JC, Redfern MG, Mahoney DW, Thorson LM, Wiseman GA. 2000. Evaluation of
macroaggregated albumin particle sizes for use in pulmonary shunt patient
studies. J Am Pharm Assoc. 40, 46–52.
Janson
ET, Westlin J-E, Öhrvall U, Öberg K, Lukinius A. 2000. Nuclear localization of 111In
after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients
with neuroendocrine tumors. J Nucl Med. 41, 1514–1518.
Karagiannis
TC, Lobachevsky PN, Martin RF. 2000. Cytotoxicity of an 125I-labelled
DNA ligand. Acta Oncol. 39, 681–685.
Karamychev
VN, Reed MW, Neumann RD, Panyutin IG. 2000. Distribution of DNA strand breaks
produced by iodine-123 and indium-111 in synthetic oligodeoxynucleotides. Acta
Oncol. 39, 687–692.
Karamychev
VN, Panyutin IG, Kim M-K, Le N, Paik CH, Carrasquillo JA, Reed MW, Neumann RD.
2000. DNA cleavage by 111In-labeled oligodeoxyribonucleotides. J
Nucl Med. 41, 1093–1101.
Kassis AI, Walicka MA, Adelstein SJ. 2000. Double-strand break yield following 125I
decay: effects of DNA conformation. Acta Oncol. 39,
721–726.
Kassis AI, Dahman BA, Adelstein SJ. 2000. In vivo therapy of neoplastic meningitis
with methotrexate and 5-[125I]iodo-2'-deoxyuridine. Acta Oncol. 39,
731–737.
King
CR. 2000. What is the Tpot for
prostate cancer? Radiobiological implications of the equivalent outcome with 125I
or 103Pd. Int J Radiat Oncol Biol Phys. 47, 1165–1167.
Krenning
EP, Valkema R, Kooij PPM, Breeman WAP, Bakker WH, de Herder WW, van Eijck CHJ,
Kwekkeboom DJ, de Jong M, Jamar F, Pauwels S. 2000. The role of radioactive
somatostatin and its analogues in the control of tumor growth. Recent Results
Cancer Res. 153, 1–13.
Kriehuber R, Simkó M. 2000. Apoptosis induction and micronucleus
formation after exposure to the Auger electron emitter zinc-65 in a human cell
line. Acta Oncol. 39, 699–706.
Le
Sech C, Takakura K, Saint-Marc C, Frohlich H, Charlier M, Usami N, Kobayashi K.
2000.
Li W, Zhang X, Li Q. 2000. Therapeutic radionuclides and spallation
neutron sources. Hejishu. 23, 828–832.
Lobachevsky
PN, Martin RF. 2000. Iodine-125 decay in a synthetic oligodeoxynucleotide. I.
Fragment size distribution and evaluation of breakage probability. Radiat Res.
153, 263–270.
Lobachevsky PN, Martin RF. 2000. Iodine-125 decay in a synthetic
oligodeoxynucleotide. II. The role of Auger electron irradiation compared to
charge neutralization in DNA breakage. Radiat Res. 153, 271–278.
Ludwików G, Hoebe RA, Franken NAP, van Oven CH,
Stap J, Aten JA. 2000. A method
for the selective irradiation of part of a genome. Acta Oncol. 39, 693–698.
Mairs
RJ, Wideman CL, Angerson WJ, Whateley TL, Reza MS, Reeves JR, Robertson LM,
Neshasteh-Riz A, Rampling R, Owens J, Allan D, Graham DI. 2000. Comparison of
different methods of intracerebral administration of radioiododeoxyuridine for
glioma therapy using a rat model. Br J Cancer. 82, 74–80.
Malkov
VA, Panyutin IG, Neumann RD, Zhurkin VB, Camerini-Otero RD. 2000. Radioprobing
of a RecA-three-stranded DNA complex with iodine 125: evidence for recognition
of homology in the major groove of the target duplex. J Mol Biol. 299, 629–640.
Mariani
G, Bodei L, Adelstein SJ, Kassis AI. 2000. Emerging roles for radiometabolic
therapy of tumors based on Auger electron emission. J Nucl Med. 41, 1519–1521.
Nguyen
BD, Roarke MC. 2000. Demonstration of non-small-cell lung carcinoma by
indium-111 octreotide scintigraphy. Clin Nucl Med. 25, 814–816.
Nikjoo
H, Laughton CA, Terrissol M, Panyutin IG, Goodhead DT. 2000. A method for
radioprobing DNA structures using Auger electrons. Int J Radiat Biol. 76, 1607–1615.
Nikjoo
H, Panyutin IG, Terrissol M, Vrigneaud J-M, Laughton CA. 2000. Distribution of
strand breaks produced by Auger electrons in decay of 125I in
triplex DNA. Acta Oncol. 39, 707–712.
Nikjoo
H, Vrigneaud JM, Terrissol M,
Panyutin IG, Winters TA, Feinendegen LE, Neumann
RD. 2000. Development of
DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene
radiotherapy. Q J Nucl Med. 44, 256–267.
Pedraza-López M, Ferro-Flores G, Mendiola-Cruz
MT, Morales-Ramírez P. 2000. Assessment
of radiation-induced DNA damage caused by the incorporation of 99mTc-radiopharmaceuticals
in murine lymphocytes using single cell gel electrophoresis. Mutat Res. 465,
139–144.
Pomplun
E. 2000. Auger electron spectra: the basic data for understanding the Auger
effect. Acta Oncol. 39, 673–679.
Reilly
RM, Kiarash R, Cameron RG, Porlier N, Sandhu J, Hill RP, Vallis K, Hendler A,
Gariépy J. 2000. 111In-labeled EGF is selectively radiotoxic to
human breast cancer cells overexpressing EGFR. J Nucl Med. 41, 429–438.
Rösch
F, Brockmann J, Lebedev NA, Qaim SM. 2000. Production and radiochemical
separation of the Auger electron emitter 140Nd. Acta Oncol. 39, 727–730.
Schönfeld E, Janßen H. 2000. Calculation of emission probabilities of
X-rays and Auger electrons emitted in radioactive disintegration processes.
Appl Radiat Isot. 52, 595–600.
Schwartz
Z, Lohmann CH, Blau G, Blanchard CR, Soskolne AW, Liu Y, Cochran DL, Dean DD,
Boyan BD. 2000. Re-use of implant coverscrews changes their surface properties
but not clinical outcome. Clin Oral Impl Res. 11, 183–194.
Sedelnikova OA, Panyutin IG, Luu AN, Reed MW, Licht
T, Gottesman MM, Neumann RD. 2000. Targeting the human mdr1 gene
by 125I-labeled triplex-forming oligonucleotides. Antisense Nucleic
Acid Drug Dev. 10, 443–452.
Shih L, Ong GL,
Stepanek
J, Ilvonen SA, Kuronen AA, Lampinen JS, Savolainen SE, Välimäki PJ. 2000.
Radiation spectra of 111In, 113mIn and 114mIn.
Acta Oncol. 39, 667–671.
Stepanek
J. 2000. Methods to determine the fluorescence and Auger spectra due to decay
of radionuclides or due to a single atomic-subshell ionization and comparisons
with experiments. Med Phys. 27, 1544–1554.
Thakur
ML, Marcus CS, Saeed S, Pallela V, Minami C, Diggles L, Le Pham H, Ahdoot R,
Kalinowski EA. 2000. 99mTc-labeled vasoactive intestinal peptide
analog for rapid localization of tumors in humans. J Nucl Med. 41, 107–110.
Tolmachev
V, Bernhardt P, Forssell-Aronsson E, Lundqvist H. 2000. 114mIn, a
candidate for radionuclide therapy: low-energy cyclotron production and
labeling of DTPA-D-Phe1-octreotide. Nucl Med Biol. 27, 183–188.
Turner
NH, Schreifels JA. 2000. Surface analysis: X-ray photoelectron spectroscopy and
Auger electron spectroscopy. Anal Chem. 72, 99R–110R.
Ünak
T. 2000. Potential use of radiolabeled glucuronide prodrugs with Auger and/or
alpha emitters in combined chemo- and radio-therapy of cancer. Curr Pharm
Design. 6, 1127–1142.
van Hagen PM, Breeman WAP, Bernard HF, Schaar M, Mooij CM, Srinivasan A, Schmidt MA, Krenning EP, de Jong M. (2000) Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy. Int J Cancer. 90, 186–198.
Walicka
MA, Ding Y, Adelstein SJ, Kassis AI. 2000. Toxicity of DNA-incorporated
iodine-125: quantifying the direct and indirect effects. Radiat Res. 154, 326–330.
Walicka MA, Ding Y, Adelstein SJ, Kassis AI. 2000. Morphological transformation of C3H 10T1/2
cells by 99mTc-Cardiolite. J Nucl Med. 41, 1545–1551.
Xiao
W-H, Dupertuis YM, Mermillod B, Sun L-Q, de Tribolet N, Buchegger F. 2000.
Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [125I]-iododeoxyuridine
in two human glioblastoma cell lines. Nucl Med Commun. 21, 947–953.
Yasui
LS, Hughes A, DeSombre ER. 2000. Production of clustered DNA damage by 125I
decay. Acta Oncol. 39, 739–740.
Zanzonico
PB. 2000. Internal radionuclide radiation dosimetry: a review of basic concepts
and recent developments. J Nucl Med. 41, 297–308.
1999
Behr
TM, Sgouros G, Stabin MG, Béhé M, Angerstein C, Blumenthal RD, Apostolidis C,
Molinet R, Sharkey RM, Koch L, Goldenberg DM, Becker W. 1999. Studies on the
red marrow dosimetry in radioimmunotherapy: an experimental investigation of
factors influencing the radiation-induced myelotoxicity in therapy with b-, Auger/conversion electron-, or a-emitters. Clin Cancer Res. 5(suppl), 3031s–3043s.
Bolch
WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW, Erdi AK,
Aydogan B, Costes S, Watson EE; in collaboration with the MIRD Committee, Society
of Nuclear Medicine, Watson EE, chair, Robertson JS, task group leader. 1999. MIRD
pamphlet no. 17: the dosimetry of nonuniform activity distributions—radionuclide
S values at the voxel level. J Nucl Med. 40, 11S–36S.
de Jong M, Breeman WAP, Bernard BF, van Gameren A,
de Bruin E, Bakker WH, van der Pluijm ME, Visser TJ, Mäcke HR, Krenning EP.
1999. Tumour uptake of the
radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide
is dependent on the peptide amount. Eur J Nucl Med. 26, 693–698.
Espenan
GD, Nelson JA,
Gardin
I, Faraggi M, Le Guludec D, Bok B. 1999. Cell irradiation caused by diagnostic
nuclear medicine procedures: dose heterogeneity and biological consequences.
Eur J Nucl Med 26, 1617–1626.
Hofland LJ, Breeman WAP, Krenning EP, de Jong M,
Waaijers M, van Koetsveld PM, Mäcke HR, Lamberts SWJ. 1999. Internalization of [DOTAo,125I-Tyr3]octreotide
by somatostatin receptor–positive cells in vitro and in vivo: implications for
somatostatin receptor–targeted radioguided surgery. Proc Assoc Am Phys. 111,
63–69.
Janson ET, Eriksson B, Öberg K, Skogseid B, Öhrvall
U, Nilsson S, Westlin J-E. 1999. Treatment
with high dose [111In-DTPA-D-Phe1]-octreotide in patients
with neuroendocrine tumors: evaluation of therapeutic and toxic effects. Acta
Oncol. 38, 373–377.
Karamychev
VN, Zhurkin VB, Garges S,
Kassis AI, Harapanhalli RS, Adelstein SJ. 1999. Comparison of strand breaks in plasmid DNA
after positional changes of Auger electron-emitting iodine-125. Radiat Res.
151, 167–176.
Kassis AI, Harapanhalli RS, Adelstein SJ. 1999. Strand breaks in plasmid DNA after
positional changes of Auger electron-emitting iodine-125: direct compared to
indirect effects. Radiat Res. 152, 530–538.
Krenning EP, de Jong M, Kooij PPM, Breeman WAP,
Bakker WH, de Herder WW, van Eijck CHJ, Kwekkeboom DJ, Jamar F, Pauwels S,
Valkema R. 1999. Radiolabelled
somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide
therapy. Ann Oncol. 10(suppl 2), S23–S29.
Krenning
EP, Valkema R, Kooij PPM, Breeman WAP, Bakker WH, deHerder WW, van Eijck CHJ,
Kwekkeboom DJ, deJong M, Pauwels S. 1999. Scintigraphy and radionuclide therapy
with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide.
Ital J Gastroenterol Hepatol. 31(suppl 2), S219–S223.
Lampinen
JS, Välimäki PJ, Kuronen AA, Stepanek J, Savolainen SE. 1999. Cluster models in
cellular level electron dose calculations. Acta Oncol. 38, 367–372.
Lukinius A, Öhrvall U, Westlin J-E, Öberg K, Janson
ET. 1999. In vivo cellular
distribution and endocytosis of the somatostatin receptor–ligand complex. Acta
Oncol. 38, 383–387.
Patel S, Stein R, Ong GL, Goldenberg DM, Mattes MJ. 1999. Enhancement of tumor-to-nontumor localization ratios by hepatocyte-directed blood clearance of antibodies labeled with certain residualizing radiolabels. J Nucl Med. 40, 1392–1401.
Radford
IR, Aldridge DR. 1999. Importance of DNA damage in the induction of apoptosis
by ionizing radiation: effect of the scid
mutation and DNA ploidy on the radiosensitivity of murine lymphoid cell
lines. Int J Radiat Biol. 75, 143–153.
Reddy
AR, Nagaratnam A, Jain SC, Gupta MM, Mehta SC. 1999. Dosimetry of internal
emitters. Quo vadis? Kerntechnik. 64, 21–28.
Rogers
BE, McLean SF, Kirkman RL, Della Manna D, Bright SJ, Olsen CC, Myracle AD, Mayo
MS, Curiel DT, Buchsbaum DJ. 1999. In
vivo localization of [111In]-DTPA-D-Phe1 octreotide to human ovarian
tumor xenografts induced to express the somatostatin receptor subtype 2 using
an adenoviral vector. Clin Cancer Res. 5, 383–393.
Sedelnikova OA, Panyutin IG, Luu AN, Neumann RD.
1999. The stability of DNA
triplexes inside cells as studied by iodine-125 radioprinting. Nucleic Acids
Res. 27, 3844–3850.
Slabbert JP, Langenhoven JH, Smit BS. 1999. Synthesis of [123I]
iodoantipyrine to study the high-LET characteristics of Auger electrons in
mammalian cells. J Radioanal Nucl Chem. 240, 505–508.
Slooter
GD, Breeman WAP, Marquet RL, Krenning EP, van Eijck CHJ. 1999.
Anti-proliferative effect of radiolabelled octreotide in a metastases model in
rat liver. Int J Cancer. 81, 767–771.
Stein R, Govindan SV, Mattes MJ, Shih LB, Griffiths
GL, Hansen HJ, Goldenberg DM. 1999. Targeting human cancer xenografts with monoclonal antibodies labeled
using radioiodinated, diethylenetriaminepentaacetic acid-appended peptides.
Clin Cancer Res. 5(10, suppl), 3079s–3087s.
Tabata M, Kondo M, Haruta Y, Seon BK. 1999. Antiangiogenic radioimmunotherapy of human
solid tumors in SCID mice using 125I-labeled anti-endoglin
monoclonal antibodies. Int J Cancer. 82, 737–742.
Thakur
ML, Li J, Kim SM, Zhang JJ, Andrews D. 1999. Targeting tumors with iodine-123
labeled deoxyuridine: distribution and DNA binding. Cancer Detect Prev. 23,
72–77.
Walicka MA, Ding Y, Roy AM, Harapanhalli RS,
Adelstein SJ, Kassis AI. 1999. Cytotoxicity
of [125I]iodoHoechst 33342: contribution of scavengeable effects.
Int J Radiat Biol. 75, 1579–1587.
Wright
A. 1999. The effect of WR, AUGER >1 for radiopharmaceuticals on equivalent
dose and other related quantities. Sixth International Radiopharmaceutical
Dosimetry Symposium, Gatlinburg, TN, May 7–10, 1996, Proceedings, vol 2, pp.
552–570.
1998
Adelstein
SJ, Howell RW, Humm JL, Makrigiorgos GM, Wessels BW. 1998. On the conceptual
basis for dose quantities in nuclear medicine. ICRU News. 1, 4–10.
Behr TM, Sgouros G, Vougioukas V, Memtsoudis S,
Gratz S, Schmidberger H, Blumenthal RD, Goldenberg DM, Becker W. 1998. Therapeutic efficacy and dose-limiting
toxicity of Auger-electron vs. beta
emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I-
vs. 131I-labeled CO17-1A
in a human colorectal cancer model. Int J Cancer. 76, 738–748.
Breeman WAP, de Jong M, Bernard B, Hofland LJ,
Srsinivasan A, van der Pluijm M, Bakker WH, Visser TJ, Krenning EP. 1998. Tissue distribution and metabolism of
radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives
of octreotide in rats. Anticancer Res. 18, 83–89.
Charlton
DE, Utteridge TD, Allen BJ. 1998. Theoretical treatment of human haemopoietic
stem cell survival following irradiation by alpha particles. Int J Radiat Biol.
74, 111–118.
Chaturvedi
S, Rodriguez J, Jirsak T, Hrbek J. 1998. Ag "promoted" sulfidation of
metal and oxide surfaces: a photoemission study of the interaction of sulfur
with Ag/Rh(111) and Ag/ZnO. Surf Sci. 412/413, 273–286.
Cunningham
SH, Mairs RJ, Wheldon TE, Welsh PC, Vaidyanathan G, Zalutsky MR. 1998. Toxicity
to neuroblastoma cells and spheroids of benzylguanidine conjugated to
radionuclides with short-range emissions. Br J Cancer. 77, 2061–2068.
de Jong M, Bernard BF, de Bruin E, van Gameren A,
Bakker WH, Visser TJ, Mäcke HR, Krenning EP. 1998. Internalization of
radiolabelled [DTPA0]octreotide and [DOTA0, Tyr3]octreotide:
peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
Nucl Med Commun. 19, 283–288.
de Jong M, Breeman WAP, Bakker WH, Kooij PPM,
Bernard BF, Hofland LJ, Visser TJ, Srinivasan A, Schmidt MA, Erion JL, Bugaj
JE, Mäcke HR, Krenning EP. 1998. Comparison
of 111In-labeled somatostatin analogues for tumor scintigraphy and
radionuclide therapy. Cancer Res. 58, 437–441.
de Jong M, Bakker WH, Breeman WAP, Bernard BF,
Hofland LJ, Visser TJ, Srinivasan A, Schmidt M, Béhé M, Mäcke HR, Krenning EP.
1998. Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3]
octreotide and [DOTA0, Tyr3] octreotide as carriers for
somatostatin receptor-targeted scintigraphy and radionuclide therapy. Int J Cancer. 75, 406–411.
Faraggi M, Gardin I, Stievenart J-L, Bok BD, Le
Guludec D. 1998. Comparison of
cellular and conventional dosimetry in assessing self-dose and cross-dose
delivered to the cell nucleus by electron emissions of 99mTc, 123I,
111In, 67Ga and 201Tl. Eur J Nucl Med. 25,
205–214.
Harapanhalli RS, Roy AM, Adelstein SJ, Kassis AI.
1998. [125I/127I/131I]iodorhodamine:
synthesis, cellular localization, and biodistribution in athymic mice bearing
human tumor xenografts and comparison with [99mTc]hexakis(2-methoxyisobutylisonitrile).
J Med Chem. 41, 2111–2117.
Howell
RW, Goddu SM, Bishayee A, Rao DV. 1998. Radioprotection against lethal damage
caused by chronic irradiation with radionuclides in vitro. Radiat Res. 150, 391–399.
Hoyes
KP, Nettleton JS, Lawson RS, Morris ID. 1998. Transferrin-dependent uptake and
dosimetry of Auger-emitting diagnostic radionuclides in human spermatozoa. J
Nucl Med. 39, 895–899.
Jääskelä-Saari
HA, Kairemo KJA, Ramsay HA, Grénman R. 1998. Labelling of bleomycin with
Auger-emitter increases cytotoxicity in squamous-cell cancer cell lines. Int J
Radiat Biol. 73, 565–570.
Kaplan
MI, Morgan WF. 1998. The nucleus is the target for radiation-induced
chromosomal instability. Radiat Res. 150, 382–390.
Kassis
AI, Wen PY, Van den Abbeele AD, Baranowska-Kortylewicz J, Makrigiorgos GM, Metz
KR, Matalka KZ, Cook CU, Sahu SK, Black PMcL, Adelstein SJ. 1998. 5-[125I]iodo-2'-deoxyuridine
in the radiotherapy of brain tumors in rats. J Nucl Med. 39, 1148–1154.
Kinne RW, Meyer P, Gründer W, Buchner E,
Palombo-Kinne E, Heinzel-Wieland R, Becker W, Wolf F, Kalden JR, Burkhardt H.
1998. Rat antigen-induced
arthritis: cartilage alterations assessed with iodine-123-antileukoproteinase.
J Nucl Med. 39, 1638–1645.
Manome Y, Kunieda T, Wen PY, Koga T, Kufe DW, Ohno
T. 1998. Transgene expression
in malignant glioma using a replication-defective adenoviral vector containing
the Egr-1 promoter: activation by
ionizing radiation or uptake of radioactive iododeoxyuridine. Hum Gene Ther. 9,
1409–1417.
Matalka
KZ. 1998. Selectivity and diffusion pattern of 5-iodo-2'-deoxyuridine into
infiltrative or metastatic 9L-gliosarcoma bearing rats following intracerebral
injection. Dirasat: Med Biol Sci. 25, 13–18.
McCarthy
KE, Woltering EA, Espenan GD, Cronin M, Maloney TJ, Anthony LB. 1998. In situ
radiotherapy with 111In-pentetreotide: initial observations and
future directions. Cancer J Sci Am. 4, 94–102.
Meyers
MO, Anthony CT, Coy DH, Murphy WA, Drouant GJ, Fuselier J, Espenan GD, Maloney
TJ, Woltering EA. 1998. Multiply radioiodinated somatostatin analogs induce
receptor-specific cytotoxicity. J Surg Res. 76, 154–158.
Murali
D, DeJesus OT. 1998. Synthesis of 4'-epi-iodo-4'-deoxy-daunorubicin, a
potential cancer radiotherapeutic agent. Bioorg Med Chem Lett. 8, 3419–3422.
Neshasteh-Riz
A, Mairs RJ, Angerson WJ,
Patton
JA. 1998. Introduction to nuclear physics. Radiographics. 18, 995–1007.
Reza
MS, Whateley TL. 1998. Iodo-2'-deoxyuridine (IUdR) and 125IUdR
loaded biodegradable microspheres for controlled delivery to the brain. J
Microencapsul. 15, 789–801.
Roa
WHY, Miller GG, McEwan AJB, McQuarrie SA, Tse J, Wu J, Wiebe LI. 1998. Targeted
radiotherapy of multicell neuroblastoma spheroids with high specific activity [125I]meta-iodobenzylguanidine.
Int J Radiat Oncol Biol Phys. 41, 425–432.
Schneiderman
MH, Jackson JD, Joshi SS, Clark-Pierce L, Murphy BJ, Schneiderman GS. 1998.
Cell cycle-based purging of lymphoma cells from bone marrow harvests using
radioiodinated 5-iodo-2'-deoxyuridine. Radiat Res. 149, 147–154.
Schomäcker
K, Fischer T, Böttcher B, Mraheel SA, Scharl A, Gabruk-Szostak B, Scheidhauer
K, Göhring U-J, Meller-Rehbein B, Shukla SK, Schicha H. 1998. Kinetics of
receptor-mediated radiotoxicity of 16a-[125I]-iodoestradiol-3,17b. Nuklearmedizin. 37, 134–140.
Sedelnikova
OA, Panyutin IG,
Sgouros
G, O'Donoghue JA, Larson SM, Macapinlac H, Larson JJ, Kemeny N. 1998.
Mathematical model of 5-[125I]iodo-2'-deoxyuridine treatment:
continuous infusion regimens for hepatic metastases. Int J Radiat Oncol Biol
Phys. 41, 1177–1183.
Shinohara
K. 1998. Photon activation therapy. Kagaku Kogyo. 49, 570–574.
Spalek A, Dragoun O, Rysavy M, Brabec V, Dragounova
N. 1998. Origin of the
low-energy lines in beta-ray spectra. Acta Polytech. 38, 31–32.
Virgolini
I, Szilvasi I, Kurtaran A, Angelberger P, Raderer M, Havlik E, Vorbeck F,
Bischof C, Leimer M, Dorner G, Kletter K, Niederle B, Scheithauer W,
Smith-Jones P. 1998. Indium-111-DOTA-lanreotide: biodistribution, safety and
radiation absorbed dose in tumor patients. J Nucl Med. 39, 1928–1936.
Walicka MA, Adelstein SJ, Kassis AI. 1998. Indirect mechanisms contribute to biological
effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: double-strand breaks. Radiat
Res. 149, 134–141.
Walicka MA, Adelstein SJ, Kassis AI. 1998. Indirect mechanisms contribute to biological
effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: clonogenic survival. Radiat
Res. 149, 142–146.
Walicka
MA, Vaidyanathan G, Zalutsky MR, Adelstein SJ, Kassis AI. 1998. Survival and
DNA damage in Chinese hamster V79 cells exposed to alpha particles emitted by
DNA-incorporated astatine-211. Radiat Res. 150, 263–268.
Wang
HE, Chi KH, Yen SH, Chen FD, Chow WL, Huang KL, Wey SP, Ting G. 1998. The
preparation and formulation study on [125I/131I]-iododeoxyuridine
radiopharmaceutical for hepatoma therapy. Therapeut Radiol Oncol. 5, 285–291.
1997
Baranowska-Kortylewicz
J, Kortylewicz ZP, Hoffman D, Dalrymple GV. 1997. Prodrugs in site-selective
delivery of radiopharmaceuticals. Q J Nucl Med. 41, 127–139.
Cederbaum
LS, Zobeley J, Tarantelli F. 1997. Giant intermolecular decay and fragmentation
of clusters. Phys Rev Lett. 79, 4778–4781.
Goddu
SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. 1997. MIRD Cellular S Values: Self-Absorbed
Dose Per Unit Cumulated Activity for Selected Radionuclides and Monoenergetic Electron
and Alpha Particle Emitters Incorporated into Different Cell Compartments.
Society of Nuclear Medicine,
Kairemo
KJA, Ramsay HA, Paavonen TK, Jääskelä-Saari HA, Tagesson M, Ljunggren K, Strand
S-E. 1997. Biokinetics of indium-111-bleomycin complex in head and neck cancer—implementations
for radiochemotherapy. Cancer Detect Prev. 21, 83–90.
Larsen
RH,
Vaidyanathan G, Zalutsky MR. 1997. Cytotoxicity of a-particle-emitting 5-[211At]astato-2'-deoxyuridine in human
cancer cells. Int J Radiat Biol. 72, 79–90.
Manetou
A, Limouris GS. 1997. Effects in the testes after SPECT myocardial perfusion
with Tl-201 or Tc-99m hexaMIBI. Anticancer Res. 17, 1841–1844.
Neshasteh-Riz
A, Angerson WJ, Reeves JR, Smith G, Rampling R, Mairs RJ. 1997. Incorporation
of iododeoxyuridine in multicellular glioma spheroids: implications for
DNA-targeted radiotherapy using Auger electron emitters. Br J Cancer. 75, 493–499.
Nikjoo
H, O'Neill P, Goodhead DT, Terrissol M. 1997. Computational modelling of
low-energy electron-induced DNA damage by early physical and chemical events.
Int J Radiat Biol. 71, 467–483.
Panyutin
IG, Neumann RD. 1997. Radioprobing of DNA: distribution of DNA breaks produced
by decay of 125I incorporated into a triplex-forming oligonucleotide
correlates with geometry of the triplex. Nucleic Acids Res. 25, 883–887.
Peral
J, Ollis DF. 1997. TiO2 photocatalyst deactivation by gas-phase
oxidation of heteroatom organics. J Mol Catal A: Chem. 115, 347–354.
Reed
MW, Panyutin IG, Hamlin D, Lucas DD, Wilbur DS. 1997. Synthesis of 125I-labeled
oligonucleotides from tributylstannylbenzamide conjugates. Bioconjugate Chem.
8, 238–243.
Sahu
SK, Kortylewicz ZP, Baranowska-Kortylewicz J, Taube RA, Adelstein SJ, Kassis
AI. 1997. Strand breaks after the decay of iodine-125 in proximity to plasmid
pBR322 DNA. Radiat Res. 147, 401–408.
Sahu
SK, Wen PYC, Foulon CF, Nagel JS, Black PMcL, Adelstein SJ, Kassis AI. 1997. Intrathecal 5-[125I]iodo-2'-deoxyuridine
in a rat model of leptomeningeal metastases. J Nucl Med. 38, 386–390.
Sharkey RM, Behr TM, Mattes MJ, Stein R, Griffiths
GL, Shih LB, Hansen HJ, Blumenthal RD, Dunn RM, Juweid ME, Goldenberg DM. 1997.
Advantage of residualizing
radiolabels for an internalizing antibody against the B-cell lymphoma antigen,
CD22. Cancer Immunol Immunother. 44, 179–188.
Ünak T, Ünak P, Ongun B, Duman Y. 1997. Synthesis and iodine-125 labelling of
glucuronide compounds for combined chemo- and radiotherapy of cancer. Appl
Radiat Isot. 48, 777–783.
Wangberg
B, Nilsson O, Johanson V, Kölby L, Forssell-Aronsson E, Andersson, P, Fjälling
M, Tisell L-E, Ahlman H. 1997. Somatostatin receptors in the diagnosis and therapy
of neuroendocrine tumor. Oncologist. 2, 50–58.
Wheldon
TE, O'Donoghue JA. 1997. Microdosimetric considerations in the targeted
radiotherapy of cancer. The Royal Society of Chemistry, Special Publication No.
204, pp. 255–261.
1996
Adelstein
SJ, Kassis AI. 1996. Strand breaks in plasmid DNA following positional changes
of Auger-electron-emitting radionuclides. Acta Oncol. 35, 797–801.
Aksela H, Jauhiainen J, Nommiste E, Sairanen O-P,
Karvonen J, Kukk E, Aksela S. 1996. Angular distribution of Auger electrons in the decay of resonantly
excited 4d–13/2,5/2
6p states in Xe. Phys Rev A. 54,
2874–2881.
Andersson P, Forssell-Aronsson E, Johanson V,
Wängberg B, Nilsson O, Fjälling M, Ahlman H. 1996. Internalization of
indium-111 into human endocrine tumor cells after incubation with
indium-111-DTPA-Phe1-octreotide. J Nucl Med. 37, 2002–2006.
Baranowska-Kortylewicz J, Dalrymple GV, Harrison
KA, Holdeman KP, Sharp J G, Cohen SM, Lieberman RP, Schneiderman MH, Clausen
SR, Hoffman D, Lai J, Schneiderman GS, Helseth L. 1996. On the safety of 5-[125I]iodo-2'-deoxyuridine:
preclinical evaluation in swine. Acta Oncol. 35, 925–933.
Bardiès M, Myers MJ. 1996. Computational methods in
radionuclide dosimetry. Phys
Med Biol. 41, 1941–1955.
Baunack
S, Kúdela S, John A, Liebich V. 1996. Application of chemometric methods in Auger
electron microanalysis of composites. Anal Bioanal Chem. 355, 633–637.
Daghighian F, Humm JL, Macapinlac HA, Zhang J, Izzo
J, Finn R, Kemeny N, Larson SM. 1996. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of
colorectal cancer metastatic to liver. J Nucl Med. 37(4, suppl), 29S–32S.
Daghighian
F, Barendswaard E, Welt S, Humm J, Scott A, Willingham MC, McGuffie E, Old LJ,
Larson SM. 1996. Enhancement of radiation dose to the nucleus by vesicular
internalization of iodine-125-labeled A33 monoclonal antibody. J Nucl Med. 37,
1052–1057.
DeSombre ER, Hughes A, Landel CC, Greene G, Hanson
R, Schwartz JL. 1996. Cellular
and subcellular studies of the radiation effects of Auger electron-emitting
estrogens. Acta Oncol. 35, 833–840.
Emrich
JG, Bender H, Class R, Eshleman J, Miyamoto C, Brady LW. 1996. In vitro
evaluation of iodine-125-labeled monoclonal antibody (MAb 425) in human
high-grade glioma cells. Am J Clin Oncol. 19, 601–608.
Fjälling
M, Andersson P, Forssell-Aronsson E, Grétarsdóttir J, Johansson V, Tisell LE,
Wängberg B, Nilsson O, Berg G, Michanek A, Lindstedt G, Ahlman H. 1996.
Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide
in midgut carcinoid syndrome. J Nucl Med. 37, 1519–1521.
Ftácniková
S. 1996. Radiopharmaceuticals in nuclear medicine diagnostic procedures and the
problem of radiation protection. J Radioanal Nucl Chem. 209, 355–360.
Furusawa Y, Maezawa H, Suzuki K, Yamamoto Y,
Kobayashi K, Hieda K. 1996. Radiolytic products of bromodeoxyuridine in solids
by 60Co g-rays and monoenergetic
soft x-rays at the K-absorption edge of bromine. Acta Oncol. 35, 877–882.
Gardin I, Faraggi M, Huc E, Bok BD. 1996. Absorbed fraction to the cell nucleus for
low energy electrons. Acta Oncol. 35, 953–958.
Goddu
SM, Howell RW, Rao DV. 1996. Calculation of equivalent dose for Auger electron
emitting radionuclides distributed in human organs. Acta Oncol. 35, 909–916.
Goddu
SM, Narra VR, Harapanhalli RS, Howell RW, Rao DV. 1996. Radioprotection by DMSO
against the biological effects of incorporated radionuclides in vivo: comparison
with other radioprotectors and evidence for indirect action of Auger electrons.
Acta Oncol. 35, 901–907.
Hanson RN, Franke L, Murphy F. 1996. Radioiododestannylation: preparation of
radioiodinated vinyl alcohols and selected evaluation in rats. Nucl Med Biol.
23, 585–588.
Harapanhalli
RS, McLaughlin LW, Howell RW, Rao DV, Adelstein SJ, Kassis AI. 1996. [125I/127I]iodoHoechst
33342: synthesis, DNA binding, and biodistribution. J Med Chem. 39, 4804–4809.
Harrison
KA, Dalrymple GV, Baranowska-Kortylewicz J, Holdeman KP, Schneiderman MH,
Lieberman RP, Sharp JG, Cohen SM, Leichner PK, Augustine SC, Tempero MA, Taylor
RJ, Chiou RK. 1996. Radiolabeled iododeoxyuridine: safety evaluation. J Nucl
Med. 37(4, suppl), 13S–16S.
Hieda
K, Hirono T, Azami A, Suzuki M, Furusawa Y, Maezawa H, Usami N, Yokoya A,
Kobayashi K. 1996. Single- and double-strand breaks in pBR322 plasmid DNA by
monochromatic X-rays on and off the K-absorption peak of phosphorus. Int J
Radiat Biol. 70, 437–445.
Hofer
KG. 1996. Biophysical aspects of Auger processes: a review. Acta Oncol. 35,
789–796.
Hofer KG, Lin X, Bao S-P. 1996. DNA damage, micronucleus formation, and cell
death from 125I decays in DNA. Acta Oncol. 35, 825–832.
Jonsson
A-C, Jönsson B-A, Strand S-E, Grafström G, Spanne P. 1996. Cell survival after
Auger electron emission from stable intracellular indium exposed to
monochromatic synchrotron radiation. Acta Oncol. 35, 947–952.
Kairemo
KJA, Ramsay HA, Paavonen T, Bondestam S. 1996. Imaging and staging of head and
neck cancer using a low pH In-111-bleomycin complex. Eur J Cancer Oral Oncol.
32B, 311–321.
Kairemo
KJA, Ramsay HA, Tagesson M, Jekunen AP, Paavonen TK, Jääskelä-Saari HA,
Liewendahl K, Ljunggren K, Savolainen S, Strand S-E. 1996. Indium-111 bleomycin
complex for radiochemotherapy of head and neck cancer — dosimetric and
biokinetic aspects. Eur J Nucl Med. 23, 631–638.
Kairemo
KJA. 1996. Radioimmunotherapy of solid cancers: a review. Acta Oncol. 35,
343–355.
Kamnev
AA, Smekhnov AA. 1996. Spectroscopic study of nickel(II) hydroxide surface
modifications induced by a small iron(III) addition. Anal Bioanal Chem. 355,
710–712.
Kandaiya
S, Lobachevsky PN, D'Cunha G, Martin RF. 1996. DNA strand breakage by 125I-decay
in a synthetic oligodeoxynucleotide: fragment distribution and evaluation of
DMSO protection effect. Acta Oncol. 35, 803–808.
Kassis AI, Adelstein SJ, Mariani G. 1996. Radiolabeled nucleoside analogs in cancer
diagnosis and therapy. Q J Nucl Med. 40, 301–319.
Kassis
AI, Tumeh SS, Wen PYC, Baranowska-Kortylewicz J, Van den Abbeele AD, Zimmerman
RE, Carvalho PA, Garada BM, DeSisto WC, Bailey NO, Castronovo FP Jr, Mariani G,
Black PMcL, Adelstein SJ. 1996. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine
in a patient with a brain tumor. J Nucl Med. 37(4, suppl), 19S–22S.
Kassis
AI, Adelstein SJ. 1996. Preclinical animal studies with radioiododeoxyuridine.
J Nucl Med. 37(4, suppl), 10S–12S.
Kassis
AI, Adelstein SJ. 1996. Preface to radiolabeled IUdr. J Nucl Med. 37(4, suppl),
i.
Kassis AI, Adelstein SJ. 1996. 5-[125I]iodo-2'-deoxyuridine in
the radiotherapy of solid CNS tumors in rats. Acta Oncol. 35,
935–939.
Laster BH, Shani G, Kahl SB, Warkentien L. 1996. The biological effects of Auger electrons
compared to a-particles and Li ions. Acta Oncol. 35,
917–923.
Leners
N, Jamar F, Fiasse R, Ferrant A, Pauwels S. 1996. Indium-111-pentetreotide
uptake in endocrine tumors and lymphoma. J Nucl Med. 37, 916–922.
Lobachevsky
PN, Martin RF. 1996. DNA strand breakage by 125I-decay in a
synthetic oligodeoxynucleotide: quantitative analysis of fragment distribution.
Acta Oncol. 35, 809–815.
Ludwików
G, Hofer KG, Bao S-P, Ludwików F. 1996. The effect of 125I decay at
different stages of S-phase on survival, expression of micronuclei and
chromosome aberrations in CHO cells. Int J Radiat Biol. 70, 177–187.
Macapinlac
HA, Kemeny N, Daghighian F, Finn R, Zhang J, Humm J, Squire O, Larson SM. 1996.
Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the
treatment of colorectal cancer metastatic to the liver. J Nucl Med. 37(4,
suppl), 25S–29S.
Maezawa H, Furusawa Y, Kobayashi K, Hieda K, Suzuki
M, Usami N, Yokoya A, Mori T. 1996. Lethal effect of K-shell absorption of
intracellular phosphorus on wild-type and radiation sensitive mutants of
Escherichia coli. Acta Oncol. 35, 889–894.
Mariani G, Di Sacco S, Volterrani D, Di Luca L,
Buralli S, Di Stefano R, Baranowska-Kortylewicz J, Bonora D, Matteucci F, Ricci
S, Bellina CR, Falcone A, Salvadori PA, Mosca F, Adelstein SJ, Kassis AI. 1996.
Tumor targeting by
intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients
with liver metastases from colorectal cancer. J Nucl Med. 37(4, suppl),
22S–25S.
Mariani
G, Collecchi P, Baldassarri S, Di Luca L, Buralli S, Fontanini G,
Baranowska-Kortylewicz J, Adelstein SJ, Kassis AI. 1996. Tumor uptake and
mitotic activity pattern of 5-[125I]iodo-2'-deoxyuridine after
intravesical infusion in patients with bladder cancer. J Nucl Med. 37(4,
suppl), 16S–19S.
Mariani G, Di Sacco S, Bonini R, Di Luca L, Buralli
S, Bonora D, Ricci S, Baranowska-Kortylewicz J, Adelstein SJ, Falcone A,
Kassis, AI. 1996. Biochemical
modulation by 5-fluorouracil and l-folinic acid of tumor uptake of
intra-arterial 5-[123I]iodo-2'-deoxyuridine in patients with liver
metastases from colorectal cancer. Acta Oncol. 35, 941–945.
Mester J, DeGoeij K, Sluyser M. 1996. Modulation of [5-125I]iododeoxyuridine
incorporation into tumour and normal tissue DNA by methotrexate and thymidylate
synthase inhibitors. Eur J Cancer. 32A, 1603–1608.
Miyamoto
CT, Brady LW, Rackover MA, Emrich J, Class R, Bender H, Micaily B, Steplewski
Z. 1996. The use of epidermal growth factor receptor-425 monoclonal antibodies
radiolabeled with iodine-125 in the adjuvant treatment of patients with high
grade gliomas of the brain. Recent Results Cancer Res. 141, 183–192.
Nettleton
JS, Lawson RS. 1996. Cellular dosimetry of diagnostic radionuclides for
spherical and ellipsoidal geometry. Phys Med Biol. 41, 1845–1854.
Nikjoo
H, Martin RF, Charlton DE, Terrissol M, Kandaiya S, Lobachevsky P. 1996.
Modelling of Auger-induced DNA damage by incorporated 125I. Acta
Oncol. 35, 849–856.
O'Donoghue
JA, Wheldon TE. 1996. Targeted radiotherapy using Auger electron emitters. Phys
Med Biol. 41, 1973–1992.
O'Donoghue
JA. 1996. Strategies for selective targeting of Auger electron emitters to
tumor cells. J Nucl Med. 37(4, suppl), 3S–6S.
Orson
FM, McShan WM, Kinsey BM. 1996. Sequence-specific binding and cleavage of
duplex DNA by a radioiodinated, intercalator-linked, triplex-forming
oligonucleotide. Nucl Med Biol. 23, 519–524.
Panyutin
IG, Neumann RD. 1996. Sequence-specific DNA breaks produced by triplex-directed
decay of iodine-125. Acta Oncol. 35, 817–823.
Parhofer S, Pfandzelter R, Potthoff M. 1996. Energy shift of the Cu L3M4,5M4,5 Auger line excited by
proton impact on Cu(110): enhanced electron correlations at the surface. Phys
Rev B 53, 10377–10381.
Persson
L. 1996. Pierre Auger—a life in the service of science. Acta Oncol. 35, 785–787.
Persson
L, 1996. Radiation protection issues of Auger electron emitters. Radiat Prot Dosimetry.
64, 189–191.
Persson
L. 1996. The Auger electron effect in radiation dosimetry - a review. IRPA9,
International Congress on Radiation Protection: Ninth International Congress of
the International Radiation Protection Association, Vienna, April 14–19, 1996,
Proceedings, vol 2, pp. 511–513.
Pomplun E. Terrissol M, Demonchy M. 1996. Modelling of initial events and chemical
behaviour of species induced in DNA units by Auger electrons from 125I,
123I and carbon. Acta Oncol. 35, 857–862.
Pomplun
E. 1996. Computer simulation of electron induced molecular radiation damage. Fortschr Strahlenschutz.
FS-96-78-T, 147–151.
Schneiderman MH, Schneiderman GS, Mühlmann-Díaz MC,
Bedford JS. 1996. The presence
of DNA breaks and the formation of chromatid aberrations after incorporation of
125IdUrd may be necessary but are not sufficient to block cell cycle
progression in G2 phase. Radiat Res. 145, 17–23.
Schneiderman
MH, Schneiderman GS. 1996. Radioiododeoxyuridine in cancer therapy: an in vitro
approach to developing in vivo strategies. J Nucl Med. 37(4, suppl), 6S–9S.
Schwartz
JL, Mustafi R, Hughes A, DeSombre ER. 1996. DNA and chromosome breaks induced
by iodine-123-labeled estrogen in Chinese hamster ovary cells. Radiat Res. 146,
151–158.
Shinohara
K, Nakano H, Ohara H. 1996. Detection of Auger enhancement induced in HeLa
cells labeled with iododeoxyuridine and irradiated with 150 kV x-rays: effects
of cysteamine and dimethylsulfoxide. Acta Oncol. 35, 869–875.
Srivastava
SC. 1996. Criteria for the selection of radionuclides for targeting nuclear
antigens for cancer radioimmunotherapy. Cancer Biother Radiopharm. 11, 43–50.
Stepanek
J, Larsson B, Weinreich R. 1996. Auger-electron spectra of radionuclides for
therapy and diagnostics. Acta Oncol. 35, 863–868.
Vaidyanathan
G, Larsen RH, Zalutsky MR. 1996. 5-[211At]astato-2'-deoxyuridine, an
a-particle-emitting endoradiotherapeutic
agent undergoing DNA incorporation. Cancer Res. 56, 1204–1209.
Van den Abbeele AD, Tutrone RF, Berman RM,
Baranowska-Kortylewicz J, Barclay PD, Richie JP, Adelstein SJ, Kassis AI. 1996.
Tumor-targeting potential of
radioiodinated iododeoxyuridine in bladder cancer. J Nucl Med. 37, 315–320.
van Dieren EB, Plaizier MABD, van Lingen A, Roos
JC, Barendsen GW, Teule GJJ. 1996. Absorbed dose distribution of the Auger emitters 67Ga and 125I
and the b-emitters 67Cu, 90Y, 131I,
and 186Re as a function of tumor size, uptake, and intracellular
distribution. Int J Radiat Oncol Biol Phys. 36, 197–204.
Weber W, Weber J, Senekowitsch-Schmidtke R. 1996. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine
on neuroblastoma multicellular tumor spheroids of different sizes. Cancer Res.
56, 5428–5434.
Welt
S, Scott AM, Divgi CR, Kemeny NE, Finn RD, Daghighian F, St. Germain J,
Richards EC, Larson SM, Old LJ. 1996. Phase I/II study of iodine 125–labeled
monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol.
14, 1787–1797.
Yasui
LS, Hughes A, DeSombre ER. 1996. DNA damage induction by 125I-estrogen.
Acta Oncol. 35, 841–847.
Zweit
J. 1996. Radionuclides and carrier molecules for therapy. Phys Med Biol. 41,
1905–1914.
1995
Adelstein SJ, Kassis AI. 1995. Radiobiology. In: Wagner HN Jr, Szabo Z,
Buchanan J (Eds). Principles of Nuclear Medicine, second edition. W. B.
Saunders Company, Philadelphia, PA, pp. 95–105.
Bauer
HE. 1995. A fast and simple method for background removal in Auger electron
spectroscopy. Anal Bioanal Chem. 353, 450–455.
Breeman
WAP, Kwekkeboom DJ, Kooij PPM, Bakker WH, Hofland LJ, Visser TJ, Ensing GJ,
Lamberts SWJ, Krenning EP. 1995. Effect of dose and specific activity on tissue
distribution of indium-111-pentetreotide in rats. J Nucl Med. 36, 623–627.
Chandra
N, Sen S. 1995. Auger-electron spectroscopy of molecules: circular dichroism in
angular correlation with photoelectrons from rotating linear molecules. Phys
Rev A. 52, 2820–2828.
Collecchi P, Baldassarri S, Di Sacco S, Di Luca L,
Buralli S, Fontanini G, Gakis D, Baranowska-Kortylewicz J, Adelstein SJ, Kassis
AI, Mariani G. 1995. Intra-tumor
distribution of tumor uptake of 5-[125I]iodo-2'-deoxyuridine after
bladder instillation and of mitotic activity in patients with bladder cancer.
Third international symposium on biophysical aspects of Auger processes, August
24–25, 1995, Lund, Sweden, p. 44.
Feinendegen LE, Loken MK, Booz J, Mühlensiepen H,
Sondhaus CA, Bond VP. 1995. Cellular
mechanisms of protection and repair induced by radiation exposure and their
consequences for cell system responses. Stem Cells. 13(suppl 1), 7–20.
Geselowitz DA, McManaway MM, Hofer KG, Neumann RD.
1995. Low-LET radiotoxicity
from incorporated 3H or 125I during the cell cycle:
implications for mechanisms of high-LET damage. In: Fuciarelli AF, Zimbrick JD (Eds).
Radiation Damage in DNA: Structure/Function Relationships at Early Times.
Battelle Press, Columbus, OH, pp. 223–230.
Geselowitz
DA, Neumann RD. 1995. Quantitation of triple-helix formation using a
photo-cross-linkable aryl azide/biotin/oligonucleotide conjugate. Bioconjugate
Chem. 6, 502–506.
Goddu
SM, Howell RW, Rao DV. 1995. Generalized approach to absorbed dose calculations
for dynamic tumor and organ masses. J Nucl Med. 36, 1923–1927.
Guo
P, Ghebremedhin A, Ariyasinghe WM, Powers D. 1995. Angular distributions of
total LMM Auger electron yields
produced by energetic He+ ions in Ar, Cl, and S. Phys Rev A. 51,
2117–2121.
Hofer
KG, Bao S-P. 1995. Low-LET and high-LET radiation action of 125I
decays in DNA: effect of cysteamine on micronucleus formation and cell killing.
Radiat Res. 141, 183–192.
Hofland
LJ, van Koetsveld PM, Waaijers M, Zuyderwijk J, Breeman WAP, Lamberts SWJ.
1995. Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide
by mouse and human pituitary tumor cells: increase by unlabeled octreotide.
Endocrinology. 136, 3698–3706.
Lipp
RW, Silly H, Ranner G, Dobnig H, Passath A, Leb G, Krejs GJ. 1995. Radiolabeled
octreotide for the demonstration of somatostatin receptors in malignant
lymphoma and lymphadenopathy. J Nucl Med. 36, 13–18.
Macapinlac
H, Daghighian F, Kemeny N, Zhang J, Sgouros G, Finn R, Squire O, Humm J,
Bertino J, Larson S. 1995. Molecular radiotherapy of hepatic metastases from
colon cancer using I-125-5-iododeoxyuridine (IUdR). J Nucl Med. 36, 214P
(abstract).
Narra
VR, Harapanhalli RS, Goddu SM, Howell RW, Rao DV. 1995. Radioprotection against
biological effects of internal radionuclides in vivo by
S-(2-aminoethyl)isothiouronium bromide hydrobromide (AET). J Nucl Med. 36,
259–266.
Persson
L. 1995. A new problem in radiation protection: the Auger electron effect. IRPS
Bull. 9(2), 7–11.
Rao
DV, Shepstone BJ, Wilkins HB, Howell RW. 1995. Kinetics and dosimetry of
thallium-201 in human testes. J Nucl Med. 36, 607–609.
Sahu
SK, Kassis AI, Makrigiorgos GM, Baranowska-Kortylewicz J, Adelstein SJ. 1995.
The effects of indium-111 decay on pBR322 DNA. Radiat Res. 141, 193–198.
Sinkovic
B, Johnson PD, Brookes NB, Clarke A, Smith NV. 1995. Spin-polarized
Auger-electron diffraction study of the magnetic poisoning of Fe(001) by
sulfur. Phys Rev B. 52, R6955–R6958.
Sjöholn
H, Ljunggren K, Adeli R, Brun A, Ceberg C, Strand S-E, Salford LG. 1995. Necrosis
of malignant gliomas after intratumoral injection of 201Tl in vivo in the rat. Anti-Cancer Drugs.
6, 109–114.
Ying W, Fang D, Zhu B. 1995. Hydrogen sulfide poisoning of methanol
synthesis Cu-based catalyst. (II). Poisoning of commercial catalyst. Fuel Sci Technol
Int. 13, 289–302.
1994
Chadwick
KH, Leenhouts HP. 1994. On the linearity of the dose–effect relationship of DNA
double strand breaks. Int J Radiat Biol. 66, 549-552.
Charlton DE, Kassis AI, Adelstein SJ. 1994. A comparison of experimental and calculated
survival curves for V79 cells grown as monolayers or in suspension exposed to
alpha irradiation from 212Bi distributed in the growth medium. Radiat Prot Dosimetry. 52, 311–315.
Charlton DE, Hofer KG, van Loon N, Schneiderman MH.
1994. Double-strand breaks from
125I incorporated in the DNA and cell death. Int J Radiat Biol. 66,
437–440.
Faraggi M, Gardin I, de Labriolle-Vaylet C, Moretti
J-L, Bok BD. 1994. The
influence of tracer localization on the electron dose rate delivered to the
cell nucleus. J Nucl Med. 35, 113–119.
Fazleev
NG, Fry JL, Kaiser JH, Koymen AR, Lee KH, Niedzwiecki TD, Weiss AH. 1994.
Positron-annihilation-induced Auger-electron-spectroscopy studies of properties
of an alkali-metal overlayer on the Cu(100) surface. Phys Rev B. 49,
10577–10584.
Feinendegen LE, Bond VP, Booz J. 1994. The quantification of physical events within
tissue at low levels of exposure to ionizing radiation. ICRU News. 2, 9–13.
Goddu
SM, Howell RW, Rao DV. 1994. Cellular dosimetry: absorbed fractions for
monoenergetic electron and alpha particle sources and S-values for
radionuclides uniformly distributed in different cell compartments. J Nucl Med.
35, 303–316.
Goddu
SM, Rao DV, Howell RW. 1994. Multicellular dosimetry for micrometastases:
dependence of self-dose versus cross-dose to cell nuclei on type and energy of
radiation and subcellular distribution of radionuclides. J Nucl Med. 35,
521–530.
Goethals P, Lodewyckx W, van Eijkeren M, Dams R.
1994. Radioiodination of
2'-deoxyuridine: preparation and preliminary evaluation in tumour-bearing rats.
Appl Radiat Isot. 45, 149–153.
Harapanhalli
RS, Narra VR, Yaghmai V, Azure MT, Goddu SM, Howell RW, Rao DV. 1994. Vitamins
as radioprotectors in vivo. II.
Protection by vitamin A and soybean oil against radiation damage caused by
internal radionuclides. Radiat Res. 139, 115–122.
Harrison
K, Dalrymple GV, Baranowska-Kortylewicz J, Schneiderman MH, Holdeman K,
Leichner P, Augustine SC, Jacobson D. 1994. Bladder cancer-[123I]IUdR imaging
in preparation for [125I]IUdR therapy. J Nucl Med. 35, 144P (abstract).
Howell
RW, Kassis AI, Adelstein SJ, Rao DV, Wright HA,
Howell
RW. 1994. The MIRD schema: from organ to cellular dimensions. J Nucl Med. 35,
531–533.
Howell
RW, Goddu SM, Rao DV. 1994. Application of the linear-quadratic model to
radioimmunotherapy: further support for the advantage of longer-lived
radionuclides. J Nucl Med. 35, 1861–1869.
Humm
JL, Howell RW, Rao DV. 1994. Dosimetry of Auger-electron-emitting
radionuclides: Report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Med
Phys. 21, 1901–1915.
Jin T, Watt DE, Kobayashi K. 1994. Damage induced by monochromatic synchrotron
x-rays at the resonance absorption energy of intracellular phosphorous in yeast
cells. Appl Radiat Isot. 45, 767–772.
Jonkhoff
AR, van Dieren EB, Huijgens PC, Versteegh RT, Drager A, van der Loosdrecht AA,
Teule GJJ. 1994. Biological effectiveness of 67-gallium decay in HL60 cells
compared with external low dose rate gamma irradiation: effects on
proliferation, G2 arrest, and clonogenic capacity. Int J Radiat Oncol Biol
Phys. 30, 117–124.
Kleiman GG, de Castro SGC, Landers R. 1994. L2,3M4,5M4,5 x-ray-excited Auger-electron spectra of Ag. Phys Rev B. 49, 2753–2759.
Krenning
EP, Kooij PPM, Bakker WH, Breeman WAP, Postema PTE, Kwekkeboom DJ, Oei HY, de
Jong M, Visser TJ, Reijs AEM, Lamberts SWJ. 1994. Radiotherapy with a
radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide: a case
history. Ann N Y Acad Sci. 733, 496–506.
Lee KH, Yang G, Koymen AR, Jensen KO, Weiss AH.
1994. Positron annihilation
induced Auger electron spectroscopy studies of submonolayer Au on Cu(100): direct
evidence for positron localization at sites containing Au atoms. Phys Rev Lett.
72, 1866–1869.
Ludwików
G, Ludwików F, Johanson KJ. 1994. Kinetics of micronuclei induced by 125IdU
in cells of two lines. Radiat Res. 138, 70–78.
Mariani G, Di Sacco S, Volterrani D, Matteucci F,
Di Luca L, Buralli S, Baranowska-Kortylewicz J, Di Stefano R, Ricci S, Bellina
CR, Falcone A, Salvadori PA, Mosca F, Adelstein SJ, Kassis AI. 1994. Tumor targeting with 5-[123I]iodo-2'-deoxyuridine
infused into the hepatic artery of patients with liver metastases from
colorectal cancer. J Nucl Biol Med. 38, 265–266.
Mattes MJ, Griffiths GL, Diril H, Goldenberg DM,
Ong GL, Shih LB. 1994. Processing
of antibody–radioisotope conjugates after binding to the surface of tumor
cells. Cancer. 73, 787–793.
Narra
VR, Harapanhalli RS, Howell RW, Sastry KSR, Rao DV. 1994. Vitamins as
radioprotectors in vivo. I.
Protection by vitamin C against internal radionuclides in mouse testes: implications
to the mechanism of damage caused by the Auger effect. Radiat Res. 137,
394–399.
Narra
VR, Howell RW, Sastry KSR, Rao DV. 1994. Auger electron emitters as tools for
elucidating the location of primary radiosensitive targets. Radiat Prot Dosimetry.
52, 229–232.
Narra
VR, Sastry KSR, Goddu SM, Howell RW,
Nikjoo
H, O'Neill P, Terrissol M, Goodhead DT. 1994. Modelling of radiation-induced
DNA damge: the early physical and chemical event. Int J Radiat Biol. 66,
453–457.
Panyutin
IG, Neumann RD. 1994. Sequence-specific DNA double-strand breaks induced by
triplex forming 125I labeled oligonucleotides. Nucleic Acids Res.
22, 4979–4982.
Persson
L. 1994. The Auger electron effect in radiation dosimetry. Health Phys. 67,
471–476.
Pomplun E, Terrissol M. 1994. Low-energy electrons inside active DNA
models: a tool to elucidate the radiation action mechanisms. Radiat Environ
Biophys. 33, 279–292.
Rabke
CE, Wenzler LA , Beebe TP Jr. 1994. Electron spectroscopy and atomic force
microscopy studies of DNA adsorption on mica. Scanning Microsc. 8, 471–480.
Remeta
EY, Lendel AI. 1994. Calculation of the Auger KL1L1 lines for Mn, Eu, Tm and W
in the decay of Fe, Gd, Yb, Re. Izvestiya Akademii Nauk, Seriya Fizicheskaya.
58, 143–146.
Siegel
JA, Stabin MG. 1994. Absorbed fractions for electrons and beta particles in
spheres of various sizes. J Nucl Med. 35, 152–156.
Story
MD, Voehringer DW, Malone CG, Hobbs ML, Meyn RE. 1994. Radiation-induced
apoptosis in sensitive and resistant cells isolated from a mouse lymphoma. Int
J Radiat Biol. 66, 659–668.
Terrissol
M. 1994. Modelling of radiation damage by 125I on a nucleosome. Int
J Radiat Biol. 66, 447–451.
Terrissol M, Pomplun E. 1994. A nucleosome model for the simulation of DNA
strand break experiments. In: Varma MN, Chatterjee A (Eds). Computational Approaches
in Molecular Radiation Biology: Monte Carlo Methods. Plenum Press, New York,
pp. 243–250.
Turner
NH, Schreifels JA. 1994. Surface analysis: X-ray photoelectron spectroscopy and
Auger electron spectroscopy. Anal Chem. 66, 163R–185R.
van Dieren EB, van Lingen A, Roos JC, Teule GJJ.
1994. The relevance of uptake
and intracellular distribution for the dosimetry of Auger and b-emitting radionuclides in micrometastases.
Radiat Prot Dosimetry. 52, 391–394.
Végh
L, Macek JH. 1994. Coherences in the decay of autoionizing states in
photoionization. I. Exchange effect between photo- and Auger electrons. Phys
Rev A. 50, 4031–4035.
Wheldon
TE. 1994. Targeting radiation to tumours. Int J Radiat Biol. 65, 109-116.
Wu
D, Gong Y. 1994. Current studies on biological effects of low level internal
irradiation. Chin Med J. 107, 610–614.
1993
Adelstein
SJ, 1993. Merrill C. Sosman Lecture. The Auger process: a therapeutic promise?
AJR Am J Roentgenol. 160, 707–713.
Beckmann
MW, Scharl A, Rosinsky BJ, Holt JA. 1993. Breaks in DNA accompany
estrogen-receptor-mediated cytotoxicity from 16a[125I]iodo-17b-estradiol. J Cancer Res Clin Oncol. 119,
207–214.
Chandra
N, Sen S. 1993. Auger-electron spectroscopy of molecules: circular dichroism
following photoabsorption in rotating linear molecules. Phys Rev A. 48,
2084–2097.
Duncan
JR, Welch MJ. 1993. Intracellular metabolism of indium-111-DTPA-labeled
receptor targeted proteins. J Nucl Med. 34, 1728–1738.
Feinendegen
LE. 1993. Contributions of nuclear medicine to the therapy of malignant tumors.
J Cancer Res Clin Oncol. 119, 320–322.
Furusawa
Y, Maezawa H, Suzuki K, Yamamoto Y, Kobayashi K, Hieda K. 1993. Uracil-DNA
glycosylase produces excess lethal damage induced by an Auger cascade in
BrdU-labelled bacteriophage T1. Int J Radiat Biol. 64, 157–164.
Ho
Y, Yuan Z, Zhang B, Pan Z. 1993. Self-consistent description for x-ray, Auger
electron, and nuclear excitation by electron transition processes. Phys Rev C.
48, 2277–2284.
Hofer KG, van Loon N, Schneiderman MH, Dalrymple
GV. 1993. Targets for
radiation-induced cell death: target replication during the cell cycle
evaluated in cells exposed to X-rays or 125I decays. Int J Radiat Biol. 64, 205–216.
Hong
C, Fang J, Yi M. 1993. Mechanism of phosphorus poisoning inhibiting Nb3Sn
formation at Nb/Cu—Sn interfaces. J Phys Chem Sol. 54, 453–456.
Howell
RW, Narra VR, Sastry KSR, Rao DV. 1993. On the equivalent dose for Auger
electron emitters. Radiat Res. 134, 71–78.
Hughes
A. Gatley SJ, DeSombre ER. 1993. Comparison of the distribution of
radioiodinated-E-17a-iodovinyl-11b-methoxyestradiol and
2-iodo-1,1-bis(4-hydroxyphenyl)-phenylethylene estrogens in the immature female
rat. J Nucl Med. 34, 272–280.
Humm JL, Roeske JC, Fisher DR, Chen GTY. 1993. Microdosimetric concepts in
radioimmunotherapy. Med Phys. 20, 535–541.
Humm
JL, Macklis RM, Bump K, Cobb LM, Chin LM. 1993. Internal dosimetry using data
derived from autoradiographs. J Nucl Med. 34, 1811–1817.
John
E, Thakur ML, DeFulvio J, McDevitt MR, Damjanov I. 1993. Rhenium-186-labeled
monoclonal antibodies for radioimmunotherapy: preparation and evaluation. J
Nucl Med. 34, 260–267.
Kassis AI, Adelstein SJ. 1993. Therapeutic potential of internally
administered radionuclides. In: Black PM, Schoene WC, Lampson LA (Eds).
Contemporary Issues in Neurological Surgery. Astrocytomas: Diagnosis, Treatment,
and Biology. Blackwell Scientific Publications, Incorporated,
Kinsey
BM, Kassis AI. 1993. Synthesis and biological activity of 125I/127I-phenylboronic
acid derivatives. Nucl Med Biol. 20, 13–22.
Laster
BH, Thomlinson WC, Fairchild RG. 1993. Photon activation of iododeoxyuridine:
biological efficacy of Auger electrons. Radiat Res. 133, 219–224.
Mariani G, Di Sacco G, Matteucci F, Volterrani D,
Baranowska-Kortylewicz J, Ricci S, Di Stefano R, Troiani R, Di Luca L, Falcone
A, Bellina CR, Salvadori PA, Conte PF, Sicari A, Mosca F, Adelstein SJ, Kassis
AI. 1993. Intra-arterial
infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver
metastases from colon cancer. J Nucl Biol Med. 37, 157–158.
Mariani
G, Cei A, Collecchi P, Baranowska-Kortylewicz J, Van den Abbeele AD, Di Luca L,
Di Stefano R, Viacava P, Ferdeghini EM, Di Sacco S, Salvadori PA, Bevilacqua G,
Adelstein SJ, Mosca F, Kassis AI. 1993. Tumor targeting in vivo and metabolic
fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in
patients with colorectal cancer. J Nucl Med. 34, 1175–1183.
Mariani
G, Giuliani L, Baranowska-Kortylewicz J, Collecchi P, Meucci G, Di Luca L,
Viacava P, Van den Abbeele AD, Bevilacqua G, Salvadori PA, Adelstein SJ, Kassis
AI. 1993. Intratumoral injection of 5-[125I]iodo-2'-deoxyuridine in
patients with breast cancer. In: Hofer R, Bergmann H, Sinzinger H (Eds).
Radioactive Isotopes in Clinical Medicine and Research. Schattauer Verlag,
Stuttgart, Germany, pp. 188–193.
Mariani G, Collecchi P, Giuliani L,
Baranowska-Kortylewicz J, Di Luca L, Meucci G, Viacava P, Van den Abbeele AD,
Salvadori PA, Di Sacco S, Adelstein SJ, Bevilacqua G, Kassis AI. 1993. Tumor targeting potential and metabolism of
5-[125I]iodo-2'-deoxyuridine injected intratumorally in patients
with breast cancer. Ann N Y Acad Sci. 698, 204–211.
Miyazaki
N, Shinohara K. 1993. Cell killing induced by decay of 125I during
the cell cycle: comparison of 125I-antipyrine with 125I-bovine
serum albumin. Radiat Res. 133, 182–186.
Olive
PL, Banáth JP. 1993. Detection of DNA double-strand breaks through the cell
cycle after exposure to X-rays, bleomycin, etoposide and 125IdUrd.
Int J Radiat Biol. 64, 349–358.
Pindzola
MS. 1993. Parity-violation effects on the Auger-electron emission from highly
charged atomic ions. Phys Rev A. 47, 4856–4858.
Scherberg
NH. 1993. The preparation of [125I]iododeoxyuridine-labeled
oligomers by automated synthesis with an 125I-nucleoside
phosphoramidite. Appl Radiat Isot. 44, 665–671.
Strand
S-E, Jönsson B-A, Ljungberg M, Tennvall J. 1993. Radioimmunotherapy dosimetry —
a review. Acta Oncol. 32, 807–817.
van Leeuwen-Stok AE, Dräger AM, Schuurhuis GJ,
Visser-Platier AWJ, Teule GJJ, Huijgens PC. 1993. Gallium 67 in the human lymphoid cell line
U-715: uptake, cytotoxicity and intracellular localization. Int J Radiat Biol.
64, 749–759.
Yoshida
K, Fujikawa T, Tanabe A, Sakurai K. 1993. Quantitative analysis of distribution
and fate of human lung cancer emboli labeled with 125I-5-iodo-2'-deoxyuridine
in nude mice. Surg Today. 23, 979–983.
1992
Adelstein
SJ. 1992. Biophysical aspects of Auger processes: a review of the literature
1987-1991. In: Howell, RW, Narra VR, Sastry KSR, Rao DV (Eds). Biophysical Aspects
of Auger Processes, AAPM symposium proceedings no. 8. American Institute of
Physics, Woodbury, NY, pp. 1–13.
Azure
MT, Sastry KSR, Archer RD, Howell RW, Rao DV. 1992. Microscale synthesis of
carboplatin labeled with the Auger emitter platinum-193m: radiotoxicity versus
chemotoxicity of the antitumor drug in mammalian cells. In: Howell, RW, Narra
VR, Sastry KSR, Rao DV (Eds). Biophysical Aspects of Auger Processes, AAPM
symposium proceedings no. 8. American Institute of Physics, Woodbury, NY, pp. 336–351.
Bockelmann U, Egeler T. 1992. Electron relaxation in quantum dots by means
of Auger processes. Phys Rev B. 46, 15574–15577.
Brady
LW, Miyamoto C, Woo DV, Rackover M, Emrich J, Bender H, Dadparvar S, Steplewski
Z, Koprowski H, Black P, Lazzaro B, Nair S, McCormack T, Nieves J, Morabito M,
Eshleman J. 1992. Malignant astrocytomas treated with iodine-125 labeled
monoclonal antibody 425 against epidermal growth factor receptor: a phase II
trial. Int J Radiat Oncol Biol Phys. 22, 225–230.
Derui
L, Woo DV, Emrich J, Steplewski Z, Rodeck U, Herlyn D, Koprowski H, Miyamoto C,
Brady LW. 1992. Radiotoxicity of 125I-labeled monoclonal antibody
425 against cancer cells containing epidermal growth factor receptor. Am J Clin
Oncol. 15, 288–294.
DeSombre
ER, Shafii B, Hanson RN, Kuivanen PC, Hughes A. 1992. Estrogen
receptor-directed radiotoxicity with Auger electrons: specificity and mean
lethal dose. Cancer Res. 52, 5752–5758.
DeSombre
ER, Hughes A, Shafii B, Púy L, Kuivanen PC, Hanson RN, Harper PV. 1992.
Estrogen receptor-directed radiotoxicity with Auger electron-emitting nuclides:
E-17a-[123I] iodovinyl-11b-methoxyestradiol and CHO-ER cells. In:
Howell, RW, Narra VR, Sastry KSR, Rao DV (Eds). Biophysical Aspects of Auger Processes,
AAPM symposium proceedings no. 8. American Institute of Physics, Woodbury, NY,
pp. 352–371.
Foulon
C, Guilloteau D, Baulieu JL, Ribeiro-Barras MJ, Desplanches G, Frangin Y,
Besnard JC. 1992. Estrogen receptor imaging with 17a-[123I]iodovinyl-11b-methoxyestradiol (MIVE2)—Part I.
Radiotracer preparation and characterization. Nucl Med Biol. 19, 257–261.
Fremont
F, Sommer K, Lecler D, Hicham S, Boduch P, Husson X, Stolterfoht N. 1992.
Angular distribution of Auger-electron emission following double-electron
capture in C6+ + He collisions. Phys Rev A. 46, 222–229.
Gardin
I,
Hofer
KG. 1992. Symposium report: biophysical aspects of Auger processes. Int J
Radiat Biol. 61, 289–292.
Hofer
KG. 1992. Closing address: biophysical aspects of Auger processes. In: Howell,
RW, Narra VR, Sastry KSR, Rao DV (Eds). Biophysical Aspects of Auger Processes,
AAPM symposium proceedings no. 8. American Institute of Physics, Woodbury, NY,
pp. 403–412.
Hofer KG, Van Loon N, Schneiderman MH, Charlton DE.
1992. High and low-LET
cytocidal effects of DNA-associated iodine-125. In: Howell, RW, Narra VR,
Sastry KSR, Rao DV (Eds). Biophysical Aspects of Auger Processes, AAPM
symposium proceedings no. 8. American Institute of Physics, Woodbury, NY, pp. 227–248.
Hofer KG, van Loon N, Schneiderman MH, Charlton DE.
1992. The paradoxical nature of
DNA damage and cell death induced by 125I decay. Radiat Res. 130, 121–124.
Holt JA, Scharl A, Kullander S, Beckmann MW. 1992. Intracellular actions of steroid hormones
and their therapeutic value, including the potential of radiohalosteroids
against ovarian cancer. Acta Obstet Gynecol Scand Suppl. 155, 39–54.
Howell
RW. 1992. Radiation spectra for Auger-electron emitting radionuclides: Report
No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys. 19, 1371–1383.
Howell
RW, Narra VR, Hou D-Y, Terrone DA, Harapanhalli RS, Sastry KSR, Rao DV. 1992.
Relative biological effectiveness of Auger emitters for cell inactivation: in vitro versus in vivo. In: Howell, RW, Narra VR, Sastry KSR, Rao DV (Eds).
Biophysical Aspects of Auger Processes, AAPM symposium proceedings no. 8.
American Institute of Physics, Woodbury, NY, pp. 290–318.
Idzerda
YU,
Jönsson
B-A,
Jönsson
B-A,
Jönsson
B-A,
Kassis AI, Adelstein SJ. 1992. Does nonuniformity of dose have implications
for radiation protection? J Nucl Med. 33, 384–387.
Kereiakes
JG, Rao DV. 1992. Auger electron dosimetry: Report of AAPM Nuclear Medicine Committee
Task Group No. 6. Med Phys. 19, 1359.
Kleiman GG, Landers R, Nascente PAP, de Castro SGC.
1992. L2,3M4,5M4,5 x-ray-excited Auger-electron spectra of In, Sn, and Sb. Phys Rev B. 46,
1970–1974.
Kyriakos RJ, Shih LB, Ong GL, Patel K, Goldenberg DM, Mattes MJ. 1992. The fate of antibodies bound to the surface of tumor cells in vitro. Cancer Res. 52, 835–842.
Ludwikow
G, Ludwikow F, Johanson KJ. 1992. Kinetics of micronucleus induction by 125I-labelled
thyroid hormone in hormone-responsive cells. Int J Radiat Biol. 61, 639–653.
Makrigiorgos
GM, Berman RM, Baranowska-Kortylewicz J, Bump E, Humm JL, Adelstein SJ, Kassis
AI. 1992. DNA damage produced in V79 cells by DNA-incorporated iodine-123: a
comparison with iodine-125. Radiat Res. 129, 309–314.
Malamut
C, Paes-Leme PJ, Paschoa AS. 1992. Diffusion of low-energy electrons in
tissue-like liquids. Radiat Res. 132, 168–177.
Mariani G, Cei A, Giuliani L,
Baranowska-Kortylewicz J, Collecchi P, Di Stefano R, Meucci G, Viacava P, Di
Luca L, Van den Abbeele AD, Bevilacqua G, Adelstein SJ, Kassis AI. 1992. Tumor targeting potential of
5-[I-125]iodo-2'-deoxyuridine injected intratumorally in patients with
gastrointestinal or breast cancers. Eur J Nucl Med. 19, 705.
Mariani G, Cei A, Giuliani L, Baranowska-Kortylewicz
J, Collecchi P, Di Stefano R, Di Luca L, Viacava P, D'Elia F, Guadagnia A,
Meucci G, Salvadori PA, Van den Abbeele AD, Bevilacqua G, Mosca F, Adelstein SJ,
Kassis AI. 1992. Tumor
targeting potential and metabolism of 5[125I]iodo-2'-deoxyuridine
injected intratumorally in patients with gastrointestinal or breast cancers. J
Nucl Biol Med. 36, 154–157.
Martin
RF, D'Cunha G. 1992. 125I decay in synthetic oligodeoxynucleotides. In: Howell, RW, Narra VR,
Sastry KSR, Rao DV (Eds). Biophysical Aspects of Auger Processes, AAPM
symposium proceedings no. 8. American Institute of Physics, Woodbury, NY, pp. 153–163.
McIntyre
CL, Baverstock KF. 1992. DNA strand breakage by 125I decay: plasmid
DNA in dilute aqueous solution. In: Howell, RW, Narra VR, Sastry KSR, Rao DV (Eds).
Biophysical Aspects of Auger Processes, AAPM symposium proceedings no. 8.
American Institute of Physics, Woodbury, NY, pp. 164–179.
Nagasawa H, Kassis AI, Berman RM, Sahu SK,
Nickoloff JA, Okinaka RT, Adelstein SJ, Little JB. 1992. Comparison of mutation induction by external
and internal radiation sources in synchronized Chinese hamster ovary (CHO)
cells. In: Howell, RW, Narra VR, Sastry KSR, Rao DV (Eds). Biophysical Aspects
of Auger Processes, AAPM symposium proceedings no. 8. American Institute of
Physics, Woodbury, NY, pp. 194–209.
Narra
VR, Harapanhalli RS, Howell RW, Sastry KSR, Rao DV. 1992. Chemical protection
against radionuclides in vivo: implications
to the mechanism of the Auger effect. In: Howell, RW, Narra VR, Sastry KSR, Rao
DV (Eds). Biophysical Aspects of Auger Processes, AAPM symposium proceedings
no. 8. American Institute of Physics, Woodbury, NY, pp. 319–335.
Narra
VR, Howell RW, Harapanhalli RS, Sastry KSR, Rao DV. 1992. Radiotoxicity of some
iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes:
implications for radiopharmaceutical design. J Nucl Med. 33, 2196–2201.
Pomplun E, Roch M, Terrissol M. 1992. Simulation of strand break induction by DNA
incorporated 125I. In: Howell, RW, Narra VR, Sastry KSR, Rao DV (Eds). Biophysical Aspects
of Auger Processes, AAPM symposium proceedings no. 8. American Institute of
Physics, Woodbury, NY, pp. 137–152.
Ribeiro-Barras
MJ, Foulon C, Baulieu JL, Guilloteau D, Bougnoux P, Lansac J, Besnard JC. 1992.
Estrogen receptor imaging with 17a-[123I]iodovinyl-11b-methoxyestradiol (MIVE2)—Part
II. Preliminary results in patients with breast carcinoma. Nucl Med Biol. 19,
263–267.
Sastry
KSR. 1992. Biological effects of the Auger emitter iodine-125: a review. Report
No. 1 of AAPM Nuclear Medicine Task Group No. 6. Med Phys. 19, 1361–1370.
Scherberg
N. 1992. Differential elimination of radioiodine from single- and
double-stranded 125I-DNA. Appl Radiat Isot. 43, 929–934.
Scherberg N, Bloch I, Gardner P. 1992. Site-specific incorporation of [125I]iododeoxyuridine
into DNA. Appl Radiat Isot. 43, 923–927.
Schwartz
JL, Moan E, Mustafi R, Fink L, Yasui LS. 1992. Faster rates of DNA unwinding
under alkaline conditions in xrs-5 cells may reflect chromatin structure
alterations. Mutat Res. 282, 13–17.
Turner
JE. 1992. An introduction to microdosimetry. Radiat Prot Management. 9(3),
25–58.
Van
den Abbeele AD, Baranowska-Kortylewicz J, Adelstein SJ, Carvalho PA, Tutrone
RF, Richie JP, Wen PYC, Black PM, Mariani G, Kassis AI. 1992. Diagnostic and
therapeutic applications of Auger electron emitting 5-[123I/125I]iodo-2'-deoxyuridine
in cancer. In: Howell, RW, Narra VR, Sastry KSR, Rao DV (Eds). Biophysical Aspects
of Auger Processes, AAPM symposium proceedings no. 8. American Institute of
Physics, Woodbury, NY, pp. 372–395.
Yasui
LS. 1992. Cytotoxicity of 125I decay in the DNA double strand break
repair deficient mutant cell line, xrs-5. Int J Radiat Biol. 62, 613–618.
1991
Adelstein
SJ, Kassis AI, Baranowska-Kortylewicz J, Van den Abbeele AD, Mariani G, Ito S.
1991. Potential for tumor therapy with iodine-125 labeled immunoglobulins. Nucl
Ned Biol. 18, 43–44.
Alfieri
AA, Bravo S, Hong SS, Tsukada J, Kawamoto Y, Watari T. 1991. A local treatment
for cancer using 125IUdR Auger electrons. Drug Deliv Sys. 6, 25–29.
Bagshawe
KD, Sharma SK, Southall PJ, Boden JA, Boxer GM, Patridge TA, Antoniw P, Pedley
RB. 1991. Selective uptake of toxic nucleoside (125IUdR) by resistant cancer. Br J Radiol. 64,
37–44.
Baranowska-Kortylewicz J, Makrigiorgos GM, Van den
Abbeele AD, Berman RM, Adelstein SJ, Kassis AI. 1991. 5-[123I]iodo-2'-deoxyuridine in
the radiotherapy of an early ascites tumor model. Int J Radiat Oncol Biol Phys.
21, 1541–1551.
Charlton
DE, Sephton R. 1991. A relationship between microdosimetric spectra and cell
survival for high-LET irradiation. Int J Radiat Biol. 59, 447–457.
Epperly
MW, Damodaran KM, McLaughlin WH, Pillai KMR, Bloomer WD. 1991. Radiotoxicity of
17a-[125I]iodovinyl-11b-methoxyestradiol in MCF-7 human breast
cancer cells. J Steroid Biochem Mol Biol. 39, 729–734.
Furusawa
Y, Maezawa H, Suzuki K. 1991. Enhanced killing effect on 5-bromodeoxyuridine
labelled bacteriophage T1 by monoenergetic synchrotron X-ray at the energy of
bromine K-shell absorption edge. J Radiat Res. 32, 1–12.
Gao
Y, Cao J. 1991. Incident-beam effects in electron-stimulated Auger-electron
diffraction. Phys Rev B. 43, 9692–9699.
Gatley
SJ, Desombre ER, Mease RC, Seevers RE, Hughes A, Li J, Pan M-L. 1991.
Synthesis, purification and stability of no carrier added radioiodinated
1,1-bis(4-hydroxyphenyl)-2-iodo-2-phenylethylene (IBHPE), a prototype
triphenylethylene estrogen-receptor binding radiopharmaceutical. Int J Rad Appl
Instrum B. 18, 769–775.
Gaze MN, Huxham IM, Mairs RJ, Barrett A. 1991. Intracellular localization
of metaiodobenzyl guanidine in human neuroblastoma cells by electron
spectroscopic imaging. Int J Cancer. 47, 875–880.
Goodhead
DT. 1991. Meeting report: microscopic features of dose from radionuclides,
particularly emitters of a-particles and Auger electrons. Int J Radiat Biol. 60, 550–553.
Howell
RW, Rao DV, Hou D-Y, Narra VR, Sastry KSR. 1991. The question of relative
biological effectiveness and quality factor for Auger emitters incorporated
into proliferating mammalian cells. Radiat Res. 128, 282–292.
Humm
JL, Bagshawe KD, Sharma SK, Boxer G. 1991. Tissue dose estimates following the
selective uptake of 125IUDR and other radiolabelled thymidine precursors in resistant tumours.
Br J Radiol. 64, 45–49.
Idzerda
YU,
Iliakis GE, Cicilioni O, Metzger L. 1991. Measurement of DNA double-strand breaks in
CHO cells at various stages of the cell cycle using pulsed field gel
electrophoresis: calibration by means of 125I decay. Int J Radiat
Biol. 59, 343–357.
Kassis AI, Guptill WE, Taube RA, Adelstein SJ.
1991. Radiotoxicity of 5-[125I]iodo-2'-deoxyuridine
in mammalian cells following treatment with 5-fluoro-2'-deoxyuridine. J Nucl
Biol Med. 35, 167–173.
Kassis
AI, Sahu SK, Fayad F, Berman RM, Kinsey BM, Speidel MT, Macklis RM, Atcher RW,
Hines JJ, Adelstein SJ. 1991. DNA damage and survival of V79 cells in culture
following the extracellular decay of bismuth-212. In: Chapman JD, Dewey WC,
Whitmore GF (Eds). Radiation Research: A Twentieth Century Perspective, vol 1. Academic Press, Incorporated,
Little
JB, Whaley JM, Liber HL. 1991. Role of energy distribution in DNA on the
mutagenic effects of internal emitters. Third Anticarcinogenic Radiation
Protection Conference Proceedings, vol 2, pp. 201–210.
Mease
RC, DeJesus OT, Gatley SJ, Harper PV, Desombre ER, Friedman AM. 1991.
Production of no carrier added 80mBr for investigation of Auger
electron toxicity. Int J Radiat Appl Instrum A. 42, 57–61.
Mease
RC, Gatley SJ, Friedman AM. 1991. Synthesis of high specific activity 80mBr
and 123I labeled 5-halodeoxyuridines and other 80mBr
compounds for the study of Auger electron toxicity. J Label Compd Radiopharm.
29, 393–403.
Menke H, Köhnlein W, Joksch S, Halpern A. 1991. Strand breaks in plasmid DNA, natural and
brominated, by low-energy X-rays. Int J Radiat Biol. 59, 85–96.
Narra
VR, Howell RW, Thanki KH, Rao DV. 1991. Radiotoxicity of 125I-iododeoxyuridine
in pre-implantation mouse embryos. Int J Radiat Biol. 60, 525–532.
Nikjoo
H, Goodhead DT, Charlton DE, Paretzke HG. 1991. Energy deposition in small
cylindrical targets by monoenergetic electrons. Int J Radiat Biol. 60, 739–756.
Pomplun
E. 1991. A new DNA target model for track structure calculations and its first
application to I-125 Auger electrons. Int J Radiat Biol. 59, 625–642.
Radford
IR. 1991. Mouse lymphoma cells that undergo interphase death show markedly
increased sensitivity to radiation-induced DNA double-strand breakage as
compared with cells that undergo mitotic death. Int J Radiat Biol. 59,
1353–1369.
Rao
DV, Narra VR, Howell RW, Lanka VK, Sastry KSR. 1991. Induction of sperm head
abnormalities by incorporated radionuclides: dependence on subcellular
distribution, type of radiation, dose rate, and presence of radioprotectors. Radiat Res.
125, 89–97.
Riklund KE, Makiya R, Sundström B, Bäck O,
Henriksson R, Hietala S-O, Stigbrand T. 1991. Inhibition of growth of HeLa cell tumours in nude mice by 125I-labeled
anticytokeratin and antiPLAP monoclonal antibodies. Anticancer Res. 11,
555–560.
Rotmensch
J, Schwartz JL, Atcher RW, Harper PV, DeSombre E. 1991. Increased nuclear
damage by high linear energy transfer radioisotopes applicable for
radiodirected therapy against radiologic malignancies. Gynecol Obstet Invest.
32, 180–184.
Schneiderman MH, Hofer KG, Schneiderman GS. 1991. An in
vitro 125IUdR-release assay for measuring the kinetics of cell
death. Int J Radiat Biol. 59, 397–408.
Sisson
JC, Shapiro B,
Turner
JE, Bolch WE, Yoshida H, Jacobson KB, Wright HA,
Ünak T, Ünak P. 1991. Microscopic energy absorption in the colloid
of thyroid follicles from Auger electrons of iodine-125. Appl Radiat Isot. 42,
291–295.
Usami
N, Kobayashi K, Maezawa H, Hieda K, Ishizaka S. 1991. Biological effects of
Auger processes of bromine on yeast cells induced by monochromatic synchrotron
X-rays. Int J Radiat Biol. 60, 757–768.
1990
Adelstein SJ, Kassis AI. 1990. Preface. In: Adelstein SJ,
Kassis AI, Burt RW (Eds). Frontiers
in Nuclear Medicine: Dosimetry of Administered Radionuclides, proceedings of
symposium, Washington, DC, 1989. American
Baranowska-Kortylewicz J, Adelstein SJ, Kassis AI.
1990. 5-Iodo-2'-deoxyuridine-protein
conjugates: synthesis and enzymatic degradation. Sel Cancer Ther. 6, 1–13.
Benhenni
M, Shafroth SM, Swenson JK, Schulz M, Giese JP, Schöne H, Vane CR, Dittner PF,
Datz S. 1990. Angular distribution of Auger electrons emitted through the
resonant transfer and excitation process following O5+ + He
collisions. Phys Rev Lett. 65, 1849–1852.
Doering
JP, Coplan MA, Cooper JW,
Goodman
JH, Gahbauer RA, Kanellitsas C, Clendenon NR, Laster BH, Fairchild RG. 1990.
Theoretical basis and clinical methodology for stereotactic interstitial brain
tumor irradiation using iododeoxyuridine as a radiation sensitizer and 145Sm
as a brachytherapy source. Stereotact Funct Neurosurg. 54–55, 531–534.
Halpern
A. 1990. Intra- and intermolecular energy transfer and superexcitation in
post-Auger processes. Radiochim Acta. 50, 129–134.
Hanson DM, Ma CI, Lee K, Lapiano-Smith D, Kim DY.
1990. Single-event,
energy-resolved, Auger–electron, multiple-ion coincidence mass spectroscopy. J
Chem Phys. 93, 9200–9202.
Howell
RW, Rao DV, Haydock C. 1990. Dosimetry techniques for therapeutic applications
of incorporated radionuclides. In: Adelstein SJ, Kassis AI, Burt RW (Eds).
Frontiers in Nuclear Medicine: Dosimetry of Administered Radionuclides,
proceedings of symposium, September 1989. American College of Nuclear
Physicians, Washington, DC, pp. 215–256.
Howell
RW, Narra VR, Rao DV, Sastry KSR. 1990. Radiobiological effects of
intracellular 210Po alpha emissions: a comparison with Auger
emitters. Radiat Prot Dosimetry. 31, 325–328.
Humm
JL, Cobb LM. 1990. Nonuniformity of tumor dose in radioimmunotherapy. J Nucl
Med. 31, 75–83.
Jensen KO, Weiss A. 1990. Theoretical study of the application of
positron-induced Auger-electron spectroscopy. Phys Rev B. 41, 3928–3936.
Kampf
G. 1990. Steps towards cancer therapy with radionuclides – a review including
radiation biophysical aspects. Radiobiol Radiother. 31, 215–229.
Kassis
AI, Van den Abbeele AD, Wen PYC, Baranowska-Kortylewicz J, Aaronson RA, DeSisto
WC, Lampson LA, Black PMcL, Adelstein SJ. 1990. Specific uptake of the Auger
electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine
in rat brain tumors: diagnostic and therapeutic implications in humans. Cancer
Res. 50, 5199–5203.
Kassis AI, Makrigiorgos GM, Adelstein SJ. 1990. Dosimetric considerations and therapeutic
potential of Auger electron emitters. In: Adelstein SJ, Kassis AI, Burt RW
(Eds). Frontiers in Nuclear Medicine: Dosimetry of Administered Radionuclides,
proceedings of symposium, 1989. American College of Nuclear Physicians,
Washington, DC, pp. 257–274.
Kassis AI, Makrigiorgos GM, Adelstein SJ. 1990. Implications of radiobiological and
dosimetric studies of DNA-incorporated 123I: the use of the Auger
effect as a biological probe at the nanometre level. Radiat Prot Dosimetry. 31,
333–338.
Kassis
AI. 1990. 5-(123I/125I)iodo-2'-deoxyuridine for cancer
diagnosis and therapy. J Nucl Med Allied Sci. 34, 299–303.
Kaszczyszyn
S, Grzeszczak A, Prazuch Z. 1990. Sputter profiling of a catalysis-poisoned
platinum-rhodium (Pt-Rh 10) alloy in a semiquantitative approach by Auger
electron spectroscopy. Diffusion and Defect Data--Solid State Data, Pt B: Solid
State Phenomena. 12, 167–176.
Kinsey
BM, Fayad F, Venkateshan CN, Adelstein SJ, Kassis AI. 1990. Synthesis and
biological activity of the intercalating agent 3-acetamido-5-[123/125I]iodo-6-aminoacridine. Nucl Med Biol. 17,
341–346.
Levin
JC, Biedermann C, Keller N, Liljeby L, O C-S, Short RT, Sellin IA, Lindle DW. 1990.
Argon-photoion–Auger-electron coincidence measurements following K-shell
excitation by synchrotron radiation. Phys Rev Lett. 65, 988–991.
Makrigiorgos G, Adelstein SJ, Kassis AI. 1990. Auger electron emitters: insights gained
from in vitro experiments. Radiat Environ Biophys. 29, 75–91.
Makrigiorgos
GM, Baranowska-Kortylewicz J, Van den Abbeele AD, Ito S, Vinter DW, Adelstein
SJ, Kassis AI. 1990. Microscopic spatial inhomogeneity of radiopharmaceutical
deposition in mammalian tissues: dosimetry at the cellular level and comparison
with conventional dosimetry. Radiat Prot Dosimetry. 31, 319–324.
Makrigiorgos GM, Adelstein SJ, Kassis AI. 1990. Limitations of MIRD at the cellular level.
In: Adelstein SJ, Kassis AI, Burt RW (Eds). Frontiers in Nuclear Medicine: Dosimetry
of Administered Radionuclides, proceedings of symposium, 1989. American College
of Nuclear Physicians, Washington, DC, pp. 44–57.
Makrigiorgos GM, Adelstein SJ, Kassis AI. 1990. Cellular radiation dosimetry and its
implications for estimation of radiation risks. Illustrative results with
technetium 99m–labeled microspheres and macroaggregates. JAMA. 264, 592–595.
Makrigiorgos
GM, Ito S, Baranowska-Kortylewicz J, Vinter DW, Iqbal A, Van den Abbeele AD,
Adelstein SJ, Kassis AI. 1990. Inhomogeneous deposition of radiopharmaceuticals
at the cellular level: experimental evidence and dosimetric implications. J
Nucl Med. 31, 1358–1363.
McGuire
EL, Dalrymple GV. 1990. Beta and electron dose calculations to skin due to
contamination by common nuclear medicine radionuclides. Health Phys. 58,
399–403.
Nath R, Bongiorni P, Rossi PI, Rockwell S. 1990. Enhanced IUdR radiosensitization by 241Am
photons relative to 226Ra and 125I photons at 0.72 Gy/hr.
Int J Radiat Oncol Biol Phys. 18, 1377–1385.
Pedley
RB, Boxer GM, Boden JA, Southall PJ, Begent RHJ, Bagshawe KD, Humm J, Searle F.
1990. Preliminary observations on the microdistribution of labelled antibodies
in human colonic adenocarcinoma xenografts: relevance to microdosimetry. Br J
Cancer. 61, 218–220.
Rao
DV, Narra VR, Howell RW, Sastry KSR. 1990. Biological consequence of nuclear
versus cytoplasmic decays of 125I: cysteamine as a radioprotector against
Auger cascades in vivo. Radiat Res.
124, 188–193.
Rao
DV, Narra VR, Govelitz GF, Lanka VK, Howell RW, Sastry KSR. 1990. In vivo effects of 5.3 MeV alpha
particles from 210Po in mouse testes: comparison with internal Auger
emitters. Radiat Prot Dosimetry. 31, 329–332.
Simpkin
DJ, Mackie TR. 1990. EGS4 Monte Carlo determination of the beta dose kernel in
water. Med Phys. 17, 179–186.
Toburen
LH, Wilson WE. 1990. Biological response to inner-shell ionization. X-Ray and
Inner-Shell Processes, American Institute of Physics Conference Proceedings,
215, 878–888.
Watababe
Y, Nakada M, Endo K, Nakahara H, Sano H. 1990. Coincidence Moessbauer
spectroscopic study of 57Co-labeled CoSeO4 and CoSeO4.H2O.
Bull Chem Soc Jpn. 63, 2790–2796.
Whaley JM, Kassis AI, Kinsey BM, Adelstein SJ,
Little JB. 1990. Mutation
induction by 125iodoacetylproflavine, a DNA-intercalating agent, in
human cells. Int J Radiat Biol. 57, 1087–1103.
Whaley
JM, Little JB. 1990. Efficient mutation induction by 125I and 131I
decays in DNA of human cells. Radiat Res. 123, 68–74.
Wheldon
TE, O'Donoghue JA. 1990. The radiobiology of targeted radiotherapy. Int J
Radiat Biol. 58, 1–21.
Wiebe LI, Knaus EE, Gati WP, Iwashina T, McQueen L.
1990. Drug-induced
perturbations in the in vivo distribution
of oncological radiotracers—II. 5-[125I]iodo-2'-deoxyuridine
influenced by nitrobenzylthioinosine-5'-phosphate (NBMPR-P) and acyclothymidine
(ACT). Appl Radiat Isot. 41, 159–162.
Woo
DV, Li DR, Brady LW, Emrich J, Mattis J, Steplewski Z. 1990. Auger electron damage
induced by radioiodinated iodine-125 monoclonal antibodies. Front Radiat Ther
Oncol. 24, 47–68.
Wright
HA,
Younis
A-RS,
1989
Adelstein SJ, Kassis AI. 1989. Radiobiology of
alpha particle and Auger electron emitters. In: DeNardo GL, Lewis JP, Raventos A, Burt RW (Eds). Frontiers in Nuclear
Medicine: Biology of Radionuclide Therapy, proceedings of symposium,
Washington, DC, 1988. American College of Nuclear Physicians, Washington, DC,
pp. 252–261.
Apelgot
S, Coppey J, Gaudemer A, Grisvard J, Guille E, Sasaki I, Sissoeff I. 1989. Similar lethal
effect in mammalian cells for two radioisotopes of copper with different decay
schemes, 64Cu and 67Cu. Int J Radiat Biol. 55, 365–384.
Baverstock
KF, Cundall RB. 1989. Are solitons responsible for energy transfer in oriented
DNA? Int J Radiat Biol. 55, 151–153.
Biersack HJ, Coenen HH, Stöcklin G, Reichmann K,
Bockisch A, Oehr P, Kashab M, Rollmann O. 1989. Imaging of brain tumors with L-3-[123I]iodo-a-methyl tyrosine and SPECT. J Nucl Med. 30,
110–112.
Blazek
ER, Peak JG, Peak MJ. 1989. Evidence from nondenaturing filter elution that
induction of double-strand breaks in the DNA of Chinese hamster V79 cells by g radiation is proportional to the square of
dose. Radiat Res. 119, 466–477.
Carlson
TA, Mullins DR, Beall CE, Yates BW, Taylor JW, Lindle DW, Grimm FA. 1989.
Angular distribution of ejected electrons in resonant Auger processes of Ar,
Kr, and Xe. Phys Rev A. 39, 1170–1185.
Cooper
JW. 1989. Angular distributions of electrons in resonant Auger spectra. Phys Rev A. 39,
3714–3716.
Flick MB, Warters RL, Yasui LS, Krisch RE. 1989. Measurement of radiation-induced DNA damage
using gel electrophoresis or neutral filter elution shows an increased
frequency of DNA strand breaks after exposure to pH 9.6. Radiat Res. 119,
452–465.
Fournier PG, Comtet G, Fournier J, Svensson S,
Karlsson L, Keane MP, Naves de Brito A. 1989. Double-ionization energies of CCl4 by double-charge-transfer
and x-ray Auger-electron spectroscopies. Phys Rev A. 40, 163–170.
Howell
RW, Rao DV, Sastry KSR. 1989. Macroscopic dosimetry for radioimmunotherapy:
nonuniform activity distributions in solid tumors. Med Phys. 16, 66–74.
Humm
JL,
Kassis
AI, Fayad F, Kinsey BM, Sastry KSR, Adelstein SJ. 1989. Radiotoxicity of an 125I-labeled
DNA intercalator in mammalian cells. Radiat Res. 118, 283–294.
Larson
D, Bodell WJ, Ling C, Phillips TL, Schell M, Shrieve D, Troxel T. 1989. Auger
electron contribution to bromodeoxyuridine cellular radiosensitization. Int J
Radiat Oncol Biol Phys. 16, 171–176.
Makrigiorgos
GM, Kassis AI, Baranowska-Kortylewicz J, McElvany KD, Welch MJ, Sastry KSR,
Adelstein SJ. 1989. Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a
comparison with 5-[125I]iodo-2'-deoxyuridine. Radiat Res. 118, 532–544.
Makrigiorgos GM, Adelstein SJ, Kassis AI. 1989. Limitations of conventional internal
dosimetry at the cellular level. J Nucl Med. 30, 1856–1864.
Martin RF, D'Cunha G, Pardee M, Allen BJ. 1989. Induction of DNA double-strand breaks by 157Gd
neutron capture. Pigment Cell Res. 2, 330–332.
McLaughlin
WH, Milius RA, Pillai KMR, Edasery JP, Blumenthal RD, Bloomer WD. 1989.
Cytotoxicity of receptor-mediated 16a-[125I]iodoestradiol
in cultured MCF-7 human breast cancer cells. J Natl Cancer Inst. 81, 437–440.
McLaughlin
WH, Pillai KMR, Edasery JP, Blumenthal RD, Bloomer WD. 1989. [125I]iodotamoxifen
cytotoxicity in cultured human (MCF-7) breast cancer cells. J Steroid Biochem.
33, 515–519.
Nikjoo
H, Goodhead DT, Charlton DE, Paretzke HG. 1989. Energy deposition in small
cylindrical targets by ultrasoft X-rays. Phys Med Biol. 34, 691–705.
Rao
DV, Narra VR, Howell RW, Govelitz GF, Sastry KSR. 1989. In-vivo radiotoxicity
of DNA-incorporated 125I compared with that of densely ionising
alpha-particles. Lancet. 2, 650–653.
Sasaki
MS, Kobayashi K, Hieda K, Yamada T, Ejima Y, Maezawa H, Furusawa Y, Ito T,
Okada S. 1989. Induction of chromosome aberrations in human lymphocytes by
monochromatic X-rays of quantum energy between 4.8 and 14.6 keV. 1989. Int J
Radiat Biol. 56, 975–988.
Takakura
K. 1989. Auger effects on bromo-deoxyuridine-monophosphate irradiated with
monochromatic X-rays around bromine K-absorption edge. Radiat Environ Biophys.
28, 177–184.
Woo
DV, Li D, Mattis JA, Steplewski Z. 1989. Selective chromosomal damage and
cytotoxicity of 125I-labeled monoclonal antibody 17-1a in human
cancer cells. Cancer Res. 49, 2952–2958.
Younis
A-RS,
1988
Adelstein SJ, Kassis AI. 1988. Criteria for the selection of nuclides for
radioimmunotherapy. In: Srivastava, SC (Ed). Radiolabeled Monoclonal Antibodies
for Imaging and Therapy, proceedings of the NATO Advanced Study Institute on
Radiolabeled Monoclonal Antibodies for Imaging and Therapy: Potential, Problems
and Prospects,
Bagshawe
KD. 1988. Radiochemotherapy with 125I-5-iodo-2-deoxyuridine. In:
Baverstock, KF, Charlton DE (Eds). DNA Damage by Auger Emitters. Taylor and
Francis, London, pp. 51–54.
Baverstock
KF, Cundall RB. 1988. Solitons and energy transfer in DNA (letter). Nature.
332, 312–313.
Bond VP, Feinendegen LE, Booz J. 1988. What is a 'low dose' of radiation? Int J Radiat
Biol. 53, 1–12.
Booz J, Feinendegen LE. 1988. A microdosimetric understanding of low-dose
radiation effects. Int J Radiat Biol. 53, 13–21.
Charlton
DE. 1988. Calculation of single and double strand DNA breakage from
incorporated 125I. In: Baverstock KF, Charlton DE (Eds). DNA Damage
by Auger Emitters. Taylor and Francis, London, pp. 89–100.
Charlton
DE. 1988. Comments on strand breaks calculated from average doses to the DNA
from incorporated isotopes. Radiat Res. 114, 192–197.
Charlton
DE, Humm JL. 1988. A method of calculating initial DNA strand breakage
following the decay of incorporated 125I. Int J Radiat Biol. 53,
353–365.
Costa DC, Lui D, Ell PJ. 1988. White cells radiolabelled with 111
In and 99
Tcm - a study
of relative sensitivity and in vivo viability. Nucl Med Commun. 9, 725–731.
Deng
Y, An L. 1988. Mechanism of sulfur poisoning and regeneration methods for
supported metal catalysts. I. Mechanism of sulfur poisoning of
palladium(platinum)/alumina catalysts in hydrogen-oxygen reaction. Fenzi
Cuihua. 2, 69–78.
DeSombre
ER, Harper PV, Hughes A, Mease RC, Gatley SJ, DeJesus OT, Schwartz JL. 1988.
Bromine-80m radiotoxicity and the potential for estrogen receptor-directed therapy
with Auger electrons. Cancer Res. 48, 5805–5809.
DeSombre
ER, Mease RC, Hughes A, Harper PV, DeJesus OT, Friedman AM. 1988.
Bromine-80m-labeled estrogens: Auger electron-emitting, estrogen
receptor-directed ligands with potential for therapy of estrogen
receptor-positive cancers. Cancer Res. 48, 899–906.
DeSombre
ER, Mease RC, Hughes A, Harper PV, DeJesus OT, Friedman AM. 1988.
Bromine-80m-Labeled Estrogens: Auger-Electron Emitting, Estrogen
Receptor-Directed Ligands with Potential for Therapy of Estrogen Receptor
Positive Cancers. Argonne National Laboratory, Argonne, IL, USA, 40 pp.
Feinendegen
LE, Bond VP, Booz J, Muhlensiepen H. 1988. Biochemical and cellular mechanisms
of low-dose effects. Int J Radiat Biol. 53, 23–37.
Fujimori A, Suga S, Negishi H, Inoue M. 1988. X-ray photoemission and Auger-electron
spectroscopic study of the electronic structure of intercalation compounds MxTiS2 (M = Mn,
Fe, Co, and Ni). Phys Rev B. 38, 3676–3689.
Goodhead
DT. 1988. Spatial and temporal distribution of energy. Health Phys. 55,
231–240.
Humm
JL,
Karlsson
L, Baltzer P, Svensson S, Wannberg B. 1988. Observation of isotope effects in
Auger-electron spectra: The predissociative 2p–2 3S state in HCl and DCl. Phys Rev Lett. 60, 2473–2475.
Kassis
AI, Howell RW, Sastry KSR, Adelstein SJ. 1988. Positional effects of Auger
decays in mammalian cells in culture. In: Baverstock KF, Charlton DE (Eds). DNA
Damage by Auger Emitters. Taylor and Francis, London, pp. 1–13.
Kovalik
A, Rysavý M, Brabec V, Dragoun O, Inoyatov A, Novgorodov AF, Vylov T, Prostakov
IA. 1988. The KLL and KLM Auger electrons of vanadium and chromium from the
radioactive decay. Phys Scr. 37, 871–875.
Maezawa H, Hieda K, Kobayashi K, Furusawa Y, Mori
T, Suzuki K, Ito T. 1988. Effects of monoenergetic X-rays with resonance energy
of bromine K-absorption edge on bromouracil-labelled E. coli cells. Int J Radiat Biol. 53, 301–308.
Martin RF, D'Cunha G, Pardee M, Allen BJ. 1988. Induction of double-strand breaks following
neutron capture by DNA-bound 157Gd. Int J Radiat Biol. 54, 205–208.
Peak
JG, Blazek ER, Hill CK, Peak MJ. 1988. Measurement of double-strand breaks in
Chinese hamster cell DNA by neutral filter elution: calibration by 125I
decay. Radiat Res. 115, 624–629.
Rao
DV, Mylavarapu VB, Sastry KSR, Howell RW. 1988. Internal Auger emitters:
effects on spermatogenesis and oogenesis in mice. In: Baverstock KF, Charlton
DE (Eds). DNA Damage by Auger Emitters. Taylor and Francis, London, pp. 15–26.
Rao
DV, Sastry KSR, Grimmond HE, Howell RW, Govelitz GF, Lanka VK, Mylavarapu VB.
1988. Cytotoxicity of some indium radiopharmaceuticals in mouse testes. J Nucl
Med. 29, 375–384.
Reiche M, Halpern A, Stöcklin G. 1988. Chemical effects of the decay of 125I
in [14C, 125I] iodobenzene in different solvents.
Radiochim Acta. 43, 191–196.
Roomans
GM, Wroblewski J, Wroblewski R. 1988. Elemental microanalysis of biological
specimens. Scanning Microsc. 2, 937–946.
Sastry
KSR, Howell RW, Rao DV, Mylavarapu VB, Kassis AI, Adelstein SJ, Wright HA, Hamm
RN, Turner JE. 1988. Dosimetry of Auger emitters: physical and phenomenological
approaches. In: Baverstock KF, Charlton DE (Eds). DNA Damage by Auger Emitters.
Taylor and Francis, London, pp. 27–38.
Thakur
ML, Leeper DB, Rowley R, Park CH. 1988. Radioiodinated rhodamine-123:
preparation and preliminary evaluation as an agent for tumor scintigraphy. Int
J Rad Appl Instrum B. 15, 517–524.
Turner
NH. 1988. Surface analysis: X-ray photoelectron spectroscopy and Auger electron
spectroscopy. Anal Chem. 60, 377R–387R.
Unak
P, Unak T. 1988. Microscopic energy absorption of the DNA molecules from Auger
electrons of iodine-125. Int J Rad Appl Instrum A. 39, 1037–1040.
Weiss
A, Mayer R, Jibaly M, Lei C, Mehl D, Lynn KG. 1988. Auger-electron emission
resulting from the annihilation of core electrons with low-energy positrons.
Phys Rev Lett. 61, 2245–2248.
1987
Adelstein SJ, Kassis AI. 1987. Radiobiologic implications of the
microscopic distribution of energy from radionuclides. Int J Rad Appl Instrum
B. 14, 165–169.
Adelstein
SJ. 1987. Meeting Report: International workshop on DNA damage by Auger
emitters: Implications and applications. Int J Radiat Biol. 52, 814–815.
Allenspach R, Mauri D, Taborelli M, Landolt M.
1987. Spin-polarized
Auger-electron spectroscopy. Phys Rev B. 35, 4801–4809.
Bagshawe
KD. 1987. Radiochemotherapy with 125I-5-iodo-2-deoxyuridine. Cancer
Treat Rev. 14, 397–399.
Bagshawe
KD, Boden J, Boxer GM, Britton DW, Green A, Partridge T, Pedley B, Sharma S,
Southall P. 1987. A cytotoxic DNA precursor is taken up selectively by human
cancer xenografts. Br J Cancer. 55, 299–302.
Booz J, Paretzke HG, Pomplun E, Olko P. 1987. Auger-electron cascades, charge potential
and microdosimetry of iodine-125. Radiat Environ Biophys. 26, 151–162.
Charlton DE, Pomplun E, Booz J. 1987. Some consequences of the Auger effect:
fluorescence yield, charge potential, and energy imparted. Radiat Res. 111,
553–564.
Fairchild
RG. 1987. Contribution to radiation enhancement from Auger cascades. Int J
Radiat Oncol Biol Phys. 13, 1262–1263.
Gibbs
RA, Camakaris J, Hodgson GS, Martin RF. 1987. Molecular characterization of 125I
decay and X-ray-induced HPRT mutants in CHO cells. Int J Radiat Biol. 51,
193–199.
Howell
RW. 1987. Radiobiological effects of Auger electrons in the decay of
platinum-195m, pp. 117.
Hughes
RH, Wattuhewa G,
Iliakis
G, Pantelias GE, Okayasu R, Seaner R. 1987. 125IdUrd-induced
chromosome fragments, assayed by premature chromosome condensation, and DNA
double-strand breaks have similar repair kinetics in G1-phase
CHO-cells. Int J Radiat Biol. 52, 705–722.
Itoh
S, Yokoyama M, Morimoto K. 1987. Poisonous gas effects on the emission of
oxide-coated cathodes. J Vac Sci Technol A. 5, 3430–3435.
Kassis
AI, Adelstein SJ, Bloomer WD. 1987. Therapeutic implications of Auger-emitting
radionuclides. In: Spencer RP, Seevers RH Jr, Friedman AM (Eds). Radionuclides
in Therapy. CRC Press, Incorporated,
Kassis AI, Sastry KSR, Adelstein SJ. 1987. Kinetics of uptake, retention, and
radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by
Auger processes. Radiat Res. 109, 78–89.
Kassis
AI, Fayad F, Kinsey BM, Sastry KSR, Taube RA, Adelstein SJ. 1987. Radiotoxicity
of 125I in mammalian cells. Radiat Res. 111, 305–318.
Kinsella
TJ, Dobson PP, Mitchell JB, Fornace AJ Jr. 1987. Enhancement of X ray induced
DNA damage by pre-treatment with halogenated pyrimidine analogs. Int J Radiat
Oncol Biol Phys. 13, 733–739.
Kinsey
BM, Kassis AI, Fayad F, Layne WW, Adelstein SJ. 1987. Synthesis and biological
studies of iodinated (127/125I) derivatives of rhodamine 123. J Med
Chem. 30, 1757–1761.
Los Arcos JM, Grau A, Fernandez A. 1987. VIASKL: a computer program to evaluate the
liquid scintillation counting efficiency and its associated uncertainty for
K-L-atomic shell electron-capture nuclides. Comput Phys Commun. 44, 209–220.
Makrigiorgos
G. 1987. Calculation of the restricted dose mean LET of Auger electron
emitters. Int J Rad Appl Instrum A. 38, 407–408.
Mann
R. 1987. High-resolution K and L Auger electron spectra induced by
single- and double-electron capture from H2, He, and Xe atoms to C4+
and C5+ ions at 10—100-keV energies. Phys Rev A. 35, 4988–5004.
Miller
RW, DeGraff W, Kinsella TJ, Mitchell JB. 1987. Evaluation of incorporated
iododeoxyuridine cellular radiosensitization by photon activation therapy. Int
J Radiat Oncol Biol Phys. 13, 1193–1197.
Nath
R, Bongiorni P, Rockwell S. 1987. Enhancement of IUdR radiosensitization by low
energy photons. Int J Radiat Oncol Biol Phys. 13, 1071–1079.
Pomplun
E, Booz J, Charlton DE. 1987. A Monte Carlo simulation of Auger cascades.
Radiat Res. 111, 533–552.
Pomplun
E, Booz J, Dydejczyk A, Feinendegen LE. 1987. A microdosimetric interpretation
of the radiobiological effectiveness of 125I and the problem of
quality factor. Radiat Environ Biophys. 26, 181–188.
Powell
GF, De Jesus OT, Harper PV, Friedman AM. 1987. A Monte Carlo treatment of the
decay of 80mBr, a novel Auger electron emitting isotope with
potential for therapy. J Radioanal Nucl Chem. 119, 159–170.
Scalliet
P, Wambersie A. 1987. Which RBE for iodine 125 in clinical applications?
Radiother Oncol. 9, 221–230.
Stepanenko
VF, Dedenkov AN, Norets TA, Dedov VI. 1987. Physical mechanisms and patterns of
biological action of Auger emitters. Izvestiya Akademii Nauk SSSR, Seriya
Biologicheskaya, 213–225.
Tisljar-Lentulis G, Schneeweiss FHA, Feinendegen
LE. 1987. 125Iodine decay in DNA: a discussion of its
effectiveness for the breaking of DNA strands. Radiat Environ Biophys. 26,
189–195.
Unak
P, Unak T. 1987. Local radiolytic effectiveness of Auger electrons of
iodine-125 in benzene-iodine solutions. J Radioanal Nucl Chem. 119, 171–180.
Vezza M, Giuliani D, Rao DV, Morse BS. 1987. Chromium-51 dosimetry of lymphocytes labeled
incidentally during nuclear medicine procedures. Int J Rad Appl Instrum B. 14,
75–77.
1986
Adelstein SJ, Bloomer WD, Kassis AI, Sastry KSR.
1986. The potential use of
alpha and Auger-electron emitting radionuclides for therapy. In: Winkler C (Ed).
Nuclear Medicine in Clinical Oncology. Springer-Verlag, Berlin, pp. 408–412.
Adelstein SJ, Kassis AI, Sastry KSR. 1986. Cellular vs. organ approaches to dose
estimates. In: Schlafke-Stelson AT, Watson EE (Eds). Fourth International
Radiopharmaceutical Dosimetry Symposium,
Baverstock
KF, Ell PJ, Gibson CJ, Charlton DE, Lavender JP, Scott D, Rao DV, Sastry KSR,
Veal N. 1986. Meeting Report: Forum on the microdosimetry of
radiopharmaceuticals. Committee on effects of ionising radiation. Int J Radiat
Biol. 50, 555–567.
Benka
O, Uda M. 1986. Resonant electron-transfer relaxation observed in fluorine K Auger spectra. Phys Rev Lett. 56,
1667–1670.
Charlton
DE. 1986. The range of high LET effects from 125I decays. Radiat Res. 107, 163–171.
Charlton
DE. 1986. Local physical effects of radionuclide decay, in meeting report of
forum on the microdosimetry of radiopharmaceuticals, Medical Research Council
Committee on Effects of Ionising Radiation (CEIR). Int J Radiat Biol. 50,
559–560.
Chorkendorff
I, Onsgaard J. 1986. High- and low-energy Auger-electron transitions in
ytterbium and gold: theory and experiments. Phys Rev B. 33, 937–942.
Eberhardt
W, Plummer EW, Lyo IW, Reininger R, Carr R, Ford WK, Sondericker D. 1986. Auger
electron-ion coincidence studies to determine the pathways in soft x-ray
induced fragmentation of isolated molecules. Australian J Phys. 39, 633–648.
Fujimori A, Sekita M, Wada H. 1986. Photoemission and Auger-electron
spectroscopic study of the Chevrel-phase compound FexMo6S8. Phys Rev B. 33, 6652–6661.
Gibson
CJ. 1986. Physical estimates of doses received by lymphocytes labelled with
indium-111, in meeting report of forum on the microdosimetry of
radiopharmaceuticals, Medical Research Council Committee on Effects of Ionising
Radiation (CEIR). Int J Radiat Biol. 50, 558–559.
Hagmann
S, Kelbch S, Cocke CL, Richard P, Skutlartz A, Schmidt-Böcking H, Schuch R,
Johnson B, Meron M, Jones K. 1986. Recoil-charge-state–target-K-Auger-electron coincidences: a
technique to study excitation patterns in K-K charge transfer. Phys Rev A. 34,
2897–2910.
Howell
RW, Sastry KSR, Hill HZ, Rao DV. 1986. Cis-platinum-193m: its microdosimetry
and potential for chemo-Auger combination therapy of cancer. In:
Schlafke-Stelson AT, Watson EE (Eds). Fourth International Radiopharmaceutical
Dosimetry Symposium,
Humm
JL. 1986. Dosimetric aspects of radiolabeled antibodies for tumor therapy. J
Nucl Med. 27, 1490–1497.
Jawad
HH,
Lavender PJ. 1986. White cell scanning using indium-111: distribution of indium and effects
on cell behaviour, in meeting report of forum on the microdosimetry of
radiopharmaceuticals, Medical Research Council Committee on Effects of Ionising
Radiation (CEIR). Int J Radiat Biol. 50, 560–561.
Misra HK, Knaus EE, Wiebe LI, Tyrrell DL. 1986. Synthesis of 131I, 125I,
123I and 82Br labelled 5-halo-1-(2-deoxy-2-fluoro-b-D-arabinofuranosyl) uracils. Int J Rad Appl
Instrum A. 37, 901–905.
Mole
RH. 1986. Biological damage caused by Auger cascades. Lancet. 1, 90-91.
Rao
DV, Govelitz GF, Sastry KSR, Howell RW. 1986. Spermatogonial cell killing by
radiolabeled methionine: a comparative study of the effects of Se-75, S-35, and
H-3. In: Schlafke-Stelson AT, Watson EE (Eds). Fourth International
Radiopharmaceutical Dosimetry Symposium,
Rao
DV, Grimmond H, Sastry KSR. 1986. Biological dosimetry of indium-radiopharmaceuticals
in mouse testes, in meeting report of forum on the microdosimetry of
radiopharmaceuticals, Medical Research Council Committee on Effects of Ionising
Radiation (CEIR). Int J Radiat Biol. 50, 561–562.
Sastry
KSR, Rao DV. 1986. Biological damage caused by Auger cascades. Lancet. 1,
858–859.
Sastry
KSR, Rao DV. 1986. Biological versus conventional dosimetry of thallium-201 in
mouse testis, in meeting report of forum on the microdosimetry of
radiopharmaceuticals, Medical Research Council Committee on Effects of Ionising
Radiation (CEIR). Int J Radiat Biol. 50, 562–563.
Schmidt R, Moenke-Blankenburg L. 1986. Modern physical methods for analysing
elements and structures in histochemistry. Acta Histochem. 80, 205–213.
Scott
D, Wagstaff J, Gibson CJ. 1986. Chromosome damage as a biological dosimeter of
indium-111 in lymphocytes, in meeting report of forum on the microdosimetry of
radiopharmaceuticals, Medical Research Council Committee on Effects of Ionising
Radiation (CEIR). Int J Radiat Biol. 50, 561.
Thakur
ML. 1986. Radiolabeled blood cells: radiation dosimetry and significance. In:
Schlafke-Stelson AT, Watson EE (Eds). Fourth International Radiopharmaceutical
Dosimetry Symposium,
Yasui
LS, Hofer KG. 1986. Role of mitochondrial DNA in cell death induced by 125I
decay. Int J Radiat Biol. 49, 601–610.
1985
Auger
cascades and nuclear medicine. 1985. Lancet. 2, 533–534.
Bhattacharya
J, Datta J, Talukdar B. 1985. Relativistic study of K-shell x-ray and Auger-electron energy shifts for additional
atomic vacancies. Phys Rev A. 32, 941–946.
Bond VP, Varma MN, Sondhaus CA, Feinendegen LE.
1985. An alternative to
absorbed dose, quality, and RBE at low exposures. Radiat Res. 104, S-52–S-57.
Hofer
KG, Warters RL. 1985. Cell lethality after selective irradiation of the DNA
replication fork. Radiat Environ Biophys. 24, 161–174.
Hou
D-Y, Hoch H, Johnston GS, Tsou KC, Jones AE, Farkas RJ, Miller EE, Larson SM.
1985. A new 111In-bleomycin complex for combined radiotherapy and
chemotherapy. J Surg Oncol. 29, 91–98.
Kassis AI, Sastry KSR, Adelstein SJ. 1985. Intracellular distribution and radiotoxicity
of chromium-51 in mammalian cells: Auger-electron dosimetry. J Nucl Med. 26,
59–67.
Kassis AI, Sastry KSR, Adelstein SJ. 1985. Intracellular localisation of Auger electron
emitters: biophysical dosimetry. Radiat Prot Dosimetry. 13, 233–236.
Kassis AI, Adelstein SJ. 1985. Chemotoxicity of indium-111 oxine in
mammalian cells. J Nucl Med. 26, 187–190.
Lavu
S, Reddy PP, Reddi OS. 1985. Chromosomal abnormalities induced by iodine-125 in
mouse germ cells. Int J Radiat Biol. 48, 603–607.
McGuire
EJ. 1985. Angular distributions in Auger-electron-cascade coincidence
measurements. Phys Rev A. 31, 235–249.
Radford
IR, Hodgson GS. 1985. 125I-induced DNA double strand breaks: use in
calibration of the neutral filter elution technique and comparison with X-ray
induced breaks. Int J Radiat Biol. 48, 555–566.
Rao
DV, Sastry KSR, Govelitz GF, Grimmond HE, Hill HZ. 1985. In vivo effects of
iron-55 and iron-59 on mouse testes: biophysical dosimetry of Auger electrons.
J Nucl Med. 26, 1456–1465.
Rao
DV, Sastry KSR, Govelitz GF, Grimmond HE, Hill HZ. 1985. Radiobiological
effects of Auger electron emitters in
vivo: spermatogenesis in mice as an experimental model. Radiat Prot Dosimetry.
13, 245–248.
Sellin
IA. 1985. Projectile K-Auger-electron
production by bare, one-electron, and two-electron ions through zero-degree
Auger spectroscopy. Phys Rev A. 32, 2494–2495.
Shinohara
K, Ohara H, Kobayashi K, Maezawa H, Hieda K, Okada S, Ito T. 1985. Enhanced
killing of HeLa cells pre-labeled with 5-bromodeoxyuridine by monochromatic
synchrotron radiation at 0.9 Å: an evidence for Auger enhancement in mammalian
cells. J Radiat Res. 26, 334–338.
Tiwary
SN, Macek J, Madison DH. 1985. Electron excitation of Auger transitions in
atoms. Phys Rev A. 32, 2541–2543.
Yasui LS, Hofer KG, Warters RL. 1985. Inhomogeneity of the nucleus to 125IUdR cytotoxicity. Radiat Res. 102, 106–118.
1984
Bloomer
WD, McLaughlin WH, Adelstein SJ, Wolf AP. 1984. Therapeutic applications of
Auger and alpha emitting radionuclides. Strahlentherapie. 160, 755–757.
Booz
J. 1984. Microdosimetric basis of individualized cancer radiotherapy by radionuclides
including Auger effect and the photon activation approach. Strahlentherapie.
160, 745–754.
Buraggi GL, Callegaro L, Turrin A, Cascinelli N,
Attili A, Emanuelli H, Gasparini M, Deleide G, Plassio G, Dovis M, Mariani G,
Natali PG, Scassellati GA, Rosa U, Ferrone S. 1984. Immunoscintigraphy with 123I, 99mTc
and 111In-labelled F(ab')2 fragments of monoclonal
antibodies to a human high molecular weight-melanoma associated antigen. J Nucl
Med Allied Sci. 28, 283–295.
Fairchild
RG, Bond VP. 1984. Photon activation therapy. Strahlentherapie. 160, 758–763.
Hanson RN, Seitz DE, Bottaro JC. 1984. Radiohalodestannylation: synthesis of 125I-labeled
17a-E-iodovinylestradiol. Int J Appl Radiat
Isot. 35, 810–812.
Hofer
KG. 1984. Microdosimetry of labelled cells. Dev Nucl Med. 7, 224–243.
Hou
D-Y, Hoch H, Johnston GS, Tsou KC, Jones AE, Farkas RJ, Miller EE. 1984. A new 111In-bleomycin
complex for tumor imaging: preparation, stability, and distribution in
glioma-bearing mice. J Surg Oncol. 25, 168–175.
Humm
JL. 1984. The analysis of Auger electrons released following the decay of
radioisotopes and photoelectric interactions and their contribution to energy deposition,
Report 1932. Kernforschungsanlage, Institut für Medizin, Jülich.
Jeppsson A, Wahren B, Millán JL, Stigbrand T. 1984.
Localization of human tumor
xenografts by 125I-labelled monoclonal and polyclonal antibodies to
placental alkaline phosphatase. In: Stigbrand T, Fishman WH (Eds). Human Alkaline
Phosphatases. Alan R. Liss, Incorporated,
Kalfas
CA, Sideris EG, Martin PW. 1984. Perturbed g–g angular correlation studies of 111In
bound to double and single stranded DNA. Int J Appl Radiat Isot. 35, 889–893.
Marcus
CS. 1984. Re: Labeling with indium-111 has detrimental effects on human
lymphocytes. J Nucl Med. 25, 406.
Roggli
VL, Ingram P, Linton RW, Gutknecht WF, Mastin P, Shelburne JD. 1984. New
techniques for imaging and analyzing lung tissue. Environ Health Perspect. 56,
163–183.
Sastry
KSR, Rao DV. 1984. Dosimetry of low energy electrons. In: Rao DV, Chandra R,
Graham MC (Eds). Physics of Nuclear Medicine: Recent Advances. American
Institute of Physics, Woodbury, NY, pp. 169–208.
ten
Berge RJM, Schellekens PTA, Natarajan AT, Hardeman MR, van Royen EA. 1984.
Reply. J Nucl Med. 25, 407.
Thakur
ML, McAfee JG. 1984. The significance of chromosomal aberrations in
indium-111-labeled lymphocytes. J Nucl Med. 25, 922–927.
1983
Bloomer WD, McLaughlin WH, Milius RA, Weichselbaum
RR, Adelstein SJ. 1983. Estrogen receptor-mediated cytotoxicity using
iodine-125. J Cell Biochem. 21, 39–45.
Cushley
W, Baker JR, Hassan IF, Williamson IH. 1983. On the fidelity of the
lactoperoxidase method of cell membrane radioiodination: an electron
microscopic autoradiographic study. J Immunol Methods. 59, 1–11.
Funck
E, Larsen AN. 1983. The influence from low energy x-rays and Auger electrons on
4pb-g coincidence measurements of
electron-capture-decaying nuclides. Int J Appl Radiat Isot. 34, 565–569.
Hendee
WR. 1983. Particulate radiations emitted during electron capture and isomeric
transitions. J Nucl Med. 24, 1192–1193.
Holt
JA, Lorincz MA, King WJ. 1983. Antibody-recognized [125I]estradiol-receptor
complex in ovarian epithelial carcinoma. Obstet Gynecol. 62, 231–235.
Kassis
AI, Adelstein SJ, Haydock C, Sastry KSR, McElvany KD, Welch MJ. 1983. Radiotoxicity of Auger electrons in the DNA
of mammalian cells: a comparison of 123I with 125I and 77Br.
In:
Broese JJ, Barendsen
GW, Kal HB, Van der Kogel AJ (Eds). Seventh International Congress of Radiation Research, Session E, Dosimetry,
Radionuclides and Technology, Proceedings. Martinus Nijhoff Publishers,
Kassis AI, Adelstein SJ, Haydock C, Sastry KSR.
1983. Thallium-201: an
experimental and a theoretical radiobiological approach to dosimetry. J Nucl
Med. 24, 1164–1175.
Lanir
A, Boss J, Naschitz JE, Yeshurun D. 1983. Analysis of thorotrast granuloma by
scanning Auger microscopy. Clin Chem. 29, 1704.
Liber
HL,
Little
JB. 1983. Effect of LET and microdistribution or radiation on the
transformation in vitro and in vivo. Harvard University, Boston, MA, 9 pp.
Martin
RF, Holmes N. 1983. Use of an 125I-labelled DNA ligand to probe DNA
structure. Nature. 302, 452–454.
Rao
DV, Govelitz GF, Sastry KSR. 1983. Radiotoxicity of thallium-201 in mouse
testes: inadequacy of conventional dosimetry. J Nucl Med. 24, 145–153.
Sundell-Bergman
S, Johanson KJ. 1983. The effects of 125I-triiodothyronine on
mammalian cells. Proceedings of an International Symposium on the Biological Effects
of Low-Level Radiation with Special Regard to Stochastic and Non-Stochastic Effects,
Sutyagina
AA, Perepelitsa VA, Semenenko MN. 1983. Study of the oxidation of sulfur on
palladium electrodes. I. Adsorption and behavior of sulfur in the
electrochemical treatment of electrodes. Zhurnal Fizicheskoi Khimii. 57,
681–684.
ten
Berge RJM, Natarajan AT, Hardeman MR, van Royen EA, Schellekens PTA. 1983. Labeling
with indium-111 has detrimental effects on human lymphocytes: concise
communication. J Nucl Med. 24, 615–620.
1982
Bloomer WD, Adelstein SJ. 1982. Therapeutic
applications of Auger and alpha emitting radionuclides. Radioakt Isot Klin
Forsch. 15, 227–234.
Bloomer WD, Adelstein SJ. 1982. Radiation
toxicology. In: Tu AT (Ed). Survey
of Contemporary Toxicology, vol 2. John Wiley and Sons, Incorporated,
Bloomer WD, McLaughlin WH, Adelstein SJ. 1982. Therapeutic implications of
iodine-125 cytotoxicity. Int J Radiat Oncol Biol Phys. 8, 1903–1908.
Brown
I, Carpenter RN, Mitchell JS. 1982. 6-125I-iodo-2-methyl-1,4-naphthoquinol
bis (diammonium phosphate) as a potential radio-halogenated anti-cancer agent:
in vitro investigations and possible clinical implications. Eur J Nucl Med. 7,
115–120.
Diel JH. 1982. Microdosimetry of internally
deposited radionuclides. Int J Appl Radiat Isot. 33, 967–979.
Fairchild RG, Brill AB, Ettinger KV. 1982. Radiation
enhancement with iodinated deoxyuridine. Invest Radiol. 17, 407–416.
Feinendegen LE, Mühlensiepen H, Porschen W, Booz J.
1982. Acute non-stochastic
effect of very low dose whole-body exposure, a thymidine equivalent serum
factor. Int J Radiat Biol. 41, 139–150.
Hagmar B, Ryd W. 1982. 125IUDR labelling efficiency and cytotoxicity for murine tumours
in vivo and in vitro. Eur J Nucl Med. 7, 108–114.
Holmes
JM. 1982. The toxicity of 125I-5-iodo-2'-deoxyuridine (125IUdR)
to canine tissue culture cells in vitro. J Comp Pathol. 92, 445–456.
Kassis
AI, Adelstein SJ, Haydock C, Sastry KSR, McElvany KD, Welch MJ. 1982. Lethality
of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells.
Radiat Res. 90, 362–373.
LeMotte PK, Adelstein SJ, Little JB. 1982. Malignant transformation induced by
incorporated radionuclides in BALB/3T3 mouse embryo fibroblasts. Proc Natl Acad
Sci USA. 79, 7763–7767.
Scheffel U, Tsan M-F, Mitchell TG, Camargo EE,
Braine H, Ezekowitz MD, Nickoloff EL, Hill-Zobel R, Murphy E, Mclntyre PA.
1982. Human platelets labeled
with In-111 8-hydroxyquinoline: kinetics, distribution, and estimates of
radiation dose. J Nucl Med. 23, 149–156.
Sundell-Bergman
S, Johanson KJ. 1982. Impaired repair capacity of DNA strand breaks induced by 125I-triiodothyronine
in Chinese hamster cells. Biochem Biophys Res Commun. 106, 546–552.
1981
Agrawal PK, Katzer JR, Manogue WH. 1981. Methanation over transition metal catalysts.
III. Co/Al2O3 in sulfur-poisoning studies. J Catal. 69,
327–344.
Bloomer
WD, Adelstein SJ. 1981. Iodine-125 cytotoxicity: implications for therapy and
estimation of radiation risk. Int J Nucl Med Biol. 8, 171–178.
Bloomer WD, McLaughlin WH, Weichselbaum RR, Hanson
RN, Adelstein SJ, Seitz DE. 1981. The role of subcellular localization in assessing the cytotoxicity of
iodine-125 labeled iododeoxyuridine, iodotamoxifen, and iodoantipyrine. J
Radioanal Chem. 65, 209–221.
Charlton
DE, Booz J. 1981. A
Deutzmann R, Stöcklin G. 1981. Chemical effects of iodine-125 decay in
aqueous solution of 5-iodouracil. Ring fragmentation as a consequence of the
Auger effect. Radiat Res. 87, 24–36.
Ettinger
KV, Srirath S, Anunuso CI, Mallard JR. 1981. Lyoluminescent dosimetry of
incorporated low energy beta emitters and of Auger electrons. Department of
Bio-Medical and Physical Bio-Engineering, Univiversity of Aberdeen, Aberdeen,
UK, pp. 1389–1398.
Halpern
SE,
Herskind
C, Jessen KA. 1981. Energy deposition spectra of the primary electrons emitted
by strontium-90, technetium-99m, iodine-125 and -131, pp. 1101–1114. Radiophys.
Laboratory, Aarhus Kommunehosp, Aarhus, Den.
Hofer
KG. 1981. Toxicity of radionuclides as a function of subcellular dose
distribution. Institute of Molecular Biophysics, Florida State University,
Tallahassee, FL, pp. 371–391.
Martin
RF, Haseltine WA. 1981. Range of radiochemical damage to DNA with decay of
iodine-125. Science. 213, 896–898.
Miyazaki
N, Fujiwara Y. 1981. Mutagenic and lethal effects of [5-125I]iodo-2'-deoxyuridine
incorporated into DNA of mammalian cells, and their RBEs. Radiat Res. 88,
456–465.
Ritter
MA. 1981. The radiotoxicity of iodine-125 in ataxia telangiectasia fibroblasts.
Biochim Biophys Acta. 652, 151–159.
Robins
AB,
1980
Bloomer
WD, McLaughlin WH, Weichselbaum RR, Tonnesen GL, Hellman S, Seitz DE, Hanson
RN, Adelstein SJ, Rosner AL, Burstein NA, Nove JJ, Little JB. 1980. Iodine-125-labelled
tamoxifen is differentially cytotoxic to cells containing oestrogen receptors.
Int J Radiat Biol. 38, 197–202.
Bouwman
R, Toneman LH. 1980. An Auger spectroscopic study of radial concentration
profiles in spent Co,Mo/g-Al2O3 hydrodesulfurization catalysts. J Catal. 61, 146–154.
Chmelevsky D, Kellerer AM, Terrissol M, Patau JP.
1980. Proximity functions for
electrons up to 10 keV. Radiat Res. 84, 219–238.
Commerford
SL, Bond VP, Cronkite EP, Reincke U. 1980. Radiotoxicity of intranuclear 125I
atoms not bound to DNA. Int J Radiat Biol. 37, 547–554.
Dillman
LT. 1980. EDISTR: A Computer Program to Obtain a Nuclear Decay Data Base for Radiation
Dosimetry.
Hofer
KG. 1980. Radiation biology and potential therapeutic applications of
radionuclides. Bull Cancer. 67, 343–353.
Hofer
KG. 1980. Biological toxicity of intracellular radionuclide decay. Part of a
coordinated program on radiation biology of Auger emitters and their
therapeutic applications. Final report for the period 15 November 1976– 31
March 1980. Institute of Molecular Biophysics, Florida State University,
Tallahassee, FL, 42 pp.
Kassis AI, Adelstein SJ, Haydock C, Sastry KSR.
1980. Radiotoxicity of 75Se
and 35S: theory and application to a cellular model. Radiat
Res. 84, 407–425.
Matsumoto Y, Soma M, Onishi T, Tamaru K. 1980. State of sulphur on the palladium surface
studied by Auger electron spectroscopy, electron energy loss spectroscopy,
ultraviolet photoelectron spectroscopy and X-ray photoelectron spectroscopy. J
Chem Soc Faraday Trans 1. 76, 1122–1130.
Paschoa
AS, Wrenn ME. 1980. Low-energy electron microdosimetry of cesium-137.
Pontificia Univ. Catol.
Schneiderman MH,
Hofer KG. 1980. The target for
radiation-induced division delay. Radiat Res. 84, 462–476.
Sundell-Bergman
S, Johanson KJ. 1980. Repairable and unrepairable DNA strand breaks induced by
decay of 3H and 125I incorporated into DNA of mammalian
cells. Radiat Environ Biophys. 18, 239–248.
Widman JC, Powsner ER, Plato PA. 1980. Absorbed fractions for photons of 125I
and 129I in the thyroid. Int J Appl Radiat Isot. 31, 421–423.
Wood
BJ, Isakson WE, Wise H. 1980. Kinetic studies of catalyst poisoning during
methanol synthesis at high pressures. Ind Eng Chem Prod Res Dev. 19, 197–204.
1979
Artamonova
KP, Grigor'ev EP, Zolotavin AV, Kamynov SV, Kuz'menko NK, Sergeev VO, Khol'nov
YV, Chechev VP. 1979. Evaluation of characteristics of widely-used
radionuclides with complex decay schemes. Tezisy Dokladov Soveshchaniya po
Yadernoi Spektroskopii i Strukture Atomnogo Yadra. 29, 543–544.
Cranley
K,
Hapke
B, Ithakissios D. 1979. Radioiodinated nucleic acids for tumor imaging. Int J
Nucl Med Biol. 6, 118–121.
Martin
RF, Bradley TR, Hodgson GS. 1979. Cytotoxicity of an 125I-labeled
DNA-binding compound that induces double-stranded DNA breaks. Cancer Res. 39,
3244–3247.
Rossi
HH. 1979. The role of microdosimetry in radiobiology. Radiat Environ Biophys.
17, 29–40.
Stepanenko
VF, Norets TA, Obaturov GM. 1979. Radiobiological importance of low-energy
electrons in the internal irradiation of cells. Radiobiologiya. 19, 577–581.
1978
Bloomer
WD, Adelstein SJ. 1978. 5-(125I)-iododeoxyuridine and the Auger
effect: biological consequences and implications for therapy. Pathobiol Annu.
8, 407–421.
Charlton DE, Booz J, Fidorra J, Smit T, Feinendegen
LE. 1978. Microdosimetry of
radioactive nuclei incorporated into the DNA of mammalian cells. In: Booz J,
Ebert HG (Eds). Sixth Symposium on Microdosimetry,
Haeussler
EN. 1978. Surface and in-depth analysis of biological and organic materials by
ion scattering spectroscopy (ISS). Microsc Acta Suppl. 377–386.
Halpern
A, Mütze B. 1978. Irradiation of micro-organisms with mono-energetic X-rays;
biological consequences of the Auger effect. Int J Radiat Biol. 34,
67–72.
Keough WG, Hofer KG. 1978. An improved method for synthesis and purification of 125I or 131I labeled carrier-free 5-iodo-2'-deoxyuridine. J Label Compd Radiopharm. 14, 83–90.
1977
Bloomer WD, Adelstein SJ. 1977. 5-125I-iododeoxyuridine as
prototype for radionuclide therapy with Auger emitters. Nature. 265, 620–621.
Bloomer WD, Adelstein SJ. 1977. Therapeutic application of iodine-125
labeled iododeoxyuridine in an early ascites tumour model. Curr Top Radiat Res
Q. 12, 513–525.
Booz
J, Smit T. 1977. Local distribution of energy deposition in and around the
follicles of a 125I contaminated thyroid. Curr Top Radiat Res Q. 12,
12–32.
Burki
HJ, Koch C, Wolff S. 1977. Molecular suicide studies of 125I and 3H
disintegration in the DNA of Chinese hamster cells. Curr Top Radiat Res Q. 12,
408–425.
Chan PC, Lisco E, Lisco H, Adelstein SJ. 1977. Cell survival and cytogenetic responses to 125I-UdR
in cultured mammalian cells. Curr Top Radiat Res Q. 12, 426–435.
Feige
Y. 1977. The Auger cascade and therapeutic applications of 125I. Curr Top Radiat
Res Q. 12, 3–11.
Feinendegen LE, Henneberg P, Tisljar-Lentulis G.
1977. DNA strand breakage and
repair in human kidney cells after exposure to incorporated iodine-125 and
cobalt-60 g-rays. Curr Top Radiat Res Q. 12, 436–452.
Halpern A, Deutzmann R, Stöcklin G. 1977. Quantitative ESR-studies of decay-produced
radicals in 5-iododeoxyuridine labeled with 125I, 131I or
tritium: role of the Auger effect. Curr Top Radiat Res Q. 12, 325–334.
Hofer
KG, Keough G, Smith JM. 1977. Biological toxicity of Auger emitters: molecular
fragmentation versus electron irradiation. Curr Top Radiat Res Q. 12, 335–354.
Hughes
WL, Weinblatt AC, Prensky W. 1977. Chromosome damage in Chinese hamster cells
produced by 125I-UdR at the site of its incorporation. Curr Top
Radiat Res Q. 12, 453–471.
Krisch
RE, Darby DM. 1977. Effect of cellular DNA content on 125I and X-ray
damage to E. coli. Int J Radiat
Biol. 32, 603–607.
Krisch RE, Krasin F, Sauri CJ. 1977. DNA breakage, repair, and lethality
accompanying 125I decay in microorganisms. Curr Top Radiat Res Q.
12, 355–368.
Linton
RW, Williams P,
Martin
RF. 1977. Induction of double-stranded breaks in DNA by binding with an 125I-labelled
acridine. Int J Radiat Biol. 32, 491–497.
Painter
RB, Young BR. 1977. Anomalous effects of 125I after its
incorporation into mammalian cell DNA. Curr Top Radiat Res Q. 12, 472–479.
Paulsen
O. 1977. Uptake of 5(125I) iodo-2-deoxyuridine (IDU) in plasma and
cerebrospinal fluid in a case of herpes encephalitis with a comparative study
on the uptake in plasma, cerebrospinal fluid and brain tissue in dogs. Scand J
Infect Dis. 9, 85–89.
Rao
DV, Hallee GJ, Ottlinger ME, Sastry KSR. 1977. Radiations emitted in the decay
of 165Er: a promising medical radionuclide. Med Phys. 4, 177–186.
Stöcklin
G. 1977. Bromine-77 and iodine-123 radiopharmaceuticals. Int J Appl Radiat
Isot. 28, 131–148.
Thakur
ML, Segal AW, Louis L, Welch MJ, Hopkins J, Peters TJ. 1977. Indium-111-labeled
cellular blood components: mechanism of labeling and intracellular location in
human neutrophils. J Nucl Med. 18, 1022–1026.
Tisljar-Lentulis G, Feinendegen LE. 1977. The bromine enhancement ratio in mammalian
cells in vitro and experimental mouse tumours. Curr Top Radiat Res Q. 12,
526–536.
Warters
RL, Hofer KG. 1977. Radionuclide toxicity in cultured mammalian cells:
elucidation of the primary site for radiation-induced division delay. Radiat
Res. 69, 348–358.
Warters
RL, Hofer KG, Harris CR, Smith JM. 1977. Radionuclide toxicity in cultured
mammalian cells: elucidation of the primary site of radiation damage. Curr Top
Radiat Res Q. 12, 389–407.
Willis
KW,
1976
Chan PC, Lisco E, Lisco H, Adelstein SJ. 1976. The radiotoxicity of iodine-125 in mammalian
cells. II. A comparative study on cell survival and cytogenetic responses to 125IUdR, 131IUdR, and 3HTdR. Radiat Res. 67, 332–343.
Keough
G, Hofer KG. 1976. Molecular consequences of the Auger effect: the fate of
iododeoxyuridine following iodine-125 decay. Radiat Res. 67, 224–234.
Krisch RE, Krasin F, Sauri CJ. 1976. DNA breakage, repair and lethality after 125I
decay in rec+ and recA strains of Escherichia coli. Int J Radiat Biol. 29, 37–50.
Turner
GN, Nobis P, Dewey WC. 1976. Fragmentation of chromatin with 125I
radioactive disintegrations. Biophys J. 16, 1003–1012.
Wittry
DB. 1976. Use of coincidence techniques to improve the detection limits of
electron spectroscopy in STEM. Ultramicroscopy. 1, 297–300.
1975
Bloomer WD, Adelstein SJ. 1975. Antineoplastic
effect of iodine-125-labelled iododeoxyuridine. Int J Radiat Biol. 27, 509–511.
Bradley
EW, Chan PC, Adelstein SJ. 1975. The radiotoxicity of iodine-125 in mammalian cells
I. Effects on the survival curve of radioiodine incorporated into DNA. Radiat
Res. 64, 555–563.
Feige
Y, Gavron A. 1975. Microdosimetry of Auger electrons. In: Nygaard OF, Adler HI, Sinclair WK (Eds).
Microdosimetry in Radiation Research: Biomedical, Chemical, and Physical Perspectives.
Academic
Press, New York, pp. 557–569.
Feinendegen LE. 1975. Biological damage from the
Auger effect, possible benefits. Radiat Environ Biophys. 12, 85–99.
Hofer
KG, Harris CR, Smith JM. 1975. Radiotoxicity of intracellular 67Ga, 125I
and 3H: nuclear versus cytoplasmic radiation effects in murine L1210
leukaemia. Int J Radiat Biol. 28, 225–241.
Koch CJ, Burki HJ. 1975. The oxygen-enhancement
ratio for reproductive death induced by 3H or 125I damage
in mammalian cells. Int J Radiat Biol. 28, 417–425.
Krisch RE, Sauri CJ. 1975. Further studies of DNA
damage and lethality from the decay of iodine-125 in bacteriophages. Int J
Radiat Biol. 27, 553–560.
Rao PV.
1975. Inner-shell transition measurements with radioactive atoms. At.
Inner-Shell Processes, Proceedings, vol 2, pp. 1–32.
Seltzer
SM. 1975. The response of scintillation detectors to internally induced
radioactivity. Nucl Instru Methods. 127, 293–304.
Wenzel
M, Wahid AA. 1975. The use of Auger and conversion-electrons for the detection
of g-emitting
radionuclides: chromatographic quality control of radiopharmaceuticals. Int J
Appl Radiat Isot. 26, 119–123.
Wenzel
M, Wahid AA. 1975. Use of Auger and conversion-electrons for the detection of g-emitting radionuclides. Chromatographic
quality control of radiopharmaceuticals. Intl J Appl Radiat Isot. 26, 119–123.
1974
Artamonova KP, Voronkov AA, Grigor'ev EP, Zolotavin
AV, Sergeev VO. 1974. L-Series Auger electron spectra for elements with Z =
66-70. Teor At. At Spektrov Mater Vses Semin., Proceedings, pp. 43–48.
Artamonova KP, Voronkov AA, Grigor'ev EP, Zolotavin
AV, Sergeev VO. 1974. Auger L-series electronic spectra accompanying the decay
of erbium-160, ytterbium-166, ytterbium-169, and lutetium-171. Twenty-fourth
Programma Tezisy Dokl Soveshch Yad Spektrosk Strukt At Yadra, Proceedings, pp.
115–116.
Halpern A, Stöcklin G. 1974. A radiation chemical
resonance effect in solid 5-bromodeoxyuridine; chemical consequences of the
Auger effect. Radiat Res. 58, 329–337.
Krisch RE, Ley RD. 1974. Induction of lethality and
DNA breakage by the decay of iodine-125 in bacteriophage T4. Int J Radiat Biol.
25, 21–30.
Mori C, Koike J, Watanabe T. 1974. A new method of
thin-film thickness measurement using radioisotope Auger electrons. Nucl Instru
Methods. 121, 253–258.
Painter RB, Young BR, Burki HJ. 1974.
Non-repairable strand breaks induced by 125I incorporated into
mammalian DNA. Proc Natl Acad Sci USA. 71, 4836–4838.
Paretzke HG. 1974. An appraisal of the relative importance for radiobiology of effects
of slow electrons. In: Booz J, Ebert HG, Smith GGR (Eds). Fifth Symposium on
Microdosimetry, Report EUR 5452, Proceedings. Luxembourg, CEC, pp.
41–58.
Springer RW, Haas TW. 1974. Auger electron spectroscopy study of cathode
surfaces during activation and poisoning.
1973
Burki HJ, Roots R, Feinendegen LE, Bond VP. 1973. Inactivation of mammalian cells after
disintegrations of 3H or 125I in cell DNA at –196oC.
Int J Radiat Biol. 24, 363–375.
Frisch
OR. 1973. Distinguished nuclear pioneer–1973: Lise Meitner. J Nucl Med. 14, 365–371.
le
Mevel BP, Oldham RK, Wells SA, Herberman RB. 1973. An evaluation of 125I-iododeoxyuridine
as a cellular label for in vitro assays: kinetics of incorporation and
toxicity. J Natl Cancer Inst. 51, 1551–1558.
Martin
RF, Hodgson GS. 1973. Estimation of DNA, RNA and 125I- and 3H-labelled
DNA in the same sample. Anal Biochem. 52, 462–469.
Oshima C, Kawai S. 1973. Auger electron spectroscopy study of
oxidation on lanthanum hexaboride. Appl Phys Lett. 23, 215–216.
Schmidt A, Hotz G. 1973. The occurrence of double-strand breaks in
coliphage T1-DNA by iodine-125 decay. Int J Radiat Biol. 24, 307–313.
Thakur
ML. 1973. The preparation of indium-111 labelled bleomycin for tumour
localisation. Int J Appl Radiat Isot. 24, 357–359.
Wrenn
ME, Howells GP, Hairr LM, Paschoa AS. 1973. Auger electron dosimetry. Health
Phys. 24, 645–653.
1972
Bambynek W, Crasemann B, Fink RW, Freund H-U, Mark
H, Swift CD, Price RE, Rao PV. 1972. X-ray fluorescence yields, Auger, and
Coster-Kronig transition probabilities. Rev Mod Phys. 44, 716–813.
Charlton
DE. 1972. Fluorescence photon and Auger electron spectra. Radiat Res. 50, 455–463.
da
Fonseca AJR, Shaw D, Shaw PFD. 1972. Chemical effects of isomeric transition in
bromoethane mixtures. Radiochim Acta. 17, 81–95.
Hofer KG. 1972. In
vivo effects of methotrexate inhibition of DNA synthesis and cell death in
sensitive and resistant L1210 ascites populations. Chemotherapy. 17, 59–70.
Krisch RE. 1972. Lethal effects of iodine-125 decay
by electron capture in Escherichia coli and
in bacteriophage T1. Int J Radiat Biol. 21, 167–189.
1971
Feinendegen LE, Ertl HH, Bond VP. 1971. Biological toxicity associated with the
Auger effect. Biophysical Aspects of Radiation Quality Symposium, Proceedings,
pp. 419–430.
Hofer
KG, Hughes WL. 1971. Radiotoxicity of intranuclear tritium, 125iodine
and 131iodine. Radiat Res. 47, 94–109.
Porteous
DD. 1971. The toxicity of 125IUdR in cultured mouse BP8 tumour
cells. Br J Cancer. 25, 594–597.
1970
Ertl HH, Feinendegen LE, Heiniger HJ. 1970. Iodine-125, a tracer in cell biology:
physical properties and biological aspects. Phys Med Biol. 15, 447–456.
Martin MJ, Blichert-Toft PH. 1970. Radioactive atoms. Auger-electron, a-, b-, g-, and x-ray data. Nucl Data, Section A. 8,
1–198.
1969
Hofer
KG, Prensky W, Hughes WL. 1969. Death and metastatic distribution of tumor
cells in mice monitored with 125I-iododeoxy-uridine. J Natl Cancer
Inst. 43, 763–773.
1967
Carlson
TA. 1967. Role of Auger processes and electron shake-off in the chemical
consequences of radioactive decay. Nihon Genshiryoku Gakkaishi. 9, 259–266.
1966
Bond
VP, Feinendegen LE. 1966. Intranuclear 3H thymidine: dosimetric, radiobiological and
radiation protection aspects. Health Phys. 12, 1007–1020.
Feinendegen
LE, Bond VP, Hughes WL. 1966. 125I-DU (5-iodo-2'-deoxyuridine) in
autoradiographic studies of cell proliferation. Exp Cell Res. 43, 107–119.
1965
Pentel
L, Tonna EA. 1965. Improved strontium autoradiography of mineralized tissues
with internal conversion and Auger electron emitting Sr85. Lab Invest. 14,
169–172.
1964
Forberg S, Odeblad E, Söremark R, Ullberg S. 1964. Autoradiography with isotopes emitting
conversion electrons and Auger electrons. Acta Radiol Ther Phys Biol. 2,
241–262.
1963
Carlson
TA, White RM. 1963. Mass spectrometric analyses of the ions resulting from the
nuclear decay of CH3I130 and C2H5I131.
Study of xenon–hydrocarbon ions. II. J Chem Phys. 38, 2075–2081.
Carlson
TA, White RM. 1963. Formation of fragment ions from CH3Te125 and
C2H5Te125 following the nuclear decays of CH3I125
and C2H5I125. J Chem Phys. 38, 2930–2934.
1962
Carlson
TA, White RM. 1962. Decomposition of (CH3Xe131)+
following the nuclear decay of CH3I131. J Chem Phys. 36,
2883–2887.
Garfinkel
SB, Hutchinson JMR. 1962. Determination of source self-absorption in the
standardization of electron-capturing radionuclides. Int J Appl Radiat Isot.
13, 629–639.
Kramer
P, de Ridder J, Blok J. 1962. A double proportional counter for absolute
measurements on low energy photons and electrons. Nucl Instru Methods. 15, 289–296.
1960
Meyers
WG, Vanderleeden JC. 1960. Radioiodine-125. J Nucl Med. 1, 149–164.
1939
1935
Bloch
F. 1935. Double electron transitions in x-ray spectra. Phys Rev. 48, 187–192.
1925
Auger P. 1925. Sur les rayons b secondaires produits
dans un gaz par des rayons X. C R Hebd Seances Acad Sci. 180, 65–68.
1923
Meitner L. 1923. Das b-strahlenspektrum von UX1 und seine deutung. Z
Phys. 17, 54–66.